Clinical Approach to Ataxia
<!DOCTYPE html>
<html lang=”en”>
<head>
<meta charset=”UTF-8″>
<meta name=”viewport” content=”width=device-width, initial-scale=1.0″>
<title>Clinical Approach to Ataxia</title>
<link rel=”stylesheet” href=”https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css”>
<link rel=”stylesheet” href=”styles.css”>
</head>
<body>
<div class=”page-wrapper”>
<div class=”tasks-container”>
<!– Hidden radio buttons for task switching –>
<input type=”radio” name=”tasks” id=”task1″ class=”task-control” checked>
<input type=”radio” name=”tasks” id=”task2″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task3″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task4″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task5″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task6″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task7″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task8″ class=”task-control”>
<!– LEFT NAVIGATION PANEL –>
<div class=”tasks-panel”>
<div class=”panel-header”>
<h2 class=”panel-title”>Clinical Approach to Ataxia</h2>
<span class=”panel-subtitle”>Pediatric Comprehensive Framework</span>
</div>
<ul class=”tasks-list”>
<li class=”task-item” data-task-id=”task1″><label class=”task-label” for=”task1″><div class=”task-number”>1</div><div class=”task-text”>Symptom Overview</div><span class=”task-meta-tag tag-overview”>Overview</span></label></li>
<li class=”task-item” data-task-id=”task2″><label class=”task-label” for=”task2″><div class=”task-number”>2</div><div class=”task-text”>Pathophysiology</div><span class=”task-meta-tag tag-pathophys”>Mechanism</span></label></li>
<li class=”task-item” data-task-id=”task3″><label class=”task-label” for=”task3″><div class=”task-number”>3</div><div class=”task-text”>History Taking</div><span class=”task-meta-tag tag-history”>History</span></label></li>
<li class=”task-item” data-task-id=”task4″><label class=”task-label” for=”task4″><div class=”task-number”>4</div><div class=”task-text”>Physical Examination</div><span class=”task-meta-tag tag-examination”>Examination</span></label></li>
<li class=”task-item” data-task-id=”task5″><label class=”task-label” for=”task5″><div class=”task-number”>5</div><div class=”task-text”>Differential Diagnosis</div><span class=”task-meta-tag tag-differential”>Differential</span></label></li>
<li class=”task-item” data-task-id=”task6″><label class=”task-label” for=”task6″><div class=”task-number”>6</div><div class=”task-text”>Investigations</div><span class=”task-meta-tag tag-investigations”>Workup</span></label></li>
<li class=”task-item” data-task-id=”task7″><label class=”task-label” for=”task7″><div class=”task-number”>7</div><div class=”task-text”>Clinical Decision-Making</div><span class=”task-meta-tag tag-decision”>Algorithm</span></label></li>
<li class=”task-item” data-task-id=”task8″><label class=”task-label” for=”task8″><div class=”task-number”>8</div><div class=”task-text”>Pearls and Pitfalls</div><span class=”task-meta-tag tag-pearls”>Summary</span></label></li>
</ul>
</div>
<!– RIGHT CONTENT PANEL –>
<div class=”content-panel”>
<!– ==================== TASK 1: SYMPTOM OVERVIEW ==================== –>
<div class=”task-content” id=”task1-content”>
<div class=”task-header”>
<h1 class=”task-title”>1. Symptom Overview</h1>
<p class=”task-subtitle”>Understanding the clinical significance and classification of ataxia in children</p>
</div>
<div class=”task-body”>
<p>Ataxia is a relatively uncommon but clinically significant presenting symptom in pediatric practice, with acute ataxia occurring in approximately 1 in 100,000 children per year. Among children presenting to emergency departments with acute ataxia, acute cerebellar ataxia (post-infectious) accounts for approximately 30-50% of cases, while drug intoxication represents another 30%. Although most cases of acute ataxia in children are benign and self-limiting, ataxia may be the presenting feature of serious conditions including posterior fossa tumors (which account for approximately 55% of pediatric brain tumors), metabolic emergencies, and stroke. The ability to rapidly distinguish benign from life-threatening causes is essential for the pediatric clinician.</p>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Definition</h4>
<p>Ataxia is the impairment of coordination of voluntary muscle movements, resulting in unsteady, clumsy, or inaccurate motion. It arises from dysfunction of the parts of the nervous system that coordinate movement, most commonly the cerebellum and its connections, but also the sensory pathways (sensory ataxia) or vestibular system (vestibular ataxia). In children, ataxia manifests as gait instability, difficulty with fine motor tasks, dysarthria, and abnormal eye movements.</p>
</div>
</div>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Key Epidemiology</h4>
<ul>
<li><strong>Acute ataxia incidence:</strong> Approximately 1 per 100,000 children per year</li>
<li><strong>Most common cause of acute ataxia:</strong> Acute cerebellar ataxia (post-infectious) — 30-50%</li>
<li><strong>Drug intoxication:</strong> Accounts for approximately 30% of acute presentations</li>
<li><strong>Peak age for acute cerebellar ataxia:</strong> 2-4 years</li>
<li><strong>Posterior fossa tumors:</strong> Represent up to 10% of acute ataxia cases</li>
<li><strong>Hereditary ataxias:</strong> Prevalence approximately 6-10 per 100,000 population</li>
</ul>
</div>
</div>
<h2>Classification by Duration</h2>
<p>Duration-based classification is the most useful initial framework for approaching pediatric ataxia, as it guides the differential diagnosis and urgency of workup.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Category</th>
<th>Duration</th>
<th>Common Causes</th>
<th>Clinical Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Acute</strong></td>
<td>Less than 72 hours onset</td>
<td>Acute cerebellar ataxia, drug intoxication, posterior fossa stroke, acute disseminated encephalomyelitis, brain tumor, trauma</td>
<td>Requires urgent evaluation to exclude life-threatening causes; imaging often indicated</td>
</tr>
<tr>
<td><strong>Acute Recurrent (Episodic)</strong></td>
<td>Repeated discrete episodes with return to baseline</td>
<td>Episodic ataxias (types 1 and 2), migraine-associated ataxia, metabolic disorders (maple syrup urine disease, pyruvate dehydrogenase deficiency), mitochondrial disease</td>
<td>Suggests channelopathy, metabolic disorder, or migraine variant; genetic and metabolic workup indicated</td>
</tr>
<tr>
<td><strong>Chronic Non-Progressive</strong></td>
<td>Present from early life, stable</td>
<td>Cerebral palsy (ataxic type), congenital malformations (Joubert syndrome, Dandy-Walker malformation), chromosomal disorders</td>
<td>Usually reflects static developmental brain abnormality; MRI and genetic evaluation helpful</td>
</tr>
<tr>
<td><strong>Chronic Progressive</strong></td>
<td>Gradual worsening over weeks to years</td>
<td>Posterior fossa tumor, Friedreich ataxia, ataxia-telangiectasia, spinocerebellar ataxias, metabolic disorders, multiple sclerosis</td>
<td>High concern for tumor or neurodegenerative condition; comprehensive workup essential</td>
</tr>
</tbody>
</table>
</div>
<h2>Classification by Anatomical Localization</h2>
<p>Determining the anatomical origin of ataxia helps narrow the differential diagnosis and direct investigations appropriately.</p>
<div class=”grid-3″>
<div class=”grid-item”>
<h3>Cerebellar Ataxia</h3>
<p><strong>Most common type in children</strong></p>
<p><strong>Features:</strong> Wide-based gait, truncal instability, limb dysmetria, intention tremor, dysarthria, nystagmus</p>
<p><strong>Key distinction:</strong> Not worsened by eye closure (Romberg negative)</p>
</div>
<div class=”grid-item”>
<h3>Sensory Ataxia</h3>
<p><strong>Less common in children</strong></p>
<p><strong>Features:</strong> Stamping gait, positive Romberg sign, absent or reduced reflexes, impaired proprioception and vibration sense</p>
<p><strong>Key distinction:</strong> Significantly worse with eyes closed</p>
</div>
<div class=”grid-item”>
<h3>Vestibular Ataxia</h3>
<p><strong>Rare in isolation in children</strong></p>
<p><strong>Features:</strong> Prominent vertigo, nausea, vomiting, tendency to fall to one side, nystagmus (often horizontal)</p>
<p><strong>Key distinction:</strong> Associated with vestibular symptoms</p>
</div>
</div>
<h2>Classification by Cerebellar Localization</h2>
<p>For cerebellar ataxia (the most common type), further localization within the cerebellum provides additional diagnostic information.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Cerebellar Region</th>
<th>Primary Manifestation</th>
<th>Clinical Features</th>
<th>Common Causes</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Midline (Vermis)</strong></td>
<td>Truncal ataxia</td>
<td>Difficulty sitting or standing, wide-based gait, minimal limb involvement</td>
<td>Medulloblastoma, acute cerebellar ataxia, alcohol/drug intoxication</td>
</tr>
<tr>
<td><strong>Hemispheric (Lateral)</strong></td>
<td>Limb ataxia (appendicular)</td>
<td>Dysmetria, intention tremor, dysdiadochokinesia, ipsilateral to lesion</td>
<td>Cerebellar astrocytoma, stroke, abscess, demyelination</td>
</tr>
<tr>
<td><strong>Diffuse/Global</strong></td>
<td>Combined truncal and limb ataxia</td>
<td>Both gait and limb coordination affected, often with dysarthria</td>
<td>Acute cerebellar ataxia, hereditary ataxias, metabolic disorders</td>
</tr>
</tbody>
</table>
</div>
<h2>Age-Specific Considerations</h2>
<p>The differential diagnosis of ataxia varies significantly by age group in pediatric patients.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Age Group</th>
<th>Common Causes</th>
<th>Key Considerations</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Infant (0-12 months)</strong></td>
<td>Congenital malformations (Joubert, Dandy-Walker), metabolic disorders, hypoxic-ischemic injury</td>
<td>May present as developmental delay or hypotonia rather than overt ataxia; early neuroimaging indicated</td>
</tr>
<tr>
<td><strong>Toddler (1-3 years)</strong></td>
<td>Acute cerebellar ataxia (peak incidence), drug ingestion, neuroblastoma (opsoclonus-myoclonus-ataxia), posterior fossa tumors</td>
<td>High suspicion for accidental ingestion; opsoclonus-myoclonus syndrome requires tumor screening</td>
</tr>
<tr>
<td><strong>Preschool and School-age (3-12 years)</strong></td>
<td>Acute cerebellar ataxia, posterior fossa tumors, ataxia-telangiectasia, Friedreich ataxia (later in range)</td>
<td>Progressive ataxia concerning for tumor or hereditary condition</td>
</tr>
<tr>
<td><strong>Adolescent (12-18 years)</strong></td>
<td>Friedreich ataxia, spinocerebellar ataxias, multiple sclerosis, conversion disorder, substance use</td>
<td>Hereditary ataxias often present in this age group; consider psychogenic causes</td>
</tr>
</tbody>
</table>
</div>
<div class=”highlight-box”>
<p><strong>Key Concept — The “Big Three” Causes of Acute Ataxia in Children:</strong></p>
<ul>
<li><strong>Acute cerebellar ataxia (post-infectious):</strong> 30-50% of cases — typically follows viral illness by 1-3 weeks, benign and self-limiting</li>
<li><strong>Drug intoxication:</strong> Up to 30% of cases — anticonvulsants, benzodiazepines, antihistamines, alcohol, and other medications</li>
<li><strong>Posterior fossa lesions:</strong> Approximately 10% of cases — tumors, stroke, hemorrhage; life-threatening and require urgent identification</li>
</ul>
<p>Always exclude drug ingestion and posterior fossa pathology before attributing acute ataxia to a benign post-infectious cause.</p>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 2: PATHOPHYSIOLOGY ==================== –>
<div class=”task-content” id=”task2-content”>
<div class=”task-header”>
<h1 class=”task-title”>2. Pathophysiology and Mechanisms</h1>
<p class=”task-subtitle”>Understanding the neural basis of coordination and how it becomes disrupted</p>
</div>
<div class=”task-body”>
<p>Coordinated movement requires the seamless integration of sensory input, motor planning, and motor execution. The cerebellum serves as the master coordinator, receiving information from multiple sources and providing real-time error correction to ensure smooth, accurate movements. Understanding the normal physiology of coordination helps explain why dysfunction at various points in this system produces ataxia.</p>
<h2>The Coordination Network</h2>
<p>Normal coordination depends on the proper function of three interconnected systems that provide complementary information about body position and movement.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>System</th>
<th>Key Structures</th>
<th>Function</th>
<th>Result of Dysfunction</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Cerebellar System</strong></td>
<td>Cerebellar cortex, deep cerebellar nuclei, cerebellar peduncles</td>
<td>Compares intended movement with actual movement; provides real-time error correction; coordinates timing and sequencing</td>
<td>Cerebellar ataxia — dysmetria, intention tremor, dysdiadochokinesia, wide-based gait</td>
</tr>
<tr>
<td><strong>Sensory (Proprioceptive) System</strong></td>
<td>Peripheral sensory receptors, dorsal columns, medial lemniscus, thalamus, sensory cortex</td>
<td>Provides information about limb position and movement without visual input</td>
<td>Sensory ataxia — positive Romberg, stamping gait, pseudoathetosis</td>
</tr>
<tr>
<td><strong>Vestibular System</strong></td>
<td>Semicircular canals, otolith organs, vestibular nuclei, vestibulocerebellum</td>
<td>Detects head position and acceleration; stabilizes gaze during movement</td>
<td>Vestibular ataxia — vertigo, nystagmus, tendency to fall to one side</td>
</tr>
</tbody>
</table>
</div>
<h2>Cerebellar Anatomy and Function</h2>
<p>The cerebellum can be divided functionally and anatomically into regions with distinct roles in motor coordination.</p>
<div class=”grid-3″>
<div class=”grid-item”>
<h3>Vestibulocerebellum</h3>
<p><strong>Anatomy:</strong> Flocculonodular lobe</p>
<p><strong>Connections:</strong> Vestibular nuclei</p>
<p><strong>Function:</strong> Balance, eye movements, gaze stabilization</p>
<p><strong>Dysfunction:</strong> Truncal ataxia, vertigo, nystagmus</p>
</div>
<div class=”grid-item”>
<h3>Spinocerebellum</h3>
<p><strong>Anatomy:</strong> Vermis and paravermal regions</p>
<p><strong>Connections:</strong> Spinal cord, trigeminal system</p>
<p><strong>Function:</strong> Posture, gait, proximal limb movements</p>
<p><strong>Dysfunction:</strong> Gait ataxia, truncal instability, titubation</p>
</div>
<div class=”grid-item”>
<h3>Cerebrocerebellum</h3>
<p><strong>Anatomy:</strong> Lateral hemispheres</p>
<p><strong>Connections:</strong> Cerebral cortex via pontine nuclei</p>
<p><strong>Function:</strong> Motor planning, fine coordination, timing</p>
<p><strong>Dysfunction:</strong> Limb dysmetria, intention tremor, dysarthria</p>
</div>
</div>
<h2>Information Flow in the Cerebellar Circuit</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Component</th>
<th>Structure</th>
<th>Input/Output</th>
<th>Clinical Relevance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Input: Mossy Fibers</strong></td>
<td>From pontine nuclei, spinal cord, vestibular nuclei</td>
<td>Carry sensory and motor command information to cerebellar cortex</td>
<td>Lesions of input pathways cause ipsilateral ataxia</td>
</tr>
<tr>
<td><strong>Input: Climbing Fibers</strong></td>
<td>From inferior olivary nucleus</td>
<td>Carry error signals; essential for motor learning</td>
<td>Damage impairs motor adaptation and learning</td>
</tr>
<tr>
<td><strong>Processing: Cerebellar Cortex</strong></td>
<td>Purkinje cells, granule cells, interneurons</td>
<td>Integrates information; Purkinje cells provide inhibitory output</td>
<td>Direct damage (tumor, inflammation) causes cerebellar signs</td>
</tr>
<tr>
<td><strong>Output: Deep Cerebellar Nuclei</strong></td>
<td>Dentate, interposed (emboliform/globose), fastigial nuclei</td>
<td>Send excitatory output to thalamus, red nucleus, vestibular nuclei</td>
<td>Lesions cause severe ataxia; crossed output means contralateral symptoms from supratentorial lesions</td>
</tr>
<tr>
<td><strong>Output Pathway: Superior Cerebellar Peduncle</strong></td>
<td>Major efferent tract to thalamus and red nucleus</td>
<td>Crosses midline in midbrain; projects to motor cortex via thalamus</td>
<td>Lesions cause ipsilateral limb ataxia</td>
</tr>
</tbody>
</table>
</div>
<h2>Mechanisms of Ataxia by Condition</h2>
<p>Understanding the specific mechanism by which each condition produces ataxia helps explain the clinical presentation and guides treatment.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Condition</th>
<th>Mechanism of Ataxia</th>
<th>Characteristic Features</th>
<th>Treatment Implication</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Acute Cerebellar Ataxia (Post-infectious)</strong></td>
<td>Immune-mediated inflammation of cerebellar tissue following viral infection; molecular mimicry suspected; transient cerebellar dysfunction</td>
<td>Acute onset 1-3 weeks after viral illness; truncal ataxia predominates; typically resolves completely in weeks to months</td>
<td>Supportive care; corticosteroids may be considered in severe cases; excellent prognosis</td>
</tr>
<tr>
<td><strong>Drug Intoxication</strong></td>
<td>Direct toxic effect on cerebellar Purkinje cells and deep nuclei; dose-dependent depression of cerebellar function; GABAergic drugs particularly implicated</td>
<td>Dose-related severity; often with altered mental status; rapid improvement with elimination of drug</td>
<td>Supportive care; eliminate offending agent; activated charcoal if recent ingestion</td>
</tr>
<tr>
<td><strong>Posterior Fossa Tumors</strong></td>
<td>Direct compression or invasion of cerebellar tissue; obstruction of cerebrospinal fluid flow causing hydrocephalus; increased intracranial pressure</td>
<td>Progressive course; often with signs of raised intracranial pressure (headache, vomiting, papilledema); focal signs depend on tumor location</td>
<td>Urgent neurosurgical evaluation; treatment of hydrocephalus; tumor resection and adjuvant therapy</td>
</tr>
<tr>
<td><strong>Opsoclonus-Myoclonus-Ataxia Syndrome</strong></td>
<td>Paraneoplastic autoimmune process; antibodies against neural antigens cross-react with tumor (neuroblastoma) and cerebellar/brainstem tissue</td>
<td>Triad of chaotic eye movements (opsoclonus), myoclonus, and ataxia; irritability common; tumor often occult</td>
<td>Urgent tumor screening; immunomodulatory therapy (corticosteroids, IVIG, rituximab); tumor resection</td>
</tr>
<tr>
<td><strong>Friedreich Ataxia</strong></td>
<td>Mutation in frataxin gene leads to mitochondrial iron accumulation and oxidative damage; progressive degeneration of dorsal root ganglia, spinocerebellar tracts, and cerebellum</td>
<td>Progressive gait and limb ataxia; areflexia; proprioceptive loss; cardiomyopathy; scoliosis; onset typically before age 25</td>
<td>Supportive care; physical therapy; cardiac monitoring; emerging disease-modifying therapies</td>
</tr>
<tr>
<td><strong>Ataxia-Telangiectasia</strong></td>
<td>Mutation in ATM gene causes defective DNA repair; progressive cerebellar degeneration (Purkinje cell loss); immunodeficiency; cancer predisposition</td>
<td>Progressive ataxia from infancy; oculomotor apraxia; telangiectasias (conjunctival, ears); recurrent sinopulmonary infections; elevated alpha-fetoprotein</td>
<td>Supportive care; infection prevention; cancer surveillance; avoid radiation exposure; no disease-modifying therapy available</td>
</tr>
<tr>
<td><strong>Episodic Ataxia Type 2</strong></td>
<td>Mutation in calcium channel gene (CACNA1A); intermittent cerebellar dysfunction triggered by stress, exercise, or caffeine; interictal nystagmus common</td>
<td>Episodes lasting hours to days; triggered by physical or emotional stress; progressive interictal ataxia may develop; responds to acetazolamide</td>
<td>Acetazolamide highly effective for prevention; avoid triggers; 4-aminopyridine may help</td>
</tr>
<tr>
<td><strong>Acute Disseminated Encephalomyelitis</strong></td>
<td>Post-infectious or post-vaccination immune-mediated demyelination affecting brain and spinal cord; cerebellar white matter involvement produces ataxia</td>
<td>Multifocal neurological deficits; encephalopathy; typically monophasic; MRI shows widespread demyelinating lesions</td>
<td>High-dose corticosteroids; IVIG or plasmapheresis for refractory cases; generally good recovery</td>
</tr>
<tr>
<td><strong>Metabolic Disorders</strong></td>
<td>Accumulation of toxic metabolites or energy failure affecting cerebellum; may be acute (metabolic crisis) or chronic (progressive degeneration)</td>
<td>Often triggered by illness, fasting, or protein intake; may have characteristic odors, acidosis, or hyperammonemia</td>
<td>Acute management of metabolic crisis; dietary modification; substrate reduction or enzyme replacement where available</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Often Overlooked Mechanism: Drug-Induced Cerebellar Toxicity</h4>
<p>Certain medications can cause cerebellar damage that may be <strong>permanent</strong> if not recognized early. Phenytoin toxicity is a classic example — acute toxicity causes reversible ataxia, but chronic exposure can lead to irreversible Purkinje cell loss. Lithium, metronidazole, and cytarabine are other important causes of potentially permanent cerebellar toxicity. Always obtain a detailed medication history and drug levels in any child with ataxia.</p>
</div>
</div>
<h2>Developmental Considerations</h2>
<p>The immature nervous system responds differently to injury than the adult brain, which has important implications for pediatric ataxia.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Developmental Factor</th>
<th>Clinical Implication</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Cerebellar Development Continues Postnatally</strong></td>
<td>The cerebellum is vulnerable to injury during infancy and early childhood; insults during this period may have lasting effects on coordination and motor learning</td>
</tr>
<tr>
<td><strong>Neuroplasticity</strong></td>
<td>Children often recover better from acute cerebellar insults than adults due to greater capacity for neural reorganization; this partly explains the excellent prognosis of acute cerebellar ataxia</td>
</tr>
<tr>
<td><strong>Ongoing Myelination</strong></td>
<td>Cerebellar white matter tracts continue to myelinate throughout childhood; demyelinating conditions may present differently across age groups</td>
</tr>
<tr>
<td><strong>Age-Related Presentation</strong></td>
<td>Younger children may present with regression of motor milestones rather than classic ataxia; careful developmental history is essential</td>
</tr>
</tbody>
</table>
</div>
<div class=”section-divider”>
<div class=”section-divider-icon”><i class=”fa fa-brain”></i></div>
</div>
<h2>Complications of Ataxia Itself</h2>
<p>Beyond the underlying cause, ataxia itself can lead to secondary complications that require attention.</p>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Acute Complications</h3>
<ul>
<li><strong>Falls and trauma:</strong> Risk of head injury and fractures</li>
<li><strong>Aspiration:</strong> If bulbar function affected (dysarthria, dysphagia)</li>
<li><strong>Respiratory compromise:</strong> If severe truncal instability or associated brainstem involvement</li>
</ul>
</div>
<div class=”grid-item”>
<h3>Chronic Complications</h3>
<ul>
<li><strong>Functional limitation:</strong> Difficulty with activities of daily living</li>
<li><strong>Scoliosis:</strong> Particularly in hereditary ataxias (Friedreich ataxia)</li>
<li><strong>Muscle contractures:</strong> From abnormal posturing and limited mobility</li>
<li><strong>Psychosocial impact:</strong> Social isolation, reduced quality of life, depression</li>
</ul>
</div>
</div>
<div class=”highlight-box”>
<p><strong>Key Mechanistic Principle:</strong> Cerebellar lesions cause ipsilateral deficits because the output of the cerebellum crosses twice — once in the superior cerebellar peduncle and again in the corticospinal tract. Supratentorial lesions affecting cerebellar pathways (such as thalamic or cortical lesions) cause contralateral cerebellar signs. In children with unilateral ataxia, localize the lesion before assuming a cerebellar origin.</p>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<html lang=”en”>
<head>
<meta charset=”UTF-8″>
<meta name=”viewport” content=”width=device-width, initial-scale=1.0″>
<title>Clinical Approach to Ataxia</title>
<link rel=”stylesheet” href=”https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css”>
<link rel=”stylesheet” href=”styles.css”>
</head>
<body>
<div class=”page-wrapper”>
<div class=”tasks-container”>
<!– Hidden radio buttons for task switching –>
<input type=”radio” name=”tasks” id=”task1″ class=”task-control” checked>
<input type=”radio” name=”tasks” id=”task2″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task3″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task4″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task5″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task6″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task7″ class=”task-control”>
<input type=”radio” name=”tasks” id=”task8″ class=”task-control”>
<!– LEFT NAVIGATION PANEL –>
<div class=”tasks-panel”>
<div class=”panel-header”>
<h2 class=”panel-title”>Clinical Approach to Ataxia</h2>
<span class=”panel-subtitle”>Pediatric Comprehensive Framework</span>
</div>
<ul class=”tasks-list”>
<li class=”task-item” data-task-id=”task1″><label class=”task-label” for=”task1″><div class=”task-number”>1</div><div class=”task-text”>Symptom Overview</div><span class=”task-meta-tag tag-overview”>Overview</span></label></li>
<li class=”task-item” data-task-id=”task2″><label class=”task-label” for=”task2″><div class=”task-number”>2</div><div class=”task-text”>Pathophysiology</div><span class=”task-meta-tag tag-pathophys”>Mechanism</span></label></li>
<li class=”task-item” data-task-id=”task3″><label class=”task-label” for=”task3″><div class=”task-number”>3</div><div class=”task-text”>History Taking</div><span class=”task-meta-tag tag-history”>History</span></label></li>
<li class=”task-item” data-task-id=”task4″><label class=”task-label” for=”task4″><div class=”task-number”>4</div><div class=”task-text”>Physical Examination</div><span class=”task-meta-tag tag-examination”>Examination</span></label></li>
<li class=”task-item” data-task-id=”task5″><label class=”task-label” for=”task5″><div class=”task-number”>5</div><div class=”task-text”>Differential Diagnosis</div><span class=”task-meta-tag tag-differential”>Differential</span></label></li>
<li class=”task-item” data-task-id=”task6″><label class=”task-label” for=”task6″><div class=”task-number”>6</div><div class=”task-text”>Investigations</div><span class=”task-meta-tag tag-investigations”>Workup</span></label></li>
<li class=”task-item” data-task-id=”task7″><label class=”task-label” for=”task7″><div class=”task-number”>7</div><div class=”task-text”>Clinical Decision-Making</div><span class=”task-meta-tag tag-decision”>Algorithm</span></label></li>
<li class=”task-item” data-task-id=”task8″><label class=”task-label” for=”task8″><div class=”task-number”>8</div><div class=”task-text”>Pearls and Pitfalls</div><span class=”task-meta-tag tag-pearls”>Summary</span></label></li>
</ul>
</div>
<!– RIGHT CONTENT PANEL –>
<div class=”content-panel”>
<!– ==================== TASK 1: SYMPTOM OVERVIEW ==================== –>
<div class=”task-content” id=”task1-content”>
<div class=”task-header”>
<h1 class=”task-title”>1. Symptom Overview</h1>
<p class=”task-subtitle”>Understanding the clinical significance and classification of ataxia in children</p>
</div>
<div class=”task-body”>
<p>Ataxia is a relatively uncommon but clinically significant presenting symptom in pediatric practice, with acute ataxia occurring in approximately 1 in 100,000 children per year. Among children presenting to emergency departments with acute ataxia, acute cerebellar ataxia (post-infectious) accounts for approximately 30-50% of cases, while drug intoxication represents another 30%. Although most cases of acute ataxia in children are benign and self-limiting, ataxia may be the presenting feature of serious conditions including posterior fossa tumors (which account for approximately 55% of pediatric brain tumors), metabolic emergencies, and stroke. The ability to rapidly distinguish benign from life-threatening causes is essential for the pediatric clinician.</p>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Definition</h4>
<p>Ataxia is the impairment of coordination of voluntary muscle movements, resulting in unsteady, clumsy, or inaccurate motion. It arises from dysfunction of the parts of the nervous system that coordinate movement, most commonly the cerebellum and its connections, but also the sensory pathways (sensory ataxia) or vestibular system (vestibular ataxia). In children, ataxia manifests as gait instability, difficulty with fine motor tasks, dysarthria, and abnormal eye movements.</p>
</div>
</div>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Key Epidemiology</h4>
<ul>
<li><strong>Acute ataxia incidence:</strong> Approximately 1 per 100,000 children per year</li>
<li><strong>Most common cause of acute ataxia:</strong> Acute cerebellar ataxia (post-infectious) — 30-50%</li>
<li><strong>Drug intoxication:</strong> Accounts for approximately 30% of acute presentations</li>
<li><strong>Peak age for acute cerebellar ataxia:</strong> 2-4 years</li>
<li><strong>Posterior fossa tumors:</strong> Represent up to 10% of acute ataxia cases</li>
<li><strong>Hereditary ataxias:</strong> Prevalence approximately 6-10 per 100,000 population</li>
</ul>
</div>
</div>
<h2>Classification by Duration</h2>
<p>Duration-based classification is the most useful initial framework for approaching pediatric ataxia, as it guides the differential diagnosis and urgency of workup.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Category</th>
<th>Duration</th>
<th>Common Causes</th>
<th>Clinical Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Acute</strong></td>
<td>Less than 72 hours onset</td>
<td>Acute cerebellar ataxia, drug intoxication, posterior fossa stroke, acute disseminated encephalomyelitis, brain tumor, trauma</td>
<td>Requires urgent evaluation to exclude life-threatening causes; imaging often indicated</td>
</tr>
<tr>
<td><strong>Acute Recurrent (Episodic)</strong></td>
<td>Repeated discrete episodes with return to baseline</td>
<td>Episodic ataxias (types 1 and 2), migraine-associated ataxia, metabolic disorders (maple syrup urine disease, pyruvate dehydrogenase deficiency), mitochondrial disease</td>
<td>Suggests channelopathy, metabolic disorder, or migraine variant; genetic and metabolic workup indicated</td>
</tr>
<tr>
<td><strong>Chronic Non-Progressive</strong></td>
<td>Present from early life, stable</td>
<td>Cerebral palsy (ataxic type), congenital malformations (Joubert syndrome, Dandy-Walker malformation), chromosomal disorders</td>
<td>Usually reflects static developmental brain abnormality; MRI and genetic evaluation helpful</td>
</tr>
<tr>
<td><strong>Chronic Progressive</strong></td>
<td>Gradual worsening over weeks to years</td>
<td>Posterior fossa tumor, Friedreich ataxia, ataxia-telangiectasia, spinocerebellar ataxias, metabolic disorders, multiple sclerosis</td>
<td>High concern for tumor or neurodegenerative condition; comprehensive workup essential</td>
</tr>
</tbody>
</table>
</div>
<h2>Classification by Anatomical Localization</h2>
<p>Determining the anatomical origin of ataxia helps narrow the differential diagnosis and direct investigations appropriately.</p>
<div class=”grid-3″>
<div class=”grid-item”>
<h3>Cerebellar Ataxia</h3>
<p><strong>Most common type in children</strong></p>
<p><strong>Features:</strong> Wide-based gait, truncal instability, limb dysmetria, intention tremor, dysarthria, nystagmus</p>
<p><strong>Key distinction:</strong> Not worsened by eye closure (Romberg negative)</p>
</div>
<div class=”grid-item”>
<h3>Sensory Ataxia</h3>
<p><strong>Less common in children</strong></p>
<p><strong>Features:</strong> Stamping gait, positive Romberg sign, absent or reduced reflexes, impaired proprioception and vibration sense</p>
<p><strong>Key distinction:</strong> Significantly worse with eyes closed</p>
</div>
<div class=”grid-item”>
<h3>Vestibular Ataxia</h3>
<p><strong>Rare in isolation in children</strong></p>
<p><strong>Features:</strong> Prominent vertigo, nausea, vomiting, tendency to fall to one side, nystagmus (often horizontal)</p>
<p><strong>Key distinction:</strong> Associated with vestibular symptoms</p>
</div>
</div>
<h2>Classification by Cerebellar Localization</h2>
<p>For cerebellar ataxia (the most common type), further localization within the cerebellum provides additional diagnostic information.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Cerebellar Region</th>
<th>Primary Manifestation</th>
<th>Clinical Features</th>
<th>Common Causes</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Midline (Vermis)</strong></td>
<td>Truncal ataxia</td>
<td>Difficulty sitting or standing, wide-based gait, minimal limb involvement</td>
<td>Medulloblastoma, acute cerebellar ataxia, alcohol/drug intoxication</td>
</tr>
<tr>
<td><strong>Hemispheric (Lateral)</strong></td>
<td>Limb ataxia (appendicular)</td>
<td>Dysmetria, intention tremor, dysdiadochokinesia, ipsilateral to lesion</td>
<td>Cerebellar astrocytoma, stroke, abscess, demyelination</td>
</tr>
<tr>
<td><strong>Diffuse/Global</strong></td>
<td>Combined truncal and limb ataxia</td>
<td>Both gait and limb coordination affected, often with dysarthria</td>
<td>Acute cerebellar ataxia, hereditary ataxias, metabolic disorders</td>
</tr>
</tbody>
</table>
</div>
<h2>Age-Specific Considerations</h2>
<p>The differential diagnosis of ataxia varies significantly by age group in pediatric patients.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Age Group</th>
<th>Common Causes</th>
<th>Key Considerations</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Infant (0-12 months)</strong></td>
<td>Congenital malformations (Joubert, Dandy-Walker), metabolic disorders, hypoxic-ischemic injury</td>
<td>May present as developmental delay or hypotonia rather than overt ataxia; early neuroimaging indicated</td>
</tr>
<tr>
<td><strong>Toddler (1-3 years)</strong></td>
<td>Acute cerebellar ataxia (peak incidence), drug ingestion, neuroblastoma (opsoclonus-myoclonus-ataxia), posterior fossa tumors</td>
<td>High suspicion for accidental ingestion; opsoclonus-myoclonus syndrome requires tumor screening</td>
</tr>
<tr>
<td><strong>Preschool and School-age (3-12 years)</strong></td>
<td>Acute cerebellar ataxia, posterior fossa tumors, ataxia-telangiectasia, Friedreich ataxia (later in range)</td>
<td>Progressive ataxia concerning for tumor or hereditary condition</td>
</tr>
<tr>
<td><strong>Adolescent (12-18 years)</strong></td>
<td>Friedreich ataxia, spinocerebellar ataxias, multiple sclerosis, conversion disorder, substance use</td>
<td>Hereditary ataxias often present in this age group; consider psychogenic causes</td>
</tr>
</tbody>
</table>
</div>
<div class=”highlight-box”>
<p><strong>Key Concept — The “Big Three” Causes of Acute Ataxia in Children:</strong></p>
<ul>
<li><strong>Acute cerebellar ataxia (post-infectious):</strong> 30-50% of cases — typically follows viral illness by 1-3 weeks, benign and self-limiting</li>
<li><strong>Drug intoxication:</strong> Up to 30% of cases — anticonvulsants, benzodiazepines, antihistamines, alcohol, and other medications</li>
<li><strong>Posterior fossa lesions:</strong> Approximately 10% of cases — tumors, stroke, hemorrhage; life-threatening and require urgent identification</li>
</ul>
<p>Always exclude drug ingestion and posterior fossa pathology before attributing acute ataxia to a benign post-infectious cause.</p>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 2: PATHOPHYSIOLOGY ==================== –>
<div class=”task-content” id=”task2-content”>
<div class=”task-header”>
<h1 class=”task-title”>2. Pathophysiology and Mechanisms</h1>
<p class=”task-subtitle”>Understanding the neural basis of coordination and how it becomes disrupted</p>
</div>
<div class=”task-body”>
<p>Coordinated movement requires the seamless integration of sensory input, motor planning, and motor execution. The cerebellum serves as the master coordinator, receiving information from multiple sources and providing real-time error correction to ensure smooth, accurate movements. Understanding the normal physiology of coordination helps explain why dysfunction at various points in this system produces ataxia.</p>
<h2>The Coordination Network</h2>
<p>Normal coordination depends on the proper function of three interconnected systems that provide complementary information about body position and movement.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>System</th>
<th>Key Structures</th>
<th>Function</th>
<th>Result of Dysfunction</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Cerebellar System</strong></td>
<td>Cerebellar cortex, deep cerebellar nuclei, cerebellar peduncles</td>
<td>Compares intended movement with actual movement; provides real-time error correction; coordinates timing and sequencing</td>
<td>Cerebellar ataxia — dysmetria, intention tremor, dysdiadochokinesia, wide-based gait</td>
</tr>
<tr>
<td><strong>Sensory (Proprioceptive) System</strong></td>
<td>Peripheral sensory receptors, dorsal columns, medial lemniscus, thalamus, sensory cortex</td>
<td>Provides information about limb position and movement without visual input</td>
<td>Sensory ataxia — positive Romberg, stamping gait, pseudoathetosis</td>
</tr>
<tr>
<td><strong>Vestibular System</strong></td>
<td>Semicircular canals, otolith organs, vestibular nuclei, vestibulocerebellum</td>
<td>Detects head position and acceleration; stabilizes gaze during movement</td>
<td>Vestibular ataxia — vertigo, nystagmus, tendency to fall to one side</td>
</tr>
</tbody>
</table>
</div>
<h2>Cerebellar Anatomy and Function</h2>
<p>The cerebellum can be divided functionally and anatomically into regions with distinct roles in motor coordination.</p>
<div class=”grid-3″>
<div class=”grid-item”>
<h3>Vestibulocerebellum</h3>
<p><strong>Anatomy:</strong> Flocculonodular lobe</p>
<p><strong>Connections:</strong> Vestibular nuclei</p>
<p><strong>Function:</strong> Balance, eye movements, gaze stabilization</p>
<p><strong>Dysfunction:</strong> Truncal ataxia, vertigo, nystagmus</p>
</div>
<div class=”grid-item”>
<h3>Spinocerebellum</h3>
<p><strong>Anatomy:</strong> Vermis and paravermal regions</p>
<p><strong>Connections:</strong> Spinal cord, trigeminal system</p>
<p><strong>Function:</strong> Posture, gait, proximal limb movements</p>
<p><strong>Dysfunction:</strong> Gait ataxia, truncal instability, titubation</p>
</div>
<div class=”grid-item”>
<h3>Cerebrocerebellum</h3>
<p><strong>Anatomy:</strong> Lateral hemispheres</p>
<p><strong>Connections:</strong> Cerebral cortex via pontine nuclei</p>
<p><strong>Function:</strong> Motor planning, fine coordination, timing</p>
<p><strong>Dysfunction:</strong> Limb dysmetria, intention tremor, dysarthria</p>
</div>
</div>
<h2>Information Flow in the Cerebellar Circuit</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Component</th>
<th>Structure</th>
<th>Input/Output</th>
<th>Clinical Relevance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Input: Mossy Fibers</strong></td>
<td>From pontine nuclei, spinal cord, vestibular nuclei</td>
<td>Carry sensory and motor command information to cerebellar cortex</td>
<td>Lesions of input pathways cause ipsilateral ataxia</td>
</tr>
<tr>
<td><strong>Input: Climbing Fibers</strong></td>
<td>From inferior olivary nucleus</td>
<td>Carry error signals; essential for motor learning</td>
<td>Damage impairs motor adaptation and learning</td>
</tr>
<tr>
<td><strong>Processing: Cerebellar Cortex</strong></td>
<td>Purkinje cells, granule cells, interneurons</td>
<td>Integrates information; Purkinje cells provide inhibitory output</td>
<td>Direct damage (tumor, inflammation) causes cerebellar signs</td>
</tr>
<tr>
<td><strong>Output: Deep Cerebellar Nuclei</strong></td>
<td>Dentate, interposed (emboliform/globose), fastigial nuclei</td>
<td>Send excitatory output to thalamus, red nucleus, vestibular nuclei</td>
<td>Lesions cause severe ataxia; crossed output means contralateral symptoms from supratentorial lesions</td>
</tr>
<tr>
<td><strong>Output Pathway: Superior Cerebellar Peduncle</strong></td>
<td>Major efferent tract to thalamus and red nucleus</td>
<td>Crosses midline in midbrain; projects to motor cortex via thalamus</td>
<td>Lesions cause ipsilateral limb ataxia</td>
</tr>
</tbody>
</table>
</div>
<h2>Mechanisms of Ataxia by Condition</h2>
<p>Understanding the specific mechanism by which each condition produces ataxia helps explain the clinical presentation and guides treatment.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Condition</th>
<th>Mechanism of Ataxia</th>
<th>Characteristic Features</th>
<th>Treatment Implication</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Acute Cerebellar Ataxia (Post-infectious)</strong></td>
<td>Immune-mediated inflammation of cerebellar tissue following viral infection; molecular mimicry suspected; transient cerebellar dysfunction</td>
<td>Acute onset 1-3 weeks after viral illness; truncal ataxia predominates; typically resolves completely in weeks to months</td>
<td>Supportive care; corticosteroids may be considered in severe cases; excellent prognosis</td>
</tr>
<tr>
<td><strong>Drug Intoxication</strong></td>
<td>Direct toxic effect on cerebellar Purkinje cells and deep nuclei; dose-dependent depression of cerebellar function; GABAergic drugs particularly implicated</td>
<td>Dose-related severity; often with altered mental status; rapid improvement with elimination of drug</td>
<td>Supportive care; eliminate offending agent; activated charcoal if recent ingestion</td>
</tr>
<tr>
<td><strong>Posterior Fossa Tumors</strong></td>
<td>Direct compression or invasion of cerebellar tissue; obstruction of cerebrospinal fluid flow causing hydrocephalus; increased intracranial pressure</td>
<td>Progressive course; often with signs of raised intracranial pressure (headache, vomiting, papilledema); focal signs depend on tumor location</td>
<td>Urgent neurosurgical evaluation; treatment of hydrocephalus; tumor resection and adjuvant therapy</td>
</tr>
<tr>
<td><strong>Opsoclonus-Myoclonus-Ataxia Syndrome</strong></td>
<td>Paraneoplastic autoimmune process; antibodies against neural antigens cross-react with tumor (neuroblastoma) and cerebellar/brainstem tissue</td>
<td>Triad of chaotic eye movements (opsoclonus), myoclonus, and ataxia; irritability common; tumor often occult</td>
<td>Urgent tumor screening; immunomodulatory therapy (corticosteroids, IVIG, rituximab); tumor resection</td>
</tr>
<tr>
<td><strong>Friedreich Ataxia</strong></td>
<td>Mutation in frataxin gene leads to mitochondrial iron accumulation and oxidative damage; progressive degeneration of dorsal root ganglia, spinocerebellar tracts, and cerebellum</td>
<td>Progressive gait and limb ataxia; areflexia; proprioceptive loss; cardiomyopathy; scoliosis; onset typically before age 25</td>
<td>Supportive care; physical therapy; cardiac monitoring; emerging disease-modifying therapies</td>
</tr>
<tr>
<td><strong>Ataxia-Telangiectasia</strong></td>
<td>Mutation in ATM gene causes defective DNA repair; progressive cerebellar degeneration (Purkinje cell loss); immunodeficiency; cancer predisposition</td>
<td>Progressive ataxia from infancy; oculomotor apraxia; telangiectasias (conjunctival, ears); recurrent sinopulmonary infections; elevated alpha-fetoprotein</td>
<td>Supportive care; infection prevention; cancer surveillance; avoid radiation exposure; no disease-modifying therapy available</td>
</tr>
<tr>
<td><strong>Episodic Ataxia Type 2</strong></td>
<td>Mutation in calcium channel gene (CACNA1A); intermittent cerebellar dysfunction triggered by stress, exercise, or caffeine; interictal nystagmus common</td>
<td>Episodes lasting hours to days; triggered by physical or emotional stress; progressive interictal ataxia may develop; responds to acetazolamide</td>
<td>Acetazolamide highly effective for prevention; avoid triggers; 4-aminopyridine may help</td>
</tr>
<tr>
<td><strong>Acute Disseminated Encephalomyelitis</strong></td>
<td>Post-infectious or post-vaccination immune-mediated demyelination affecting brain and spinal cord; cerebellar white matter involvement produces ataxia</td>
<td>Multifocal neurological deficits; encephalopathy; typically monophasic; MRI shows widespread demyelinating lesions</td>
<td>High-dose corticosteroids; IVIG or plasmapheresis for refractory cases; generally good recovery</td>
</tr>
<tr>
<td><strong>Metabolic Disorders</strong></td>
<td>Accumulation of toxic metabolites or energy failure affecting cerebellum; may be acute (metabolic crisis) or chronic (progressive degeneration)</td>
<td>Often triggered by illness, fasting, or protein intake; may have characteristic odors, acidosis, or hyperammonemia</td>
<td>Acute management of metabolic crisis; dietary modification; substrate reduction or enzyme replacement where available</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Often Overlooked Mechanism: Drug-Induced Cerebellar Toxicity</h4>
<p>Certain medications can cause cerebellar damage that may be <strong>permanent</strong> if not recognized early. Phenytoin toxicity is a classic example — acute toxicity causes reversible ataxia, but chronic exposure can lead to irreversible Purkinje cell loss. Lithium, metronidazole, and cytarabine are other important causes of potentially permanent cerebellar toxicity. Always obtain a detailed medication history and drug levels in any child with ataxia.</p>
</div>
</div>
<h2>Developmental Considerations</h2>
<p>The immature nervous system responds differently to injury than the adult brain, which has important implications for pediatric ataxia.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Developmental Factor</th>
<th>Clinical Implication</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Cerebellar Development Continues Postnatally</strong></td>
<td>The cerebellum is vulnerable to injury during infancy and early childhood; insults during this period may have lasting effects on coordination and motor learning</td>
</tr>
<tr>
<td><strong>Neuroplasticity</strong></td>
<td>Children often recover better from acute cerebellar insults than adults due to greater capacity for neural reorganization; this partly explains the excellent prognosis of acute cerebellar ataxia</td>
</tr>
<tr>
<td><strong>Ongoing Myelination</strong></td>
<td>Cerebellar white matter tracts continue to myelinate throughout childhood; demyelinating conditions may present differently across age groups</td>
</tr>
<tr>
<td><strong>Age-Related Presentation</strong></td>
<td>Younger children may present with regression of motor milestones rather than classic ataxia; careful developmental history is essential</td>
</tr>
</tbody>
</table>
</div>
<div class=”section-divider”>
<div class=”section-divider-icon”><i class=”fa fa-brain”></i></div>
</div>
<h2>Complications of Ataxia Itself</h2>
<p>Beyond the underlying cause, ataxia itself can lead to secondary complications that require attention.</p>
<div class=”grid-2″>
<div class=”grid-item”>
<h3>Acute Complications</h3>
<ul>
<li><strong>Falls and trauma:</strong> Risk of head injury and fractures</li>
<li><strong>Aspiration:</strong> If bulbar function affected (dysarthria, dysphagia)</li>
<li><strong>Respiratory compromise:</strong> If severe truncal instability or associated brainstem involvement</li>
</ul>
</div>
<div class=”grid-item”>
<h3>Chronic Complications</h3>
<ul>
<li><strong>Functional limitation:</strong> Difficulty with activities of daily living</li>
<li><strong>Scoliosis:</strong> Particularly in hereditary ataxias (Friedreich ataxia)</li>
<li><strong>Muscle contractures:</strong> From abnormal posturing and limited mobility</li>
<li><strong>Psychosocial impact:</strong> Social isolation, reduced quality of life, depression</li>
</ul>
</div>
</div>
<div class=”highlight-box”>
<p><strong>Key Mechanistic Principle:</strong> Cerebellar lesions cause ipsilateral deficits because the output of the cerebellum crosses twice — once in the superior cerebellar peduncle and again in the corticospinal tract. Supratentorial lesions affecting cerebellar pathways (such as thalamic or cortical lesions) cause contralateral cerebellar signs. In children with unilateral ataxia, localize the lesion before assuming a cerebellar origin.</p>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 3: HISTORY TAKING ==================== –>
<div class=”task-content” id=”task3-content”>
<div class=”task-header”>
<h1 class=”task-title”>3. History Taking</h1>
<p class=”task-subtitle”>A comprehensive approach to eliciting the ataxia history in children</p>
</div>
<div class=”task-body”>
<!– RED FLAGS – MUST BE FIRST –>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Red Flags — Require Urgent Evaluation</h4>
<div class=”grid-2″>
<div>
<ul>
<li><strong>Altered mental status</strong> — Intoxication, encephalitis, raised intracranial pressure</li>
<li><strong>Severe headache or vomiting</strong> — Posterior fossa mass, hydrocephalus</li>
<li><strong>Papilledema or bulging fontanelle</strong> — Raised intracranial pressure</li>
<li><strong>Focal neurological deficits</strong> — Stroke, tumor, demyelination</li>
<li><strong>Neck stiffness</strong> — Meningitis, cerebellar tonsillar herniation</li>
<li><strong>Opsoclonus (chaotic eye movements)</strong> — Neuroblastoma, autoimmune encephalitis</li>
</ul>
</div>
<div>
<ul>
<li><strong>Progressive course over days to weeks</strong> — Tumor, metabolic crisis, neurodegenerative disease</li>
<li><strong>Recent head trauma</strong> — Intracranial hemorrhage, posterior fossa injury</li>
<li><strong>Fever with neurological signs</strong> — Encephalitis, cerebellitis, abscess</li>
<li><strong>Known or suspected ingestion</strong> — Drug toxicity requiring urgent management</li>
<li><strong>Acute hemiparesis or hemiataxia</strong> — Stroke, acute demyelination</li>
<li><strong>Infant with hypotonia and poor feeding</strong> — Metabolic emergency, structural malformation</li>
</ul>
</div>
</div>
</div>
</div>
<!– MNEMONIC –>
<h2>Systematic History: The “WOBBLE” Approach</h2>
<div class=”highlight-box”>
<p>Use the mnemonic <strong>”WOBBLE”</strong> to ensure comprehensive history taking for pediatric ataxia:</p>
<ul>
<li><strong>W</strong> — <strong>When and How:</strong> Exact timing of onset, acute versus gradual, progression over time, episodic or constant</li>
<li><strong>O</strong> — <strong>Other Symptoms:</strong> Headache, vomiting, vision changes, weakness, sensory changes, speech difficulties, behavioral changes</li>
<li><strong>B</strong> — <strong>Before It Started:</strong> Recent illness (viral prodrome), trauma, vaccinations, new medications, dietary changes, fasting</li>
<li><strong>B</strong> — <strong>Background:</strong> Past medical history, developmental milestones, birth history, family history of ataxia or neurological disease</li>
<li><strong>L</strong> — <strong>Look for Ingestion:</strong> Access to medications, household chemicals, alcohol, recreational drugs; detailed medication review</li>
<li><strong>E</strong> — <strong>Effect on Function:</strong> Impact on walking, writing, feeding, speech; comparison to baseline; school performance</li>
</ul>
</div>
<h2>Characterizing the Ataxia</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Characteristic</th>
<th>Questions to Ask</th>
<th>Clinical Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Onset and Tempo</strong></td>
<td>”When did you first notice the unsteadiness?” “Did it come on suddenly or gradually?” “Has it been getting worse, staying the same, or improving?”</td>
<td>Sudden onset suggests vascular, toxic, or infectious cause; gradual progression suggests tumor or degenerative process</td>
</tr>
<tr>
<td><strong>Pattern</strong></td>
<td>”Is the unsteadiness constant or does it come and go?” “If episodic, how long do episodes last?” “What brings on episodes?”</td>
<td>Episodic ataxia suggests channelopathy, migraine variant, or metabolic disorder; constant suggests structural or inflammatory cause</td>
</tr>
<tr>
<td><strong>Distribution</strong></td>
<td>”Is the wobbliness mainly when sitting/standing, or also when reaching for things?” “Is it worse on one side?”</td>
<td>Truncal ataxia suggests midline cerebellar lesion; limb ataxia suggests hemispheric lesion; unilateral suggests focal pathology</td>
</tr>
<tr>
<td><strong>Associated Symptoms</strong></td>
<td>”Has your child had headaches, vomiting, or vision changes?” “Any weakness or numbness?” “Any changes in speech?”</td>
<td>Headache and vomiting suggest raised intracranial pressure; weakness suggests stroke or demyelination; dysarthria localizes to cerebellum</td>
</tr>
</tbody>
</table>
</div>
<h2>Targeted Questions by Suspected Cause</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Suspected Cause</th>
<th>Key Features</th>
<th>Ask This Question</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Acute Cerebellar Ataxia (Post-infectious)</strong></td>
<td>Viral prodrome 1-3 weeks prior; age 2-4 years most common; self-limiting</td>
<td>”Was your child sick with a cold, flu, or stomach bug in the past few weeks?” “Did they have chickenpox or any rash recently?”</td>
</tr>
<tr>
<td><strong>Drug Intoxication</strong></td>
<td>Access to medications; altered mental status; rapid onset</td>
<td>”Could your child have gotten into any medications, even ones in a purse or grandparents’ home?” “Any prescription medicines in the house — especially seizure medications, sleeping pills, or blood pressure pills?”</td>
</tr>
<tr>
<td><strong>Posterior Fossa Tumor</strong></td>
<td>Progressive course; morning headache and vomiting; cranial nerve signs</td>
<td>”Has the walking been getting steadily worse over weeks?” “Does your child wake up with headaches or vomit in the morning?” “Any double vision or face weakness?”</td>
</tr>
<tr>
<td><strong>Opsoclonus-Myoclonus-Ataxia Syndrome</strong></td>
<td>Chaotic eye movements; myoclonic jerks; irritability; median age 18 months</td>
<td>”Have you noticed any unusual eye movements — like the eyes dancing around?” “Any sudden jerky movements of the body?” “Has your child become extremely irritable?”</td>
</tr>
<tr>
<td><strong>Episodic Ataxia</strong></td>
<td>Discrete episodes with return to normal; family history; triggers identifiable</td>
<td>”Does the unsteadiness come in episodes that go away completely?” “Does stress, exercise, or being startled bring it on?” “Does anyone in the family have similar episodes or migraines?”</td>
</tr>
<tr>
<td><strong>Friedreich Ataxia</strong></td>
<td>Progressive gait and limb ataxia; scoliosis; cardiomyopathy; onset before age 25</td>
<td>”Has the walking been slowly getting worse over months to years?” “Does your child have any spine curvature?” “Any heart problems or diabetes in your child or family?”</td>
</tr>
<tr>
<td><strong>Ataxia-Telangiectasia</strong></td>
<td>Progressive ataxia from early childhood; frequent infections; telangiectasias</td>
<td>”Has your child had frequent sinus or lung infections?” “Have you noticed any red streaks in the eyes or on the ears?” “Any family members with similar problems or cancer at a young age?”</td>
</tr>
<tr>
<td><strong>Metabolic Disorder</strong></td>
<td>Episodes triggered by illness or fasting; developmental regression; unusual odors</td>
<td>”Does the ataxia get worse when your child is sick or hasn’t eaten?” “Have you noticed any unusual smells?” “Has your child lost any skills they used to have?”</td>
</tr>
<tr>
<td><strong>Migraine-Associated Ataxia</strong></td>
<td>Episodes with headache, visual aura, vertigo; family history of migraine</td>
<td>”Does your child get headaches with the wobbly episodes?” “Any flashing lights or blind spots before it happens?” “Do migraines run in your family?”</td>
</tr>
<tr>
<td><strong>Conversion Disorder</strong></td>
<td>Inconsistent examination; recent stressor; often adolescent</td>
<td>”Has there been any recent stress at school or home?” “Does the unsteadiness change depending on the situation?” “Has your child missed school because of this?”</td>
</tr>
</tbody>
</table>
</div>
<h2>Pediatric-Specific History Components</h2>
<h3>Birth and Perinatal History</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Component</th>
<th>Questions</th>
<th>Relevance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Pregnancy</strong></td>
<td>Complications, infections, substance use, prenatal care</td>
<td>Congenital infections and teratogens can cause cerebellar malformations</td>
</tr>
<tr>
<td><strong>Delivery</strong></td>
<td>Gestational age, mode of delivery, complications</td>
<td>Prematurity and birth asphyxia are risk factors for cerebellar injury</td>
</tr>
<tr>
<td><strong>Neonatal Period</strong></td>
<td>NICU admission, intubation, seizures, hyperbilirubinemia</td>
<td>Kernicterus, hypoxic-ischemic injury can affect cerebellum</td>
</tr>
</tbody>
</table>
</div>
<h3>Developmental History</h3>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Key Developmental Questions</h4>
<ul>
<li><strong>Gross motor milestones:</strong> When did they sit, crawl, walk independently? Was walking always unsteady or did it develop normally first?</li>
<li><strong>Fine motor milestones:</strong> Can they use utensils, write, button clothes appropriately for age?</li>
<li><strong>Language milestones:</strong> First words, sentences — any speech difficulties or slurring?</li>
<li><strong>Regression:</strong> Has your child lost any skills they previously had? This is a red flag for neurodegenerative disease.</li>
</ul>
</div>
</div>
<h3>Family History</h3>
<p>A detailed three-generation family history is essential, as many ataxias have genetic components.</p>
<div class=”grid-2″>
<div class=”grid-item”>
<h4>Ask About:</h4>
<ul>
<li>Ataxia or “clumsiness” in relatives</li>
<li>Neurological diseases (multiple sclerosis, Parkinson’s, Huntington’s)</li>
<li>Early-onset cardiomyopathy or heart failure</li>
<li>Early-onset diabetes</li>
<li>Childhood cancers (particularly neuroblastoma)</li>
<li>Recurrent infections or immunodeficiency</li>
<li>Consanguinity</li>
<li>Migraines</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Inheritance Patterns to Consider:</h4>
<ul>
<li><strong>Autosomal recessive:</strong> Friedreich ataxia, ataxia-telangiectasia, most metabolic ataxias — parents unaffected but may be carriers</li>
<li><strong>Autosomal dominant:</strong> Spinocerebellar ataxias, episodic ataxias — affected parent present</li>
<li><strong>X-linked:</strong> Rare ataxias — may see affected males in maternal lineage</li>
<li><strong>Mitochondrial:</strong> Variable expression — maternal inheritance pattern</li>
</ul>
</div>
</div>
<h2>Medication and Toxin History</h2>
<div class=”columns”>
<div class=”column”>
<h3>Medications That Cause Ataxia</h3>
<ul>
<li><strong>Anticonvulsants</strong> — Phenytoin (most common), carbamazepine, phenobarbital, valproate, gabapentin</li>
<li><strong>Benzodiazepines</strong> — Diazepam, lorazepam, clonazepam, midazolam</li>
<li><strong>Antihistamines</strong> — Diphenhydramine, promethazine</li>
<li><strong>Lithium</strong> — Toxicity or even therapeutic levels</li>
<li><strong>Chemotherapy</strong> — Cytarabine, 5-fluorouracil</li>
<li><strong>Antibiotics</strong> — Metronidazole (with prolonged use)</li>
<li><strong>Antipsychotics</strong> — May cause extrapyramidal symptoms mimicking ataxia</li>
</ul>
</div>
<div class=”column”>
<h3>Toxins and Substances</h3>
<ul>
<li><strong>Alcohol</strong> — Acute intoxication; also chronic cerebellar degeneration with prolonged use (rare in children)</li>
<li><strong>Lead</strong> — May cause ataxia in chronic exposure</li>
<li><strong>Mercury</strong> — Rare but important neurotoxin</li>
<li><strong>Carbon monoxide</strong> — May cause delayed cerebellar injury</li>
<li><strong>Recreational drugs</strong> — Cannabis, synthetic cannabinoids, solvents (consider in adolescents)</li>
<li><strong>Household products</strong> — Consider accidental ingestion in toddlers</li>
</ul>
</div>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Collateral History Is Essential</h4>
<p>Always obtain history from caregivers, but also interview the child separately when age-appropriate. Adolescents may not disclose substance use or psychosocial stressors in front of parents. Teachers and school nurses can provide valuable information about baseline function and when changes were first noticed. Video recordings from parents showing the ataxic gait or movements can be extremely helpful, especially if symptoms are episodic.</p>
</div>
</div>
<h2>Social and Environmental History</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Domain</th>
<th>Questions</th>
<th>Relevance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>School Performance</strong></td>
<td>Any decline in grades? Difficulty with handwriting or physical education?</td>
<td>May reveal subtle progressive ataxia; also relevant for conversion disorder</td>
</tr>
<tr>
<td><strong>Psychosocial Stressors</strong></td>
<td>Any recent changes at home or school? Bullying, family stress, bereavement?</td>
<td>Conversion disorder is an important consideration, especially in adolescents</td>
</tr>
<tr>
<td><strong>Home Environment</strong></td>
<td>Access to medications? Older siblings with medications? Grandparents’ pill boxes?</td>
<td>Critical for excluding toxic ingestion</td>
</tr>
<tr>
<td><strong>Travel</strong></td>
<td>Recent travel? Endemic area exposures?</td>
<td>Some infectious causes have geographic associations</td>
</tr>
</tbody>
</table>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 4: PHYSICAL EXAMINATION ==================== –>
<div class=”task-content” id=”task4-content”>
<div class=”task-header”>
<h1 class=”task-title”>4. Physical Examination</h1>
<p class=”task-subtitle”>A systematic neurological approach for pediatric ataxia</p>
</div>
<div class=”task-body”>
<div class=”highlight-box”>
<p><strong>Examination Framework:</strong> The examination of a child with ataxia requires a systematic approach that includes general assessment, focused neurological examination (with emphasis on cerebellar testing), and evaluation for signs suggesting specific underlying causes. The examination should be adapted to the child’s age and developmental level.</p>
</div>
<h2>General Inspection</h2>
<ul>
<li><strong>Level of consciousness:</strong> Alert, drowsy, confused — altered mental status suggests intoxication, encephalitis, or raised intracranial pressure</li>
<li><strong>General appearance:</strong> Unwell versus well-appearing; cachexia may suggest malignancy or chronic disease</li>
<li><strong>Posture:</strong> Head tilt (may indicate posterior fossa pathology), truncal instability when sitting</li>
<li><strong>Spontaneous movements:</strong> Myoclonus, tremor, opsoclonus, abnormal posturing</li>
<li><strong>Dysmorphic features:</strong> May suggest genetic syndrome</li>
<li><strong>Skin findings:</strong> Telangiectasias (ataxia-telangiectasia), café-au-lait spots, rashes (post-infectious)</li>
</ul>
<h2>Growth Parameters</h2>
<p>Plot weight, height, and head circumference on appropriate growth charts.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Parameter</th>
<th>Abnormality</th>
<th>Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Weight</strong></td>
<td>Poor weight gain or weight loss</td>
<td>May indicate chronic disease, malignancy, or metabolic disorder</td>
</tr>
<tr>
<td><strong>Height</strong></td>
<td>Short stature</td>
<td>Seen in some genetic ataxia syndromes; chronic disease</td>
</tr>
<tr>
<td><strong>Head Circumference</strong></td>
<td>Macrocephaly (progressive)</td>
<td>Suggests hydrocephalus — posterior fossa tumor until proven otherwise</td>
</tr>
<tr>
<td><strong>Head Circumference</strong></td>
<td>Microcephaly</td>
<td>Suggests congenital brain malformation or early insult</td>
</tr>
</tbody>
</table>
</div>
<h2>Vital Signs</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Age</th>
<th>Heart Rate (bpm)</th>
<th>Respiratory Rate (/min)</th>
<th>Systolic BP (mmHg)</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Infant (1-12 months)</strong></td>
<td>100-150</td>
<td>25-40</td>
<td>80-100</td>
</tr>
<tr>
<td><strong>Toddler (1-3 years)</strong></td>
<td>90-140</td>
<td>20-30</td>
<td>90-105</td>
</tr>
<tr>
<td><strong>Preschool (3-6 years)</strong></td>
<td>80-120</td>
<td>18-25</td>
<td>95-110</td>
</tr>
<tr>
<td><strong>School age (6-12 years)</strong></td>
<td>70-110</td>
<td>16-22</td>
<td>100-115</td>
</tr>
<tr>
<td><strong>Adolescent (12-18 years)</strong></td>
<td>60-100</td>
<td>12-20</td>
<td>110-130</td>
</tr>
</tbody>
</table>
</div>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Vital Sign</th>
<th>What to Look For</th>
<th>Clinical Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Temperature</strong></td>
<td>Fever</td>
<td>Suggests infectious or inflammatory cause (acute cerebellitis, encephalitis, ADEM)</td>
</tr>
<tr>
<td><strong>Heart Rate</strong></td>
<td>Bradycardia</td>
<td>May indicate raised intracranial pressure (Cushing reflex) or drug effect</td>
</tr>
<tr>
<td><strong>Blood Pressure</strong></td>
<td>Hypertension (especially with bradycardia)</td>
<td>Cushing response — suggests raised intracranial pressure; urgent imaging needed</td>
</tr>
<tr>
<td><strong>Respiratory Pattern</strong></td>
<td>Irregular breathing, apnea</td>
<td>Brainstem involvement — medical emergency</td>
</tr>
<tr>
<td><strong>Oxygen Saturation</strong></td>
<td>Desaturation</td>
<td>May indicate aspiration, respiratory depression from intoxication, or severe neurological compromise</td>
</tr>
</tbody>
</table>
</div>
<h2>Head, Eyes, Ears, and Neck</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h4>Head</h4>
<ul>
<li><strong>Fontanelle (if open):</strong> Bulging suggests raised intracranial pressure</li>
<li><strong>Head tilt:</strong> May indicate posterior fossa lesion or CN IV palsy</li>
<li><strong>Trauma signs:</strong> Bruising, swelling (recent or healing)</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Eyes</h4>
<ul>
<li><strong>Pupils:</strong> Unequal or poorly reactive pupils suggest serious pathology</li>
<li><strong>Papilledema:</strong> Indicates raised intracranial pressure — do not delay imaging</li>
<li><strong>Conjunctival telangiectasias:</strong> Pathognomonic for ataxia-telangiectasia (may not appear until age 3-6 years)</li>
<li><strong>Kayser-Fleischer rings:</strong> Wilson disease (rare cause of ataxia)</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Ears</h4>
<ul>
<li><strong>Telangiectasias:</strong> Ataxia-telangiectasia (check ears, neck, antecubital fossae)</li>
<li><strong>Signs of infection:</strong> Mastoiditis can cause cerebellar abscess</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Neck</h4>
<ul>
<li><strong>Meningismus:</strong> Stiff neck suggests meningitis or cerebellar tonsillar herniation</li>
<li><strong>Limited range of motion:</strong> Consider posterior fossa pathology</li>
</ul>
</div>
</div>
<div class=”section-divider”>
<div class=”section-divider-icon”><i class=”fa fa-stethoscope”></i></div>
</div>
<h2>Neurological Examination</h2>
<h3>Mental Status and Speech</h3>
<ul>
<li><strong>Level of alertness:</strong> GCS or AVPU scale; document any fluctuation</li>
<li><strong>Speech:</strong> Listen for cerebellar dysarthria — scanning speech with irregular rhythm and volume; slurred speech may indicate intoxication</li>
<li><strong>Behavior:</strong> Irritability is a key feature of opsoclonus-myoclonus-ataxia syndrome</li>
</ul>
<h3>Cranial Nerves</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Cranial Nerve</th>
<th>How to Test</th>
<th>Abnormality and Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>II – Optic</strong></td>
<td>Fundoscopy, visual fields, visual acuity</td>
<td>Papilledema (raised ICP); visual field defects (supratentorial lesion)</td>
</tr>
<tr>
<td><strong>III, IV, VI – Ocular Motor</strong></td>
<td>Eye movements in all directions; cover test</td>
<td>CN VI palsy (raised ICP or brainstem lesion); CN IV palsy with head tilt; complete CN III palsy (emergency)</td>
</tr>
<tr>
<td><strong>V – Trigeminal</strong></td>
<td>Facial sensation, corneal reflex, jaw clench</td>
<td>Numbness may indicate brainstem or skull base lesion</td>
</tr>
<tr>
<td><strong>VII – Facial</strong></td>
<td>Smile, close eyes tightly, wrinkle forehead</td>
<td>Lower motor neuron weakness suggests brainstem lesion; may see with posterior fossa tumor</td>
</tr>
<tr>
<td><strong>VIII – Vestibulocochlear</strong></td>
<td>Hearing screen, assess for vertigo</td>
<td>Hearing loss and vertigo suggest vestibular/CPA lesion</td>
</tr>
<tr>
<td><strong>IX, X – Glossopharyngeal, Vagus</strong></td>
<td>Gag reflex, palate elevation, voice quality</td>
<td>Bulbar dysfunction suggests brainstem involvement; risk of aspiration</td>
</tr>
<tr>
<td><strong>XII – Hypoglossal</strong></td>
<td>Tongue protrusion, look for fasciculations</td>
<td>Deviation suggests lower motor neuron lesion</td>
</tr>
</tbody>
</table>
</div>
<h3>Eye Movement Abnormalities in Ataxia</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Finding</th>
<th>Description</th>
<th>Conditions</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Nystagmus</strong></td>
<td>Rhythmic oscillation of eyes; note direction and whether it changes with gaze</td>
<td>Cerebellar lesions typically cause gaze-evoked nystagmus; central causes may show vertical or direction-changing nystagmus</td>
</tr>
<tr>
<td><strong>Opsoclonus</strong></td>
<td>Chaotic, multidirectional, conjugate saccadic eye movements (“dancing eyes”)</td>
<td>Opsoclonus-myoclonus-ataxia syndrome — requires urgent neuroblastoma screening</td>
</tr>
<tr>
<td><strong>Oculomotor Apraxia</strong></td>
<td>Difficulty initiating saccades; compensatory head thrusts to shift gaze</td>
<td>Ataxia-telangiectasia, ataxia with oculomotor apraxia types 1 and 2</td>
</tr>
<tr>
<td><strong>Dysmetric Saccades</strong></td>
<td>Overshooting or undershooting when looking at a target</td>
<td>Cerebellar dysfunction</td>
</tr>
<tr>
<td><strong>Slow Saccades</strong></td>
<td>Reduced velocity of rapid eye movements</td>
<td>Spinocerebellar ataxias, ataxia-telangiectasia</td>
</tr>
</tbody>
</table>
</div>
<h2>Cerebellar Examination</h2>
<p>The cerebellar examination is the cornerstone of evaluating ataxia. Tests should be adapted to the child’s age and developmental level.</p>
<h3>Gait Assessment</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Test</th>
<th>How to Perform</th>
<th>What to Look For</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Observation of Walking</strong></td>
<td>Watch child walk across room; observe spontaneous gait first</td>
<td>Wide-based gait; staggering; veering to one side; inability to walk in a straight line</td>
</tr>
<tr>
<td><strong>Tandem Gait</strong></td>
<td>Walk heel-to-toe in a straight line</td>
<td>Highly sensitive for cerebellar dysfunction; difficult for young children normally</td>
</tr>
<tr>
<td><strong>Running</strong></td>
<td>Ask child to run short distance (if safe)</td>
<td>May exaggerate mild ataxia that is not obvious on walking</td>
</tr>
<tr>
<td><strong>Turning</strong></td>
<td>Observe turning while walking</td>
<td>Unsteadiness on turning; wide turn radius</td>
</tr>
</tbody>
</table>
</div>
<h3>Stance and Truncal Stability</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Test</th>
<th>How to Perform</th>
<th>What to Look For</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Standing with Feet Together</strong></td>
<td>Stand with feet together, arms at sides</td>
<td>Truncal sway; inability to maintain position; need to widen base</td>
</tr>
<tr>
<td><strong>Romberg Test</strong></td>
<td>Stand with feet together, eyes closed for 30 seconds</td>
<td>Positive Romberg (falls with eyes closed) suggests sensory ataxia; cerebellar ataxia is present with eyes open AND closed</td>
</tr>
<tr>
<td><strong>Sitting Unsupported</strong></td>
<td>Sit on examination table without using arms</td>
<td>Truncal titubation (rhythmic oscillation); inability to sit unsupported indicates severe truncal ataxia</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Romberg Test Interpretation</h4>
<p><strong>Positive Romberg:</strong> Patient is stable with eyes open but falls with eyes closed → indicates sensory ataxia (proprioceptive loss)</p>
<p><strong>Negative Romberg:</strong> Patient is unsteady with eyes BOTH open and closed → indicates cerebellar ataxia (not dependent on visual input)</p>
<p>The Romberg test helps distinguish cerebellar from sensory ataxia, which is important for directing the diagnostic workup.</p>
</div>
</div>
<h3>Limb Coordination Tests</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Test</th>
<th>How to Perform</th>
<th>What to Look For</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Finger-to-Nose Test</strong></td>
<td>Touch your finger, then your nose repeatedly; test with eyes open, then closed</td>
<td>Dysmetria (past-pointing); intention tremor (worse approaching target); decomposition of movement</td>
</tr>
<tr>
<td><strong>Finger-to-Finger Test</strong></td>
<td>Touch examiner’s finger, which is moved to different positions</td>
<td>Dysmetria; delay in initiating movement</td>
</tr>
<tr>
<td><strong>Heel-to-Shin Test</strong></td>
<td>Run heel down opposite shin from knee to ankle smoothly</td>
<td>Dysmetria; irregular trajectory; tremor</td>
</tr>
<tr>
<td><strong>Rapid Alternating Movements (Dysdiadochokinesia)</strong></td>
<td>Rapidly pronate/supinate hand on thigh; tap fingers rapidly</td>
<td>Irregular rhythm; slowness; breakdown of pattern indicates cerebellar dysfunction</td>
</tr>
<tr>
<td><strong>Rebound Test</strong></td>
<td>Push down on outstretched arms, then suddenly release</td>
<td>Excessive rebound (arms fly up) due to inability to check movement</td>
</tr>
</tbody>
</table>
</div>
<h3>Age-Appropriate Cerebellar Testing</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Age Group</th>
<th>Adaptations</th>
<th>What Can Be Reliably Assessed</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Infant</strong></td>
<td>Observe reaching for objects; assess sitting and supported standing</td>
<td>Truncal stability; hypotonia; reaching accuracy; tremor</td>
</tr>
<tr>
<td><strong>Toddler</strong></td>
<td>Use toys to assess reaching; observe gait and play</td>
<td>Gait pattern; ability to pick up small objects; sitting stability</td>
</tr>
<tr>
<td><strong>Preschool</strong></td>
<td>Make tests into games; “touch my finger then touch your nose”</td>
<td>Most cerebellar tests can be performed with engagement</td>
</tr>
<tr>
<td><strong>School-age and Adolescent</strong></td>
<td>Full adult examination appropriate</td>
<td>Complete cerebellar battery including tandem gait</td>
</tr>
</tbody>
</table>
</div>
<h2>Motor, Sensory, and Reflex Examination</h2>
<h3>Motor Examination</h3>
<ul>
<li><strong>Tone:</strong> Cerebellar lesions typically cause hypotonia on the affected side</li>
<li><strong>Power:</strong> Strength is usually preserved in pure cerebellar disease; weakness suggests additional pathology</li>
<li><strong>Involuntary movements:</strong> Myoclonus (opsoclonus-myoclonus syndrome), tremor, chorea</li>
</ul>
<h3>Sensory Examination</h3>
<ul>
<li><strong>Proprioception:</strong> Test joint position sense (toe/finger position with eyes closed) — impaired in sensory ataxia</li>
<li><strong>Vibration sense:</strong> Test with tuning fork at bony prominences — reduced in Friedreich ataxia and other sensory neuropathies</li>
<li><strong>Light touch and pain:</strong> Usually preserved in cerebellar ataxia; abnormal in spinal cord or peripheral nerve pathology</li>
</ul>
<h3>Reflexes</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Finding</th>
<th>Description</th>
<th>Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Pendular Reflexes</strong></td>
<td>Knee jerk swings back and forth rather than damping quickly</td>
<td>Classic but inconsistent sign of cerebellar dysfunction</td>
</tr>
<tr>
<td><strong>Areflexia</strong></td>
<td>Absent deep tendon reflexes</td>
<td>Friedreich ataxia (areflexia with extensor plantars is characteristic); peripheral neuropathy</td>
</tr>
<tr>
<td><strong>Hyperreflexia</strong></td>
<td>Brisk reflexes with clonus</td>
<td>Upper motor neuron involvement — consider spinal cord pathology, leukodystrophy</td>
</tr>
<tr>
<td><strong>Extensor Plantar Response (Babinski)</strong></td>
<td>Upgoing great toe with fanning of other toes</td>
<td>Corticospinal tract involvement — seen in Friedreich ataxia (combined with areflexia), tumors compressing spinal cord</td>
</tr>
</tbody>
</table>
</div>
<h2>Other Systems Examination</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h4>Cardiovascular</h4>
<ul>
<li><strong>Heart sounds:</strong> Murmur or gallop may indicate cardiomyopathy (Friedreich ataxia)</li>
<li><strong>Signs of heart failure:</strong> Important to screen in hereditary ataxias</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Musculoskeletal</h4>
<ul>
<li><strong>Scoliosis:</strong> Common in Friedreich ataxia and ataxia-telangiectasia</li>
<li><strong>Pes cavus:</strong> High-arched feet seen in Friedreich ataxia, Charcot-Marie-Tooth disease</li>
<li><strong>Contractures:</strong> May develop with chronic motor impairment</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Skin</h4>
<ul>
<li><strong>Telangiectasias:</strong> Conjunctiva, ears, neck — ataxia-telangiectasia</li>
<li><strong>Café-au-lait spots:</strong> Neurofibromatosis (associated with gliomas)</li>
<li><strong>Xanthomas:</strong> Cerebrotendinous xanthomatosis (rare metabolic ataxia)</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Abdominal</h4>
<ul>
<li><strong>Hepatomegaly:</strong> Metabolic disorders, Wilson disease</li>
<li><strong>Abdominal mass:</strong> Neuroblastoma (opsoclonus-myoclonus-ataxia syndrome)</li>
</ul>
</div>
</div>
<h2>Expected Findings by Etiology</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Condition</th>
<th>Cerebellar Signs</th>
<th>Other Key Findings</th>
<th>Typical Age</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Acute Cerebellar Ataxia</strong></td>
<td>Truncal ataxia predominates; gait affected more than limbs; may have nystagmus</td>
<td>Otherwise normal neurological exam; no raised intracranial pressure signs; may have mild irritability</td>
<td>2-4 years</td>
</tr>
<tr>
<td><strong>Drug Intoxication</strong></td>
<td>Global cerebellar dysfunction; dysarthria; nystagmus (often horizontal)</td>
<td>Altered mental status (drowsy or agitated); dilated or constricted pupils depending on drug</td>
<td>Any age</td>
</tr>
<tr>
<td><strong>Posterior Fossa Tumor</strong></td>
<td>Progressive ataxia; may be truncal or limb depending on location</td>
<td>Papilledema; cranial nerve palsies (especially VI, VII); head tilt; macrocephaly; vomiting</td>
<td>Peak 5-9 years</td>
</tr>
<tr>
<td><strong>Opsoclonus-Myoclonus-Ataxia Syndrome</strong></td>
<td>Truncal and limb ataxia</td>
<td>Opsoclonus (chaotic eye movements); myoclonus; marked irritability; may have normal exam between episodes</td>
<td>Median 18 months</td>
</tr>
<tr>
<td><strong>Friedreich Ataxia</strong></td>
<td>Progressive gait and limb ataxia; dysarthria</td>
<td>Areflexia; extensor plantars; loss of vibration/proprioception; scoliosis; pes cavus; cardiomyopathy</td>
<td>Onset before 25 years</td>
</tr>
<tr>
<td><strong>Ataxia-Telangiectasia</strong></td>
<td>Progressive cerebellar ataxia from infancy</td>
<td>Oculomotor apraxia; conjunctival telangiectasias (develop age 3-6); dystonia; chorea may develop</td>
<td>Onset by age 2 years</td>
</tr>
<tr>
<td><strong>Acute Disseminated Encephalomyelitis</strong></td>
<td>Ataxia if cerebellum involved</td>
<td>Encephalopathy; multifocal neurological signs (weakness, sensory loss, optic neuritis)</td>
<td>Any age</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Important Teaching Point</h4>
<p><strong>Normal examination outside of ataxia is possible!</strong> In acute cerebellar ataxia (post-infectious), the examination is often remarkable only for gait and truncal ataxia with minimal other neurological findings. However, <strong>always examine for papilledema and signs of raised intracranial pressure</strong> before attributing acute ataxia to a benign cause. A “normal” examination that includes papilledema, cranial nerve palsies, or altered mental status is not normal and requires urgent imaging.</p>
</div>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<div class=”task-content” id=”task3-content”>
<div class=”task-header”>
<h1 class=”task-title”>3. History Taking</h1>
<p class=”task-subtitle”>A comprehensive approach to eliciting the ataxia history in children</p>
</div>
<div class=”task-body”>
<!– RED FLAGS – MUST BE FIRST –>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Red Flags — Require Urgent Evaluation</h4>
<div class=”grid-2″>
<div>
<ul>
<li><strong>Altered mental status</strong> — Intoxication, encephalitis, raised intracranial pressure</li>
<li><strong>Severe headache or vomiting</strong> — Posterior fossa mass, hydrocephalus</li>
<li><strong>Papilledema or bulging fontanelle</strong> — Raised intracranial pressure</li>
<li><strong>Focal neurological deficits</strong> — Stroke, tumor, demyelination</li>
<li><strong>Neck stiffness</strong> — Meningitis, cerebellar tonsillar herniation</li>
<li><strong>Opsoclonus (chaotic eye movements)</strong> — Neuroblastoma, autoimmune encephalitis</li>
</ul>
</div>
<div>
<ul>
<li><strong>Progressive course over days to weeks</strong> — Tumor, metabolic crisis, neurodegenerative disease</li>
<li><strong>Recent head trauma</strong> — Intracranial hemorrhage, posterior fossa injury</li>
<li><strong>Fever with neurological signs</strong> — Encephalitis, cerebellitis, abscess</li>
<li><strong>Known or suspected ingestion</strong> — Drug toxicity requiring urgent management</li>
<li><strong>Acute hemiparesis or hemiataxia</strong> — Stroke, acute demyelination</li>
<li><strong>Infant with hypotonia and poor feeding</strong> — Metabolic emergency, structural malformation</li>
</ul>
</div>
</div>
</div>
</div>
<!– MNEMONIC –>
<h2>Systematic History: The “WOBBLE” Approach</h2>
<div class=”highlight-box”>
<p>Use the mnemonic <strong>”WOBBLE”</strong> to ensure comprehensive history taking for pediatric ataxia:</p>
<ul>
<li><strong>W</strong> — <strong>When and How:</strong> Exact timing of onset, acute versus gradual, progression over time, episodic or constant</li>
<li><strong>O</strong> — <strong>Other Symptoms:</strong> Headache, vomiting, vision changes, weakness, sensory changes, speech difficulties, behavioral changes</li>
<li><strong>B</strong> — <strong>Before It Started:</strong> Recent illness (viral prodrome), trauma, vaccinations, new medications, dietary changes, fasting</li>
<li><strong>B</strong> — <strong>Background:</strong> Past medical history, developmental milestones, birth history, family history of ataxia or neurological disease</li>
<li><strong>L</strong> — <strong>Look for Ingestion:</strong> Access to medications, household chemicals, alcohol, recreational drugs; detailed medication review</li>
<li><strong>E</strong> — <strong>Effect on Function:</strong> Impact on walking, writing, feeding, speech; comparison to baseline; school performance</li>
</ul>
</div>
<h2>Characterizing the Ataxia</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Characteristic</th>
<th>Questions to Ask</th>
<th>Clinical Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Onset and Tempo</strong></td>
<td>”When did you first notice the unsteadiness?” “Did it come on suddenly or gradually?” “Has it been getting worse, staying the same, or improving?”</td>
<td>Sudden onset suggests vascular, toxic, or infectious cause; gradual progression suggests tumor or degenerative process</td>
</tr>
<tr>
<td><strong>Pattern</strong></td>
<td>”Is the unsteadiness constant or does it come and go?” “If episodic, how long do episodes last?” “What brings on episodes?”</td>
<td>Episodic ataxia suggests channelopathy, migraine variant, or metabolic disorder; constant suggests structural or inflammatory cause</td>
</tr>
<tr>
<td><strong>Distribution</strong></td>
<td>”Is the wobbliness mainly when sitting/standing, or also when reaching for things?” “Is it worse on one side?”</td>
<td>Truncal ataxia suggests midline cerebellar lesion; limb ataxia suggests hemispheric lesion; unilateral suggests focal pathology</td>
</tr>
<tr>
<td><strong>Associated Symptoms</strong></td>
<td>”Has your child had headaches, vomiting, or vision changes?” “Any weakness or numbness?” “Any changes in speech?”</td>
<td>Headache and vomiting suggest raised intracranial pressure; weakness suggests stroke or demyelination; dysarthria localizes to cerebellum</td>
</tr>
</tbody>
</table>
</div>
<h2>Targeted Questions by Suspected Cause</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Suspected Cause</th>
<th>Key Features</th>
<th>Ask This Question</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Acute Cerebellar Ataxia (Post-infectious)</strong></td>
<td>Viral prodrome 1-3 weeks prior; age 2-4 years most common; self-limiting</td>
<td>”Was your child sick with a cold, flu, or stomach bug in the past few weeks?” “Did they have chickenpox or any rash recently?”</td>
</tr>
<tr>
<td><strong>Drug Intoxication</strong></td>
<td>Access to medications; altered mental status; rapid onset</td>
<td>”Could your child have gotten into any medications, even ones in a purse or grandparents’ home?” “Any prescription medicines in the house — especially seizure medications, sleeping pills, or blood pressure pills?”</td>
</tr>
<tr>
<td><strong>Posterior Fossa Tumor</strong></td>
<td>Progressive course; morning headache and vomiting; cranial nerve signs</td>
<td>”Has the walking been getting steadily worse over weeks?” “Does your child wake up with headaches or vomit in the morning?” “Any double vision or face weakness?”</td>
</tr>
<tr>
<td><strong>Opsoclonus-Myoclonus-Ataxia Syndrome</strong></td>
<td>Chaotic eye movements; myoclonic jerks; irritability; median age 18 months</td>
<td>”Have you noticed any unusual eye movements — like the eyes dancing around?” “Any sudden jerky movements of the body?” “Has your child become extremely irritable?”</td>
</tr>
<tr>
<td><strong>Episodic Ataxia</strong></td>
<td>Discrete episodes with return to normal; family history; triggers identifiable</td>
<td>”Does the unsteadiness come in episodes that go away completely?” “Does stress, exercise, or being startled bring it on?” “Does anyone in the family have similar episodes or migraines?”</td>
</tr>
<tr>
<td><strong>Friedreich Ataxia</strong></td>
<td>Progressive gait and limb ataxia; scoliosis; cardiomyopathy; onset before age 25</td>
<td>”Has the walking been slowly getting worse over months to years?” “Does your child have any spine curvature?” “Any heart problems or diabetes in your child or family?”</td>
</tr>
<tr>
<td><strong>Ataxia-Telangiectasia</strong></td>
<td>Progressive ataxia from early childhood; frequent infections; telangiectasias</td>
<td>”Has your child had frequent sinus or lung infections?” “Have you noticed any red streaks in the eyes or on the ears?” “Any family members with similar problems or cancer at a young age?”</td>
</tr>
<tr>
<td><strong>Metabolic Disorder</strong></td>
<td>Episodes triggered by illness or fasting; developmental regression; unusual odors</td>
<td>”Does the ataxia get worse when your child is sick or hasn’t eaten?” “Have you noticed any unusual smells?” “Has your child lost any skills they used to have?”</td>
</tr>
<tr>
<td><strong>Migraine-Associated Ataxia</strong></td>
<td>Episodes with headache, visual aura, vertigo; family history of migraine</td>
<td>”Does your child get headaches with the wobbly episodes?” “Any flashing lights or blind spots before it happens?” “Do migraines run in your family?”</td>
</tr>
<tr>
<td><strong>Conversion Disorder</strong></td>
<td>Inconsistent examination; recent stressor; often adolescent</td>
<td>”Has there been any recent stress at school or home?” “Does the unsteadiness change depending on the situation?” “Has your child missed school because of this?”</td>
</tr>
</tbody>
</table>
</div>
<h2>Pediatric-Specific History Components</h2>
<h3>Birth and Perinatal History</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Component</th>
<th>Questions</th>
<th>Relevance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Pregnancy</strong></td>
<td>Complications, infections, substance use, prenatal care</td>
<td>Congenital infections and teratogens can cause cerebellar malformations</td>
</tr>
<tr>
<td><strong>Delivery</strong></td>
<td>Gestational age, mode of delivery, complications</td>
<td>Prematurity and birth asphyxia are risk factors for cerebellar injury</td>
</tr>
<tr>
<td><strong>Neonatal Period</strong></td>
<td>NICU admission, intubation, seizures, hyperbilirubinemia</td>
<td>Kernicterus, hypoxic-ischemic injury can affect cerebellum</td>
</tr>
</tbody>
</table>
</div>
<h3>Developmental History</h3>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Key Developmental Questions</h4>
<ul>
<li><strong>Gross motor milestones:</strong> When did they sit, crawl, walk independently? Was walking always unsteady or did it develop normally first?</li>
<li><strong>Fine motor milestones:</strong> Can they use utensils, write, button clothes appropriately for age?</li>
<li><strong>Language milestones:</strong> First words, sentences — any speech difficulties or slurring?</li>
<li><strong>Regression:</strong> Has your child lost any skills they previously had? This is a red flag for neurodegenerative disease.</li>
</ul>
</div>
</div>
<h3>Family History</h3>
<p>A detailed three-generation family history is essential, as many ataxias have genetic components.</p>
<div class=”grid-2″>
<div class=”grid-item”>
<h4>Ask About:</h4>
<ul>
<li>Ataxia or “clumsiness” in relatives</li>
<li>Neurological diseases (multiple sclerosis, Parkinson’s, Huntington’s)</li>
<li>Early-onset cardiomyopathy or heart failure</li>
<li>Early-onset diabetes</li>
<li>Childhood cancers (particularly neuroblastoma)</li>
<li>Recurrent infections or immunodeficiency</li>
<li>Consanguinity</li>
<li>Migraines</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Inheritance Patterns to Consider:</h4>
<ul>
<li><strong>Autosomal recessive:</strong> Friedreich ataxia, ataxia-telangiectasia, most metabolic ataxias — parents unaffected but may be carriers</li>
<li><strong>Autosomal dominant:</strong> Spinocerebellar ataxias, episodic ataxias — affected parent present</li>
<li><strong>X-linked:</strong> Rare ataxias — may see affected males in maternal lineage</li>
<li><strong>Mitochondrial:</strong> Variable expression — maternal inheritance pattern</li>
</ul>
</div>
</div>
<h2>Medication and Toxin History</h2>
<div class=”columns”>
<div class=”column”>
<h3>Medications That Cause Ataxia</h3>
<ul>
<li><strong>Anticonvulsants</strong> — Phenytoin (most common), carbamazepine, phenobarbital, valproate, gabapentin</li>
<li><strong>Benzodiazepines</strong> — Diazepam, lorazepam, clonazepam, midazolam</li>
<li><strong>Antihistamines</strong> — Diphenhydramine, promethazine</li>
<li><strong>Lithium</strong> — Toxicity or even therapeutic levels</li>
<li><strong>Chemotherapy</strong> — Cytarabine, 5-fluorouracil</li>
<li><strong>Antibiotics</strong> — Metronidazole (with prolonged use)</li>
<li><strong>Antipsychotics</strong> — May cause extrapyramidal symptoms mimicking ataxia</li>
</ul>
</div>
<div class=”column”>
<h3>Toxins and Substances</h3>
<ul>
<li><strong>Alcohol</strong> — Acute intoxication; also chronic cerebellar degeneration with prolonged use (rare in children)</li>
<li><strong>Lead</strong> — May cause ataxia in chronic exposure</li>
<li><strong>Mercury</strong> — Rare but important neurotoxin</li>
<li><strong>Carbon monoxide</strong> — May cause delayed cerebellar injury</li>
<li><strong>Recreational drugs</strong> — Cannabis, synthetic cannabinoids, solvents (consider in adolescents)</li>
<li><strong>Household products</strong> — Consider accidental ingestion in toddlers</li>
</ul>
</div>
</div>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Collateral History Is Essential</h4>
<p>Always obtain history from caregivers, but also interview the child separately when age-appropriate. Adolescents may not disclose substance use or psychosocial stressors in front of parents. Teachers and school nurses can provide valuable information about baseline function and when changes were first noticed. Video recordings from parents showing the ataxic gait or movements can be extremely helpful, especially if symptoms are episodic.</p>
</div>
</div>
<h2>Social and Environmental History</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Domain</th>
<th>Questions</th>
<th>Relevance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>School Performance</strong></td>
<td>Any decline in grades? Difficulty with handwriting or physical education?</td>
<td>May reveal subtle progressive ataxia; also relevant for conversion disorder</td>
</tr>
<tr>
<td><strong>Psychosocial Stressors</strong></td>
<td>Any recent changes at home or school? Bullying, family stress, bereavement?</td>
<td>Conversion disorder is an important consideration, especially in adolescents</td>
</tr>
<tr>
<td><strong>Home Environment</strong></td>
<td>Access to medications? Older siblings with medications? Grandparents’ pill boxes?</td>
<td>Critical for excluding toxic ingestion</td>
</tr>
<tr>
<td><strong>Travel</strong></td>
<td>Recent travel? Endemic area exposures?</td>
<td>Some infectious causes have geographic associations</td>
</tr>
</tbody>
</table>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 4: PHYSICAL EXAMINATION ==================== –>
<div class=”task-content” id=”task4-content”>
<div class=”task-header”>
<h1 class=”task-title”>4. Physical Examination</h1>
<p class=”task-subtitle”>A systematic neurological approach for pediatric ataxia</p>
</div>
<div class=”task-body”>
<div class=”highlight-box”>
<p><strong>Examination Framework:</strong> The examination of a child with ataxia requires a systematic approach that includes general assessment, focused neurological examination (with emphasis on cerebellar testing), and evaluation for signs suggesting specific underlying causes. The examination should be adapted to the child’s age and developmental level.</p>
</div>
<h2>General Inspection</h2>
<ul>
<li><strong>Level of consciousness:</strong> Alert, drowsy, confused — altered mental status suggests intoxication, encephalitis, or raised intracranial pressure</li>
<li><strong>General appearance:</strong> Unwell versus well-appearing; cachexia may suggest malignancy or chronic disease</li>
<li><strong>Posture:</strong> Head tilt (may indicate posterior fossa pathology), truncal instability when sitting</li>
<li><strong>Spontaneous movements:</strong> Myoclonus, tremor, opsoclonus, abnormal posturing</li>
<li><strong>Dysmorphic features:</strong> May suggest genetic syndrome</li>
<li><strong>Skin findings:</strong> Telangiectasias (ataxia-telangiectasia), café-au-lait spots, rashes (post-infectious)</li>
</ul>
<h2>Growth Parameters</h2>
<p>Plot weight, height, and head circumference on appropriate growth charts.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Parameter</th>
<th>Abnormality</th>
<th>Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Weight</strong></td>
<td>Poor weight gain or weight loss</td>
<td>May indicate chronic disease, malignancy, or metabolic disorder</td>
</tr>
<tr>
<td><strong>Height</strong></td>
<td>Short stature</td>
<td>Seen in some genetic ataxia syndromes; chronic disease</td>
</tr>
<tr>
<td><strong>Head Circumference</strong></td>
<td>Macrocephaly (progressive)</td>
<td>Suggests hydrocephalus — posterior fossa tumor until proven otherwise</td>
</tr>
<tr>
<td><strong>Head Circumference</strong></td>
<td>Microcephaly</td>
<td>Suggests congenital brain malformation or early insult</td>
</tr>
</tbody>
</table>
</div>
<h2>Vital Signs</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Age</th>
<th>Heart Rate (bpm)</th>
<th>Respiratory Rate (/min)</th>
<th>Systolic BP (mmHg)</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Infant (1-12 months)</strong></td>
<td>100-150</td>
<td>25-40</td>
<td>80-100</td>
</tr>
<tr>
<td><strong>Toddler (1-3 years)</strong></td>
<td>90-140</td>
<td>20-30</td>
<td>90-105</td>
</tr>
<tr>
<td><strong>Preschool (3-6 years)</strong></td>
<td>80-120</td>
<td>18-25</td>
<td>95-110</td>
</tr>
<tr>
<td><strong>School age (6-12 years)</strong></td>
<td>70-110</td>
<td>16-22</td>
<td>100-115</td>
</tr>
<tr>
<td><strong>Adolescent (12-18 years)</strong></td>
<td>60-100</td>
<td>12-20</td>
<td>110-130</td>
</tr>
</tbody>
</table>
</div>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Vital Sign</th>
<th>What to Look For</th>
<th>Clinical Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Temperature</strong></td>
<td>Fever</td>
<td>Suggests infectious or inflammatory cause (acute cerebellitis, encephalitis, ADEM)</td>
</tr>
<tr>
<td><strong>Heart Rate</strong></td>
<td>Bradycardia</td>
<td>May indicate raised intracranial pressure (Cushing reflex) or drug effect</td>
</tr>
<tr>
<td><strong>Blood Pressure</strong></td>
<td>Hypertension (especially with bradycardia)</td>
<td>Cushing response — suggests raised intracranial pressure; urgent imaging needed</td>
</tr>
<tr>
<td><strong>Respiratory Pattern</strong></td>
<td>Irregular breathing, apnea</td>
<td>Brainstem involvement — medical emergency</td>
</tr>
<tr>
<td><strong>Oxygen Saturation</strong></td>
<td>Desaturation</td>
<td>May indicate aspiration, respiratory depression from intoxication, or severe neurological compromise</td>
</tr>
</tbody>
</table>
</div>
<h2>Head, Eyes, Ears, and Neck</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h4>Head</h4>
<ul>
<li><strong>Fontanelle (if open):</strong> Bulging suggests raised intracranial pressure</li>
<li><strong>Head tilt:</strong> May indicate posterior fossa lesion or CN IV palsy</li>
<li><strong>Trauma signs:</strong> Bruising, swelling (recent or healing)</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Eyes</h4>
<ul>
<li><strong>Pupils:</strong> Unequal or poorly reactive pupils suggest serious pathology</li>
<li><strong>Papilledema:</strong> Indicates raised intracranial pressure — do not delay imaging</li>
<li><strong>Conjunctival telangiectasias:</strong> Pathognomonic for ataxia-telangiectasia (may not appear until age 3-6 years)</li>
<li><strong>Kayser-Fleischer rings:</strong> Wilson disease (rare cause of ataxia)</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Ears</h4>
<ul>
<li><strong>Telangiectasias:</strong> Ataxia-telangiectasia (check ears, neck, antecubital fossae)</li>
<li><strong>Signs of infection:</strong> Mastoiditis can cause cerebellar abscess</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Neck</h4>
<ul>
<li><strong>Meningismus:</strong> Stiff neck suggests meningitis or cerebellar tonsillar herniation</li>
<li><strong>Limited range of motion:</strong> Consider posterior fossa pathology</li>
</ul>
</div>
</div>
<div class=”section-divider”>
<div class=”section-divider-icon”><i class=”fa fa-stethoscope”></i></div>
</div>
<h2>Neurological Examination</h2>
<h3>Mental Status and Speech</h3>
<ul>
<li><strong>Level of alertness:</strong> GCS or AVPU scale; document any fluctuation</li>
<li><strong>Speech:</strong> Listen for cerebellar dysarthria — scanning speech with irregular rhythm and volume; slurred speech may indicate intoxication</li>
<li><strong>Behavior:</strong> Irritability is a key feature of opsoclonus-myoclonus-ataxia syndrome</li>
</ul>
<h3>Cranial Nerves</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Cranial Nerve</th>
<th>How to Test</th>
<th>Abnormality and Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>II – Optic</strong></td>
<td>Fundoscopy, visual fields, visual acuity</td>
<td>Papilledema (raised ICP); visual field defects (supratentorial lesion)</td>
</tr>
<tr>
<td><strong>III, IV, VI – Ocular Motor</strong></td>
<td>Eye movements in all directions; cover test</td>
<td>CN VI palsy (raised ICP or brainstem lesion); CN IV palsy with head tilt; complete CN III palsy (emergency)</td>
</tr>
<tr>
<td><strong>V – Trigeminal</strong></td>
<td>Facial sensation, corneal reflex, jaw clench</td>
<td>Numbness may indicate brainstem or skull base lesion</td>
</tr>
<tr>
<td><strong>VII – Facial</strong></td>
<td>Smile, close eyes tightly, wrinkle forehead</td>
<td>Lower motor neuron weakness suggests brainstem lesion; may see with posterior fossa tumor</td>
</tr>
<tr>
<td><strong>VIII – Vestibulocochlear</strong></td>
<td>Hearing screen, assess for vertigo</td>
<td>Hearing loss and vertigo suggest vestibular/CPA lesion</td>
</tr>
<tr>
<td><strong>IX, X – Glossopharyngeal, Vagus</strong></td>
<td>Gag reflex, palate elevation, voice quality</td>
<td>Bulbar dysfunction suggests brainstem involvement; risk of aspiration</td>
</tr>
<tr>
<td><strong>XII – Hypoglossal</strong></td>
<td>Tongue protrusion, look for fasciculations</td>
<td>Deviation suggests lower motor neuron lesion</td>
</tr>
</tbody>
</table>
</div>
<h3>Eye Movement Abnormalities in Ataxia</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Finding</th>
<th>Description</th>
<th>Conditions</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Nystagmus</strong></td>
<td>Rhythmic oscillation of eyes; note direction and whether it changes with gaze</td>
<td>Cerebellar lesions typically cause gaze-evoked nystagmus; central causes may show vertical or direction-changing nystagmus</td>
</tr>
<tr>
<td><strong>Opsoclonus</strong></td>
<td>Chaotic, multidirectional, conjugate saccadic eye movements (“dancing eyes”)</td>
<td>Opsoclonus-myoclonus-ataxia syndrome — requires urgent neuroblastoma screening</td>
</tr>
<tr>
<td><strong>Oculomotor Apraxia</strong></td>
<td>Difficulty initiating saccades; compensatory head thrusts to shift gaze</td>
<td>Ataxia-telangiectasia, ataxia with oculomotor apraxia types 1 and 2</td>
</tr>
<tr>
<td><strong>Dysmetric Saccades</strong></td>
<td>Overshooting or undershooting when looking at a target</td>
<td>Cerebellar dysfunction</td>
</tr>
<tr>
<td><strong>Slow Saccades</strong></td>
<td>Reduced velocity of rapid eye movements</td>
<td>Spinocerebellar ataxias, ataxia-telangiectasia</td>
</tr>
</tbody>
</table>
</div>
<h2>Cerebellar Examination</h2>
<p>The cerebellar examination is the cornerstone of evaluating ataxia. Tests should be adapted to the child’s age and developmental level.</p>
<h3>Gait Assessment</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Test</th>
<th>How to Perform</th>
<th>What to Look For</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Observation of Walking</strong></td>
<td>Watch child walk across room; observe spontaneous gait first</td>
<td>Wide-based gait; staggering; veering to one side; inability to walk in a straight line</td>
</tr>
<tr>
<td><strong>Tandem Gait</strong></td>
<td>Walk heel-to-toe in a straight line</td>
<td>Highly sensitive for cerebellar dysfunction; difficult for young children normally</td>
</tr>
<tr>
<td><strong>Running</strong></td>
<td>Ask child to run short distance (if safe)</td>
<td>May exaggerate mild ataxia that is not obvious on walking</td>
</tr>
<tr>
<td><strong>Turning</strong></td>
<td>Observe turning while walking</td>
<td>Unsteadiness on turning; wide turn radius</td>
</tr>
</tbody>
</table>
</div>
<h3>Stance and Truncal Stability</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Test</th>
<th>How to Perform</th>
<th>What to Look For</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Standing with Feet Together</strong></td>
<td>Stand with feet together, arms at sides</td>
<td>Truncal sway; inability to maintain position; need to widen base</td>
</tr>
<tr>
<td><strong>Romberg Test</strong></td>
<td>Stand with feet together, eyes closed for 30 seconds</td>
<td>Positive Romberg (falls with eyes closed) suggests sensory ataxia; cerebellar ataxia is present with eyes open AND closed</td>
</tr>
<tr>
<td><strong>Sitting Unsupported</strong></td>
<td>Sit on examination table without using arms</td>
<td>Truncal titubation (rhythmic oscillation); inability to sit unsupported indicates severe truncal ataxia</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Romberg Test Interpretation</h4>
<p><strong>Positive Romberg:</strong> Patient is stable with eyes open but falls with eyes closed → indicates sensory ataxia (proprioceptive loss)</p>
<p><strong>Negative Romberg:</strong> Patient is unsteady with eyes BOTH open and closed → indicates cerebellar ataxia (not dependent on visual input)</p>
<p>The Romberg test helps distinguish cerebellar from sensory ataxia, which is important for directing the diagnostic workup.</p>
</div>
</div>
<h3>Limb Coordination Tests</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Test</th>
<th>How to Perform</th>
<th>What to Look For</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Finger-to-Nose Test</strong></td>
<td>Touch your finger, then your nose repeatedly; test with eyes open, then closed</td>
<td>Dysmetria (past-pointing); intention tremor (worse approaching target); decomposition of movement</td>
</tr>
<tr>
<td><strong>Finger-to-Finger Test</strong></td>
<td>Touch examiner’s finger, which is moved to different positions</td>
<td>Dysmetria; delay in initiating movement</td>
</tr>
<tr>
<td><strong>Heel-to-Shin Test</strong></td>
<td>Run heel down opposite shin from knee to ankle smoothly</td>
<td>Dysmetria; irregular trajectory; tremor</td>
</tr>
<tr>
<td><strong>Rapid Alternating Movements (Dysdiadochokinesia)</strong></td>
<td>Rapidly pronate/supinate hand on thigh; tap fingers rapidly</td>
<td>Irregular rhythm; slowness; breakdown of pattern indicates cerebellar dysfunction</td>
</tr>
<tr>
<td><strong>Rebound Test</strong></td>
<td>Push down on outstretched arms, then suddenly release</td>
<td>Excessive rebound (arms fly up) due to inability to check movement</td>
</tr>
</tbody>
</table>
</div>
<h3>Age-Appropriate Cerebellar Testing</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Age Group</th>
<th>Adaptations</th>
<th>What Can Be Reliably Assessed</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Infant</strong></td>
<td>Observe reaching for objects; assess sitting and supported standing</td>
<td>Truncal stability; hypotonia; reaching accuracy; tremor</td>
</tr>
<tr>
<td><strong>Toddler</strong></td>
<td>Use toys to assess reaching; observe gait and play</td>
<td>Gait pattern; ability to pick up small objects; sitting stability</td>
</tr>
<tr>
<td><strong>Preschool</strong></td>
<td>Make tests into games; “touch my finger then touch your nose”</td>
<td>Most cerebellar tests can be performed with engagement</td>
</tr>
<tr>
<td><strong>School-age and Adolescent</strong></td>
<td>Full adult examination appropriate</td>
<td>Complete cerebellar battery including tandem gait</td>
</tr>
</tbody>
</table>
</div>
<h2>Motor, Sensory, and Reflex Examination</h2>
<h3>Motor Examination</h3>
<ul>
<li><strong>Tone:</strong> Cerebellar lesions typically cause hypotonia on the affected side</li>
<li><strong>Power:</strong> Strength is usually preserved in pure cerebellar disease; weakness suggests additional pathology</li>
<li><strong>Involuntary movements:</strong> Myoclonus (opsoclonus-myoclonus syndrome), tremor, chorea</li>
</ul>
<h3>Sensory Examination</h3>
<ul>
<li><strong>Proprioception:</strong> Test joint position sense (toe/finger position with eyes closed) — impaired in sensory ataxia</li>
<li><strong>Vibration sense:</strong> Test with tuning fork at bony prominences — reduced in Friedreich ataxia and other sensory neuropathies</li>
<li><strong>Light touch and pain:</strong> Usually preserved in cerebellar ataxia; abnormal in spinal cord or peripheral nerve pathology</li>
</ul>
<h3>Reflexes</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Finding</th>
<th>Description</th>
<th>Significance</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Pendular Reflexes</strong></td>
<td>Knee jerk swings back and forth rather than damping quickly</td>
<td>Classic but inconsistent sign of cerebellar dysfunction</td>
</tr>
<tr>
<td><strong>Areflexia</strong></td>
<td>Absent deep tendon reflexes</td>
<td>Friedreich ataxia (areflexia with extensor plantars is characteristic); peripheral neuropathy</td>
</tr>
<tr>
<td><strong>Hyperreflexia</strong></td>
<td>Brisk reflexes with clonus</td>
<td>Upper motor neuron involvement — consider spinal cord pathology, leukodystrophy</td>
</tr>
<tr>
<td><strong>Extensor Plantar Response (Babinski)</strong></td>
<td>Upgoing great toe with fanning of other toes</td>
<td>Corticospinal tract involvement — seen in Friedreich ataxia (combined with areflexia), tumors compressing spinal cord</td>
</tr>
</tbody>
</table>
</div>
<h2>Other Systems Examination</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h4>Cardiovascular</h4>
<ul>
<li><strong>Heart sounds:</strong> Murmur or gallop may indicate cardiomyopathy (Friedreich ataxia)</li>
<li><strong>Signs of heart failure:</strong> Important to screen in hereditary ataxias</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Musculoskeletal</h4>
<ul>
<li><strong>Scoliosis:</strong> Common in Friedreich ataxia and ataxia-telangiectasia</li>
<li><strong>Pes cavus:</strong> High-arched feet seen in Friedreich ataxia, Charcot-Marie-Tooth disease</li>
<li><strong>Contractures:</strong> May develop with chronic motor impairment</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Skin</h4>
<ul>
<li><strong>Telangiectasias:</strong> Conjunctiva, ears, neck — ataxia-telangiectasia</li>
<li><strong>Café-au-lait spots:</strong> Neurofibromatosis (associated with gliomas)</li>
<li><strong>Xanthomas:</strong> Cerebrotendinous xanthomatosis (rare metabolic ataxia)</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Abdominal</h4>
<ul>
<li><strong>Hepatomegaly:</strong> Metabolic disorders, Wilson disease</li>
<li><strong>Abdominal mass:</strong> Neuroblastoma (opsoclonus-myoclonus-ataxia syndrome)</li>
</ul>
</div>
</div>
<h2>Expected Findings by Etiology</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Condition</th>
<th>Cerebellar Signs</th>
<th>Other Key Findings</th>
<th>Typical Age</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Acute Cerebellar Ataxia</strong></td>
<td>Truncal ataxia predominates; gait affected more than limbs; may have nystagmus</td>
<td>Otherwise normal neurological exam; no raised intracranial pressure signs; may have mild irritability</td>
<td>2-4 years</td>
</tr>
<tr>
<td><strong>Drug Intoxication</strong></td>
<td>Global cerebellar dysfunction; dysarthria; nystagmus (often horizontal)</td>
<td>Altered mental status (drowsy or agitated); dilated or constricted pupils depending on drug</td>
<td>Any age</td>
</tr>
<tr>
<td><strong>Posterior Fossa Tumor</strong></td>
<td>Progressive ataxia; may be truncal or limb depending on location</td>
<td>Papilledema; cranial nerve palsies (especially VI, VII); head tilt; macrocephaly; vomiting</td>
<td>Peak 5-9 years</td>
</tr>
<tr>
<td><strong>Opsoclonus-Myoclonus-Ataxia Syndrome</strong></td>
<td>Truncal and limb ataxia</td>
<td>Opsoclonus (chaotic eye movements); myoclonus; marked irritability; may have normal exam between episodes</td>
<td>Median 18 months</td>
</tr>
<tr>
<td><strong>Friedreich Ataxia</strong></td>
<td>Progressive gait and limb ataxia; dysarthria</td>
<td>Areflexia; extensor plantars; loss of vibration/proprioception; scoliosis; pes cavus; cardiomyopathy</td>
<td>Onset before 25 years</td>
</tr>
<tr>
<td><strong>Ataxia-Telangiectasia</strong></td>
<td>Progressive cerebellar ataxia from infancy</td>
<td>Oculomotor apraxia; conjunctival telangiectasias (develop age 3-6); dystonia; chorea may develop</td>
<td>Onset by age 2 years</td>
</tr>
<tr>
<td><strong>Acute Disseminated Encephalomyelitis</strong></td>
<td>Ataxia if cerebellum involved</td>
<td>Encephalopathy; multifocal neurological signs (weakness, sensory loss, optic neuritis)</td>
<td>Any age</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Important Teaching Point</h4>
<p><strong>Normal examination outside of ataxia is possible!</strong> In acute cerebellar ataxia (post-infectious), the examination is often remarkable only for gait and truncal ataxia with minimal other neurological findings. However, <strong>always examine for papilledema and signs of raised intracranial pressure</strong> before attributing acute ataxia to a benign cause. A “normal” examination that includes papilledema, cranial nerve palsies, or altered mental status is not normal and requires urgent imaging.</p>
</div>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 5: DIFFERENTIAL DIAGNOSIS ==================== –>
<div class=”task-content” id=”task5-content”>
<div class=”task-header”>
<h1 class=”task-title”>5. Differential Diagnosis</h1>
<p class=”task-subtitle”>Systematic approach organized by probability, duration, and clinical features</p>
</div>
<div class=”task-body”>
<p>The differential diagnosis of pediatric ataxia is broad, but a systematic approach based on duration of symptoms, age of the child, and associated features allows for efficient prioritization. The key clinical question is: <strong>Is this an emergency requiring immediate intervention, or can workup proceed in a measured fashion?</strong></p>
<h2>Acute Ataxia (Onset within 72 hours)</h2>
<p>Acute ataxia in a previously well child requires urgent evaluation to exclude life-threatening causes before considering benign etiologies.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Probability</th>
<th>Condition</th>
<th>Key Features</th>
<th>Red Flags</th>
</tr>
</thead>
<tbody>
<tr class=”bg-common”>
<td rowspan=”3″><strong>COMMON<br>(approximately 60-70%)</strong></td>
<td><strong>Acute Cerebellar Ataxia (Post-infectious)</strong></td>
<td>Age 2-4 years; viral prodrome 1-3 weeks prior (varicella, Epstein-Barr virus, enterovirus); truncal ataxia predominates; otherwise well-appearing</td>
<td>Diagnosis of exclusion — must rule out other causes first</td>
</tr>
<tr class=”bg-common”>
<td><strong>Drug Intoxication/Toxicity</strong></td>
<td>Access to medications; altered mental status; anticonvulsants, benzodiazepines, antihistamines most common; rapid onset</td>
<td>Severe obtundation; respiratory depression; unknown ingestion</td>
</tr>
<tr class=”bg-common”>
<td><strong>Migraine-Associated Vertigo/Ataxia</strong></td>
<td>Episodic; associated headache or aura; family history of migraine; school-age and adolescent</td>
<td>First episode requires imaging to exclude structural cause</td>
</tr>
<tr class=”bg-less-common”>
<td rowspan=”4″><strong>LESS COMMON<br>(approximately 20-30%)</strong></td>
<td><strong>Acute Disseminated Encephalomyelitis</strong></td>
<td>Post-infectious or post-vaccination; encephalopathy; multifocal neurological deficits; MRI shows diffuse white matter lesions</td>
<td>Altered mental status; rapid progression; seizures</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Acute Cerebellitis</strong></td>
<td>Severe form of post-infectious cerebellar inflammation; may have cerebellar swelling on MRI; headache and vomiting common</td>
<td>Signs of raised intracranial pressure; hydrocephalus</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Viral/Bacterial Meningoencephalitis</strong></td>
<td>Fever; headache; altered mental status; meningismus; cerebellar involvement variable</td>
<td>Fever with neurological signs; nuchal rigidity</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Conversion Disorder (Functional Ataxia)</strong></td>
<td>Adolescents; inconsistent examination; recent psychosocial stressor; no objective findings on testing</td>
<td>Must exclude organic causes first; sudden onset without prodrome</td>
</tr>
<tr class=”bg-uncommon”>
<td rowspan=”5″><strong>UNCOMMON BUT SERIOUS<br>(approximately 10%)</strong></td>
<td><strong>Posterior Fossa Tumor</strong></td>
<td>May present acutely if hemorrhage or hydrocephalus; progressive symptoms often precede; morning headache and vomiting</td>
<td>Papilledema; cranial nerve palsies; altered mental status; macrocephaly</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Posterior Fossa Stroke</strong></td>
<td>Sudden onset; may have cardiac disease, sickle cell disease, or coagulopathy; focal deficits</td>
<td>Sudden onset with focal signs; altered consciousness</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Cerebellar Hemorrhage</strong></td>
<td>Sudden severe headache; vomiting; rapid deterioration; may follow trauma or occur with vascular malformation</td>
<td>Rapid deterioration; signs of herniation</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Opsoclonus-Myoclonus-Ataxia Syndrome</strong></td>
<td>Opsoclonus (dancing eyes); myoclonus; irritability; median age 18 months; 50% have occult neuroblastoma</td>
<td>Requires urgent tumor screening; paraneoplastic emergency</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Metabolic Crisis</strong></td>
<td>Known metabolic disorder or consanguinity; triggered by illness or fasting; acidosis, hyperammonemia, or hypoglycemia</td>
<td>Altered mental status; vomiting; known metabolic disease</td>
</tr>
</tbody>
</table>
</div>
<h2>Episodic/Recurrent Ataxia</h2>
<p>Children who experience discrete episodes of ataxia with return to baseline between episodes represent a distinct diagnostic category.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Probability</th>
<th>Condition</th>
<th>Episode Duration</th>
<th>Key Features</th>
</tr>
</thead>
<tbody>
<tr class=”bg-common”>
<td rowspan=”2″><strong>COMMON</strong></td>
<td><strong>Migraine with Brainstem Aura (Basilar Migraine)</strong></td>
<td>Hours</td>
<td>Vertigo, visual symptoms, dysarthria followed by headache; family history of migraine; adolescents</td>
</tr>
<tr class=”bg-common”>
<td><strong>Benign Paroxysmal Vertigo of Childhood</strong></td>
<td>Minutes</td>
<td>Brief episodes of vertigo with ataxia; age 2-6 years; associated with pallor and nystagmus; migraine precursor</td>
</tr>
<tr class=”bg-less-common”>
<td rowspan=”3″><strong>LESS COMMON</strong></td>
<td><strong>Episodic Ataxia Type 2</strong></td>
<td>Hours to days</td>
<td>CACNA1A mutation; triggered by stress, exercise, caffeine; interictal nystagmus; responds to acetazolamide</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Episodic Ataxia Type 1</strong></td>
<td>Seconds to minutes</td>
<td>KCNA1 mutation; very brief attacks; associated myokymia (muscle rippling); triggered by startle</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Metabolic Disorders</strong></td>
<td>Variable</td>
<td>Maple syrup urine disease, pyruvate dehydrogenase deficiency, mitochondrial disorders; triggered by illness or dietary changes</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>UNCOMMON</strong></td>
<td><strong>Epileptic Ataxia</strong></td>
<td>Minutes to hours</td>
<td>Ataxia as ictal or post-ictal phenomenon; may have subtle seizures</td>
</tr>
</tbody>
</table>
</div>
<h2>Chronic Progressive Ataxia</h2>
<p>Progressive ataxia developing over weeks to months is concerning for serious underlying pathology and requires thorough investigation.</p>
<div class=”highlight-box”>
<p><strong>Step-by-Step Approach to Chronic Progressive Ataxia:</strong></p>
<ol>
<li><strong>Step 1:</strong> Urgent MRI brain and spine — Rule out posterior fossa tumor, hydrocephalus, structural malformation</li>
<li><strong>Step 2:</strong> If MRI normal, consider hereditary and metabolic causes based on associated features</li>
<li><strong>Step 3:</strong> Directed genetic and metabolic testing based on clinical phenotype</li>
<li><strong>Step 4:</strong> If diagnosis remains elusive, consider comprehensive genetic panel or whole exome sequencing</li>
</ol>
</div>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Probability</th>
<th>Condition</th>
<th>Typical Age of Onset</th>
<th>Key Distinguishing Features</th>
</tr>
</thead>
<tbody>
<tr class=”bg-common”>
<td rowspan=”2″><strong>COMMON<br>(among progressive ataxias)</strong></td>
<td><strong>Posterior Fossa Tumor</strong></td>
<td>Any; peak 5-9 years</td>
<td>Morning headache/vomiting; papilledema; cranial nerve palsies; medulloblastoma, pilocytic astrocytoma, ependymoma most common</td>
</tr>
<tr class=”bg-common”>
<td><strong>Friedreich Ataxia</strong></td>
<td>Before age 25; typical onset 10-15 years</td>
<td>Gait ataxia → limb ataxia → dysarthria; areflexia with extensor plantars; scoliosis; pes cavus; cardiomyopathy; diabetes</td>
</tr>
<tr class=”bg-less-common”>
<td rowspan=”4″><strong>LESS COMMON</strong></td>
<td><strong>Ataxia-Telangiectasia</strong></td>
<td>Infancy to early childhood</td>
<td>Progressive ataxia by age 2; oculomotor apraxia; telangiectasias (age 3-6); recurrent sinopulmonary infections; elevated alpha-fetoprotein; cancer risk</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Spinocerebellar Ataxias (various types)</strong></td>
<td>Variable; some childhood-onset</td>
<td>Autosomal dominant inheritance (usually affected parent); progressive cerebellar syndrome; variable associated features by type</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Ataxia with Oculomotor Apraxia Types 1 and 2</strong></td>
<td>Childhood</td>
<td>Progressive ataxia with oculomotor apraxia; peripheral neuropathy; elevated alpha-fetoprotein (type 2); autosomal recessive</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Multiple Sclerosis</strong></td>
<td>Adolescence (rare before puberty)</td>
<td>Relapsing-remitting course; optic neuritis; sensory symptoms; MRI shows periventricular white matter lesions</td>
</tr>
<tr class=”bg-uncommon”>
<td rowspan=”4″><strong>UNCOMMON</strong></td>
<td><strong>Neuronal Ceroid Lipofuscinosis</strong></td>
<td>Variable by subtype</td>
<td>Progressive visual loss; seizures; cognitive decline; ataxia; neurodegenerative</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Niemann-Pick Disease Type C</strong></td>
<td>Childhood to adolescence</td>
<td>Vertical supranuclear gaze palsy; hepatosplenomegaly; cognitive decline; ataxia; dystonia</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Wilson Disease</strong></td>
<td>School-age to adolescence</td>
<td>Hepatic dysfunction; Kayser-Fleischer rings; psychiatric symptoms; movement disorders including ataxia</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Abetalipoproteinemia</strong></td>
<td>Early childhood</td>
<td>Steatorrhea; failure to thrive; retinitis pigmentosa; acanthocytes on blood smear; progressive ataxia and neuropathy</td>
</tr>
</tbody>
</table>
</div>
<h2>Chronic Non-Progressive (Static) Ataxia</h2>
<p>Ataxia present from early life without progression suggests a congenital or early-acquired structural abnormality.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Condition</th>
<th>Key Features</th>
<th>Diagnostic Approach</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Ataxic Cerebral Palsy</strong></td>
<td>Nonprogressive motor disorder from early brain injury; hypotonia in infancy evolving to ataxia; may have associated cognitive impairment</td>
<td>MRI may show cerebellar hypoplasia or periventricular leukomalacia; history of prematurity or perinatal insult</td>
</tr>
<tr>
<td><strong>Joubert Syndrome</strong></td>
<td>”Molar tooth sign” on MRI; hypotonia; developmental delay; abnormal breathing patterns in infancy; oculomotor apraxia</td>
<td>MRI shows characteristic molar tooth sign; genetic testing confirms diagnosis</td>
</tr>
<tr>
<td><strong>Dandy-Walker Malformation</strong></td>
<td>Cystic dilation of fourth ventricle; cerebellar hypoplasia; hydrocephalus common; variable cognitive impairment</td>
<td>MRI shows characteristic posterior fossa cyst and vermian hypoplasia</td>
</tr>
<tr>
<td><strong>Pontocerebellar Hypoplasia</strong></td>
<td>Severe microcephaly; profound developmental delay; seizures; early death in severe forms</td>
<td>MRI shows marked cerebellar and pontine hypoplasia; genetic testing</td>
</tr>
<tr>
<td><strong>Congenital Disorders of Glycosylation</strong></td>
<td>Multisystem involvement; inverted nipples; abnormal fat distribution; cerebellar hypoplasia; developmental delay</td>
<td>Transferrin isoelectric focusing; genetic testing</td>
</tr>
</tbody>
</table>
</div>
<h2>Anatomical Approach to Ataxia</h2>
<div class=”eisenhower-matrix”>
<div class=”quadrant q2″>
<h3>Cerebellar (Most Common)</h3>
<p><strong>Acute:</strong> Acute cerebellar ataxia, intoxication, stroke, hemorrhage, ADEM</p>
<p><strong>Chronic:</strong> Tumors, Friedreich ataxia, ataxia-telangiectasia, spinocerebellar ataxias</p>
<p><strong>Congenital:</strong> Joubert syndrome, Dandy-Walker, cerebellar hypoplasia</p>
</div>
<div class=”quadrant q1″>
<h3>Sensory (Proprioceptive)</h3>
<p><strong>Peripheral neuropathy:</strong> Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, hereditary neuropathies</p>
<p><strong>Dorsal column:</strong> Friedreich ataxia, vitamin B12 deficiency, subacute combined degeneration</p>
<p><strong>Key feature:</strong> Positive Romberg sign</p>
</div>
<div class=”quadrant q4″>
<h3>Vestibular</h3>
<p><strong>Peripheral:</strong> Labyrinthitis, vestibular neuritis, benign paroxysmal positional vertigo</p>
<p><strong>Central:</strong> Brainstem lesions, cerebellar lesions affecting vestibulocerebellum</p>
<p><strong>Key feature:</strong> Prominent vertigo and nystagmus</p>
</div>
<div class=”quadrant q3″>
<h3>Supratentorial/Mixed</h3>
<p><strong>Frontal lobe:</strong> Frontal gait disorder (gait apraxia)</p>
<p><strong>Basal ganglia:</strong> Movement disorders may mimic ataxia</p>
<p><strong>Functional:</strong> Conversion disorder — inconsistent findings</p>
</div>
</div>
<h2>Age-Based Differential Diagnosis</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Age Group</th>
<th>Most Likely Causes</th>
<th>Must Not Miss</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Infant (0-12 months)</strong></td>
<td>Congenital malformations (Joubert, Dandy-Walker); metabolic disorders; hypoxic-ischemic injury; genetic syndromes</td>
<td>Hydrocephalus; metabolic crisis; brain tumor (rare but possible)</td>
</tr>
<tr>
<td><strong>Toddler (1-3 years)</strong></td>
<td>Acute cerebellar ataxia (peak age); drug ingestion; opsoclonus-myoclonus-ataxia syndrome</td>
<td>Neuroblastoma; posterior fossa tumor; metabolic disorder</td>
</tr>
<tr>
<td><strong>Preschool (3-6 years)</strong></td>
<td>Acute cerebellar ataxia; drug ingestion; ataxia-telangiectasia (becoming apparent)</td>
<td>Posterior fossa tumor; ADEM; ataxia-telangiectasia</td>
</tr>
<tr>
<td><strong>School-age (6-12 years)</strong></td>
<td>Posterior fossa tumor (peak incidence); migraine-associated; Friedreich ataxia (late in range)</td>
<td>Brain tumor; demyelinating disease; hereditary ataxia</td>
</tr>
<tr>
<td><strong>Adolescent (12-18 years)</strong></td>
<td>Friedreich ataxia; spinocerebellar ataxias; migraine; conversion disorder; substance use</td>
<td>Multiple sclerosis; Wilson disease; brain tumor</td>
</tr>
</tbody>
</table>
</div>
<h2>Drug-Induced Ataxia in Children</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Drug or Drug Class</th>
<th>Mechanism</th>
<th>Characteristics</th>
<th>Resolution After Stopping</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Phenytoin</strong></td>
<td>Cerebellar Purkinje cell toxicity; dose-related and idiosyncratic</td>
<td>Nystagmus often first sign; ataxia with higher levels; chronic use may cause permanent damage</td>
<td>Acute toxicity: days; chronic damage may be irreversible</td>
</tr>
<tr>
<td><strong>Carbamazepine</strong></td>
<td>Cerebellar toxicity at supratherapeutic levels</td>
<td>Diplopia, dizziness, ataxia; usually with toxic levels</td>
<td>Days with dose reduction</td>
</tr>
<tr>
<td><strong>Benzodiazepines</strong></td>
<td>GABAergic suppression of cerebellar function</td>
<td>Sedation, ataxia, dysarthria; dose-dependent</td>
<td>Hours to days depending on half-life</td>
</tr>
<tr>
<td><strong>Antihistamines (diphenhydramine)</strong></td>
<td>Anticholinergic effects; CNS depression</td>
<td>Sedation, ataxia, mydriasis, dry mucous membranes; common in accidental ingestion</td>
<td>Hours to 1 day</td>
</tr>
<tr>
<td><strong>Valproic Acid</strong></td>
<td>Multiple mechanisms including cerebellar toxicity</td>
<td>Tremor, ataxia; may occur at therapeutic levels</td>
<td>Days to weeks</td>
</tr>
<tr>
<td><strong>Lithium</strong></td>
<td>Direct cerebellar toxicity</td>
<td>Tremor progressing to ataxia; may cause permanent damage</td>
<td>Variable; some damage irreversible</td>
</tr>
<tr>
<td><strong>Metronidazole</strong></td>
<td>Cerebellar white matter toxicity with prolonged use</td>
<td>Progressive ataxia, dysarthria; MRI shows cerebellar lesions</td>
<td>Weeks to months; usually reversible</td>
</tr>
<tr>
<td><strong>Alcohol</strong></td>
<td>Acute: GABAergic effect; Chronic: direct cerebellar toxicity</td>
<td>Acute intoxication features; consider in adolescents</td>
<td>Acute: hours; chronic damage irreversible</td>
</tr>
</tbody>
</table>
</div>
<h2>Quick Reference: “If You See This, Think This First”</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Clue</th>
<th>Think This First</th>
<th>Next Step</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Well child, age 2-4, recent viral illness, acute truncal ataxia</strong></td>
<td>Acute cerebellar ataxia (post-infectious)</td>
<td>MRI to exclude other causes; supportive care if imaging normal</td>
</tr>
<tr>
<td><strong>Altered mental status + ataxia, access to medications</strong></td>
<td>Drug intoxication</td>
<td>Toxicology screen; check anticonvulsant levels if applicable</td>
</tr>
<tr>
<td><strong>Morning headache, vomiting, progressive ataxia</strong></td>
<td>Posterior fossa tumor</td>
<td>Urgent MRI brain with contrast</td>
</tr>
<tr>
<td><strong>Dancing eyes (opsoclonus), myoclonus, irritability</strong></td>
<td>Opsoclonus-myoclonus-ataxia syndrome (neuroblastoma)</td>
<td>Urgent: urine catecholamines, CT/MRI chest-abdomen-pelvis, MIBG scan</td>
</tr>
<tr>
<td><strong>Progressive ataxia + areflexia + extensor plantars</strong></td>
<td>Friedreich ataxia</td>
<td>Genetic testing for FXN gene GAA repeat expansion</td>
</tr>
<tr>
<td><strong>Ataxia + oculomotor apraxia + telangiectasias</strong></td>
<td>Ataxia-telangiectasia</td>
<td>Alpha-fetoprotein level; immunoglobulin levels; ATM gene testing</td>
</tr>
<tr>
<td><strong>Recurrent episodes + family history + responds to acetazolamide</strong></td>
<td>Episodic ataxia type 2</td>
<td>Trial of acetazolamide; CACNA1A gene testing</td>
</tr>
<tr>
<td><strong>Infant with hypotonia, molar tooth sign on MRI</strong></td>
<td>Joubert syndrome</td>
<td>Genetic panel for Joubert-related genes; renal and ophthalmologic evaluation</td>
</tr>
<tr>
<td><strong>Fever + encephalopathy + multifocal deficits</strong></td>
<td>Acute disseminated encephalomyelitis</td>
<td>MRI brain and spine; CSF analysis; high-dose corticosteroids</td>
</tr>
<tr>
<td><strong>Adolescent + inconsistent exam + recent stressor</strong></td>
<td>Conversion disorder (functional ataxia)</td>
<td>Exclude organic causes; supportive approach; psychology/psychiatry referral</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Critical Diagnostic Principle</h4>
<p><strong>Acute cerebellar ataxia is a diagnosis of exclusion.</strong> Before attributing acute ataxia in a child to a benign post-infectious cause, you must:</p>
<ul>
<li>Exclude drug intoxication (history, toxicology screen)</li>
<li>Exclude posterior fossa pathology (MRI brain)</li>
<li>Exclude opsoclonus-myoclonus-ataxia syndrome (careful examination for opsoclonus)</li>
<li>Ensure no features of raised intracranial pressure</li>
</ul>
<p>Only when these serious causes have been ruled out can a diagnosis of acute cerebellar ataxia be made.</p>
</div>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 6: INVESTIGATIONS ==================== –>
<div class=”task-content” id=”task6-content”>
<div class=”task-header”>
<h1 class=”task-title”>6. Diagnostic Investigations</h1>
<p class=”task-subtitle”>A stepwise, clinically-guided approach to investigating pediatric ataxia</p>
</div>
<div class=”task-body”>
<p>The investigation of pediatric ataxia should be guided by the clinical presentation, particularly the temporal profile (acute versus chronic) and associated features. A stepwise approach avoids unnecessary testing while ensuring serious conditions are not missed.</p>
<h2>Urgent Investigations for Acute Ataxia</h2>
<p>All children presenting with acute ataxia require urgent evaluation to exclude life-threatening causes.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Investigation</th>
<th>Purpose</th>
<th>What to Look For</th>
<th>Practical Points</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>MRI Brain (with and without contrast)</strong></td>
<td>Exclude structural lesion, stroke, demyelination, cerebellar swelling</td>
<td>Mass lesion; hydrocephalus; hemorrhage; infarction; demyelinating lesions; cerebellar swelling</td>
<td>Gold standard for posterior fossa imaging; CT acceptable if MRI not immediately available but less sensitive</td>
</tr>
<tr>
<td><strong>CT Head (if MRI not immediately available)</strong></td>
<td>Rapid assessment for mass, hemorrhage, hydrocephalus</td>
<td>Large mass; blood; dilated ventricles; midline shift</td>
<td>Useful for emergencies; posterior fossa artifact limits cerebellar visualization; follow with MRI</td>
</tr>
<tr>
<td><strong>Toxicology Screen</strong></td>
<td>Detect drug intoxication</td>
<td>Benzodiazepines, barbiturates, anticonvulsants, antihistamines, alcohol</td>
<td>Include urine and serum; many anticonvulsants not on standard panels — request specifically</td>
</tr>
<tr>
<td><strong>Anticonvulsant Levels</strong></td>
<td>Assess for toxicity in children on these medications</td>
<td>Phenytoin, carbamazepine, valproate, phenobarbital levels</td>
<td>Phenytoin toxicity is a common cause; check levels even if “compliant”</td>
</tr>
<tr>
<td><strong>Blood Glucose</strong></td>
<td>Exclude hypoglycemia</td>
<td>Low glucose causing neurological symptoms</td>
<td>Point-of-care testing for rapid result</td>
</tr>
<tr>
<td><strong>Basic Metabolic Panel</strong></td>
<td>Assess electrolytes, renal function</td>
<td>Hyponatremia; hypoglycemia; metabolic acidosis</td>
<td>Acidosis may suggest metabolic disorder</td>
</tr>
<tr>
<td><strong>Complete Blood Count</strong></td>
<td>Assess for infection, anemia</td>
<td>Leukocytosis (infection); anemia (chronic disease)</td>
<td>Baseline for all patients</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Imaging Considerations in Children</h4>
<ul>
<li><strong>MRI is preferred</strong> over CT for posterior fossa evaluation due to superior resolution and absence of radiation</li>
<li><strong>Sedation</strong> may be required for young children; discuss urgency with radiology to determine if sedation can be arranged emergently</li>
<li><strong>CT with contrast</strong> is acceptable for emergency evaluation if MRI is not immediately available, but should be followed by MRI</li>
<li><strong>Do not delay imaging</strong> in a child with signs of raised intracranial pressure or rapid deterioration</li>
</ul>
</div>
</div>
<h2>Second-Line Investigations Based on Clinical Suspicion</h2>
<h3>If Suspecting Opsoclonus-Myoclonus-Ataxia Syndrome</h3>
<div class=”columns”>
<div class=”column”>
<h4>Tumor Screening (Urgent)</h4>
<ul>
<li><strong>Urine catecholamines:</strong> Vanillylmandelic acid (VMA), homovanillic acid (HVA) — elevated in neuroblastoma</li>
<li><strong>CT or MRI chest, abdomen, pelvis:</strong> Look for primary tumor (adrenal, paraspinal, mediastinal)</li>
<li><strong>MIBG scan:</strong> Metaiodobenzylguanidine scan for neuroblastoma if initial imaging negative</li>
<li><strong>Bone marrow biopsy:</strong> If metastatic disease suspected</li>
</ul>
</div>
<div class=”column”>
<h4>Additional Workup</h4>
<ul>
<li><strong>CSF analysis:</strong> May show pleocytosis, oligoclonal bands</li>
<li><strong>Anti-neuronal antibodies:</strong> Anti-Hu, others (often negative in pediatric cases)</li>
<li><strong>Note:</strong> Tumor may be occult — repeat screening at intervals if initial workup negative</li>
</ul>
</div>
</div>
<h3>If Suspecting Infectious or Inflammatory Cause</h3>
<div class=”columns”>
<div class=”column”>
<h4>Lumbar Puncture (if safe)</h4>
<ul>
<li><strong>Opening pressure:</strong> Elevated in raised intracranial pressure</li>
<li><strong>Cell count and differential:</strong> Pleocytosis in infection/inflammation</li>
<li><strong>Protein and glucose:</strong> Elevated protein in inflammation; low glucose in bacterial infection</li>
<li><strong>Viral PCR panel:</strong> Enterovirus, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus</li>
<li><strong>Oligoclonal bands:</strong> Positive in multiple sclerosis, ADEM</li>
</ul>
</div>
<div class=”column”>
<h4>Serology</h4>
<ul>
<li><strong>Epstein-Barr virus serology:</strong> Associated with acute cerebellar ataxia</li>
<li><strong>Mycoplasma pneumoniae:</strong> Associated with ADEM and cerebellitis</li>
<li><strong>Varicella-zoster virus:</strong> Common trigger for acute cerebellar ataxia</li>
<li><strong>Anti-MOG antibodies:</strong> Associated with ADEM; helps distinguish from multiple sclerosis</li>
</ul>
</div>
</div>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Lumbar Puncture Safety</h4>
<p>Perform lumbar puncture <strong>only after</strong> neuroimaging has excluded a mass lesion or significant raised intracranial pressure. In acute cerebellar ataxia without red flags and with normal MRI, lumbar puncture is often not necessary but may be performed to confirm the diagnosis or exclude encephalitis if there are atypical features.</p>
</div>
</div>
<h3>If Suspecting Hereditary Ataxia</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Suspected Condition</th>
<th>First-Line Tests</th>
<th>Second-Line Tests</th>
<th>Key Findings</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Friedreich Ataxia</strong></td>
<td>Genetic testing for FXN gene GAA repeat expansion</td>
<td>Echocardiogram; glucose tolerance test; nerve conduction studies</td>
<td>Homozygous GAA expansion (>66 repeats); cardiomyopathy in most; sensory axonal neuropathy</td>
</tr>
<tr>
<td><strong>Ataxia-Telangiectasia</strong></td>
<td>Serum alpha-fetoprotein (elevated); immunoglobulin levels (low IgA, IgG)</td>
<td>ATM gene sequencing; chromosomal radiosensitivity testing</td>
<td>Alpha-fetoprotein persistently elevated (95%); low IgA (70%); lymphopenia</td>
</tr>
<tr>
<td><strong>Ataxia with Oculomotor Apraxia Type 1</strong></td>
<td>Serum albumin (low); cholesterol (elevated)</td>
<td>APTX gene testing</td>
<td>Hypoalbuminemia; hypercholesterolemia; sensorimotor neuropathy</td>
</tr>
<tr>
<td><strong>Ataxia with Oculomotor Apraxia Type 2</strong></td>
<td>Serum alpha-fetoprotein (elevated)</td>
<td>SETX gene testing</td>
<td>Elevated alpha-fetoprotein (90%); sensorimotor neuropathy</td>
</tr>
<tr>
<td><strong>Spinocerebellar Ataxias</strong></td>
<td>Targeted genetic testing based on phenotype</td>
<td>SCA gene panel or whole exome sequencing</td>
<td>Variable; autosomal dominant inheritance pattern</td>
</tr>
<tr>
<td><strong>Episodic Ataxia Type 2</strong></td>
<td>CACNA1A gene testing; trial of acetazolamide</td>
<td>EEG (interictal abnormalities may be seen)</td>
<td>CACNA1A mutation; clinical response to acetazolamide is diagnostic clue</td>
</tr>
</tbody>
</table>
</div>
<h3>If Suspecting Metabolic Disorder</h3>
<div class=”columns”>
<div class=”column”>
<h4>Initial Metabolic Screen</h4>
<ul>
<li><strong>Blood gas:</strong> Metabolic acidosis</li>
<li><strong>Ammonia:</strong> Elevated in urea cycle disorders</li>
<li><strong>Lactate:</strong> Elevated in mitochondrial disorders, pyruvate metabolism defects</li>
<li><strong>Plasma amino acids:</strong> Maple syrup urine disease, other aminoacidopathies</li>
<li><strong>Urine organic acids:</strong> Organic acidemias</li>
<li><strong>Acylcarnitine profile:</strong> Fatty acid oxidation defects</li>
</ul>
</div>
<div class=”column”>
<h4>Specific Tests</h4>
<ul>
<li><strong>Very long chain fatty acids:</strong> Adrenoleukodystrophy, peroxisomal disorders</li>
<li><strong>Vitamin E level:</strong> Ataxia with vitamin E deficiency</li>
<li><strong>Ceruloplasmin and 24-hour urine copper:</strong> Wilson disease</li>
<li><strong>Lysosomal enzyme panel:</strong> Storage disorders</li>
<li><strong>Transferrin isoelectric focusing:</strong> Congenital disorders of glycosylation</li>
<li><strong>CSF lactate:</strong> Mitochondrial disorders (if serum lactate elevated)</li>
</ul>
</div>
</div>
<h2>Neuroimaging Findings in Pediatric Ataxia</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Condition</th>
<th>MRI Findings</th>
<th>Key Features</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Acute Cerebellar Ataxia</strong></td>
<td>Often normal; may show subtle cerebellar signal change</td>
<td>Normal MRI supports diagnosis if clinical picture fits</td>
</tr>
<tr>
<td><strong>Acute Cerebellitis</strong></td>
<td>Cerebellar swelling, increased T2 signal, possible hydrocephalus</td>
<td>More severe than acute cerebellar ataxia; may need neurosurgical involvement</td>
</tr>
<tr>
<td><strong>ADEM</strong></td>
<td>Multifocal T2/FLAIR hyperintense lesions in white matter; may enhance</td>
<td>Lesions typically larger and more diffuse than in multiple sclerosis</td>
</tr>
<tr>
<td><strong>Medulloblastoma</strong></td>
<td>Midline posterior fossa mass; typically hyperdense on CT; restricted diffusion on MRI</td>
<td>Arises from vermis; often causes hydrocephalus; contrast enhancement</td>
</tr>
<tr>
<td><strong>Pilocytic Astrocytoma</strong></td>
<td>Cystic mass with enhancing nodule; cerebellar hemisphere</td>
<td>Classic “cyst with mural nodule”; excellent prognosis</td>
</tr>
<tr>
<td><strong>Joubert Syndrome</strong></td>
<td>Molar tooth sign on axial imaging</td>
<td>Pathognomonic appearance due to vermian hypoplasia and elongated superior cerebellar peduncles</td>
</tr>
<tr>
<td><strong>Dandy-Walker Malformation</strong></td>
<td>Cystic dilation of fourth ventricle; vermian hypoplasia; elevated torcula</td>
<td>Associated with hydrocephalus in most cases</td>
</tr>
<tr>
<td><strong>Friedreich Ataxia</strong></td>
<td>Cervical spinal cord atrophy; cerebellar atrophy (late); normal initially</td>
<td>Spinal cord atrophy may precede cerebellar changes</td>
</tr>
<tr>
<td><strong>Ataxia-Telangiectasia</strong></td>
<td>Progressive cerebellar atrophy (vermis > hemispheres)</td>
<td>May be normal early in disease; atrophy develops over time</td>
</tr>
</tbody>
</table>
</div>
<h2>Additional Investigations</h2>
<h3>Electrodiagnostic Studies</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Test</th>
<th>When to Order</th>
<th>What It Shows</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Nerve Conduction Studies/EMG</strong></td>
<td>Suspected sensory ataxia; Friedreich ataxia; peripheral neuropathy</td>
<td>Sensory axonal neuropathy in Friedreich ataxia; demyelinating pattern in Guillain-Barré syndrome</td>
</tr>
<tr>
<td><strong>EEG</strong></td>
<td>Suspected seizures; episodic ataxia; encephalopathy</td>
<td>Epileptiform activity; encephalopathic pattern; may show interictal abnormalities in episodic ataxia</td>
</tr>
<tr>
<td><strong>Visual Evoked Potentials</strong></td>
<td>Suspected multiple sclerosis; optic pathway involvement</td>
<td>Delayed latency suggests demyelination</td>
</tr>
<tr>
<td><strong>Somatosensory Evoked Potentials</strong></td>
<td>Assessing dorsal column function; Friedreich ataxia</td>
<td>Abnormal in sensory ataxias; absent in Friedreich ataxia</td>
</tr>
</tbody>
</table>
</div>
<h3>Cardiac Evaluation</h3>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>When to Order Echocardiogram</h4>
<ul>
<li><strong>Suspected Friedreich ataxia:</strong> Hypertrophic cardiomyopathy present in majority of patients; may cause arrhythmias and heart failure</li>
<li><strong>Unexplained progressive ataxia:</strong> Cardiac involvement may suggest specific diagnoses</li>
<li><strong>Mitochondrial disorders:</strong> Often have cardiac involvement</li>
</ul>
<p>Also consider ECG for arrhythmia screening in hereditary ataxias.</p>
</div>
</div>
<div class=”section-divider”>
<div class=”section-divider-icon”><i class=”fa fa-flask”></i></div>
</div>
<h2>Empiric Treatment Trials as Diagnostic Tools</h2>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Therapeutic Trials in Episodic Ataxia</h4>
<p>In children with episodic ataxia and a clinical picture consistent with episodic ataxia type 2, a trial of <strong>acetazolamide</strong> can be both therapeutic and diagnostic:</p>
<ul>
<li><strong>Dose:</strong> Start at 5 mg/kg/day divided twice daily; may increase to 10-20 mg/kg/day</li>
<li><strong>Response:</strong> Dramatic reduction in episode frequency and severity suggests episodic ataxia type 2</li>
<li><strong>Side effects:</strong> Paresthesias, fatigue, nephrolithiasis; monitor electrolytes</li>
<li><strong>Confirmation:</strong> Positive response supports diagnosis; genetic testing can confirm</li>
</ul>
</div>
</div>
<h2>Investigation Algorithm Summary</h2>
<div class=”highlight-box”>
<p><strong>Acute Ataxia Investigation Pathway:</strong></p>
<ol>
<li><strong>All patients:</strong> Blood glucose, electrolytes, toxicology screen, anticonvulsant levels (if applicable)</li>
<li><strong>If any red flags:</strong> Urgent MRI brain (or CT if MRI not available)</li>
<li><strong>If opsoclonus present:</strong> Urine catecholamines, imaging for neuroblastoma</li>
<li><strong>If febrile with encephalopathy:</strong> Lumbar puncture (after imaging), viral studies</li>
<li><strong>If well-appearing, post-viral, MRI normal:</strong> Diagnosis of acute cerebellar ataxia; supportive care</li>
</ol>
</div>
<div class=”highlight-box”>
<p><strong>Chronic Progressive Ataxia Investigation Pathway:</strong></p>
<ol>
<li><strong>All patients:</strong> MRI brain and spine with contrast</li>
<li><strong>If MRI shows tumor:</strong> Refer to neurosurgery/oncology</li>
<li><strong>If MRI normal or shows atrophy:</strong> Alpha-fetoprotein, vitamin E, immunoglobulins</li>
<li><strong>Based on phenotype:</strong> Targeted genetic testing (Friedreich ataxia, ataxia-telangiectasia, and others)</li>
<li><strong>If diagnosis elusive:</strong> Comprehensive ataxia gene panel or whole exome sequencing</li>
<li><strong>Consider metabolic workup:</strong> If acute-on-chronic pattern or developmental regression</li>
</ol>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<div class=”task-content” id=”task5-content”>
<div class=”task-header”>
<h1 class=”task-title”>5. Differential Diagnosis</h1>
<p class=”task-subtitle”>Systematic approach organized by probability, duration, and clinical features</p>
</div>
<div class=”task-body”>
<p>The differential diagnosis of pediatric ataxia is broad, but a systematic approach based on duration of symptoms, age of the child, and associated features allows for efficient prioritization. The key clinical question is: <strong>Is this an emergency requiring immediate intervention, or can workup proceed in a measured fashion?</strong></p>
<h2>Acute Ataxia (Onset within 72 hours)</h2>
<p>Acute ataxia in a previously well child requires urgent evaluation to exclude life-threatening causes before considering benign etiologies.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Probability</th>
<th>Condition</th>
<th>Key Features</th>
<th>Red Flags</th>
</tr>
</thead>
<tbody>
<tr class=”bg-common”>
<td rowspan=”3″><strong>COMMON<br>(approximately 60-70%)</strong></td>
<td><strong>Acute Cerebellar Ataxia (Post-infectious)</strong></td>
<td>Age 2-4 years; viral prodrome 1-3 weeks prior (varicella, Epstein-Barr virus, enterovirus); truncal ataxia predominates; otherwise well-appearing</td>
<td>Diagnosis of exclusion — must rule out other causes first</td>
</tr>
<tr class=”bg-common”>
<td><strong>Drug Intoxication/Toxicity</strong></td>
<td>Access to medications; altered mental status; anticonvulsants, benzodiazepines, antihistamines most common; rapid onset</td>
<td>Severe obtundation; respiratory depression; unknown ingestion</td>
</tr>
<tr class=”bg-common”>
<td><strong>Migraine-Associated Vertigo/Ataxia</strong></td>
<td>Episodic; associated headache or aura; family history of migraine; school-age and adolescent</td>
<td>First episode requires imaging to exclude structural cause</td>
</tr>
<tr class=”bg-less-common”>
<td rowspan=”4″><strong>LESS COMMON<br>(approximately 20-30%)</strong></td>
<td><strong>Acute Disseminated Encephalomyelitis</strong></td>
<td>Post-infectious or post-vaccination; encephalopathy; multifocal neurological deficits; MRI shows diffuse white matter lesions</td>
<td>Altered mental status; rapid progression; seizures</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Acute Cerebellitis</strong></td>
<td>Severe form of post-infectious cerebellar inflammation; may have cerebellar swelling on MRI; headache and vomiting common</td>
<td>Signs of raised intracranial pressure; hydrocephalus</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Viral/Bacterial Meningoencephalitis</strong></td>
<td>Fever; headache; altered mental status; meningismus; cerebellar involvement variable</td>
<td>Fever with neurological signs; nuchal rigidity</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Conversion Disorder (Functional Ataxia)</strong></td>
<td>Adolescents; inconsistent examination; recent psychosocial stressor; no objective findings on testing</td>
<td>Must exclude organic causes first; sudden onset without prodrome</td>
</tr>
<tr class=”bg-uncommon”>
<td rowspan=”5″><strong>UNCOMMON BUT SERIOUS<br>(approximately 10%)</strong></td>
<td><strong>Posterior Fossa Tumor</strong></td>
<td>May present acutely if hemorrhage or hydrocephalus; progressive symptoms often precede; morning headache and vomiting</td>
<td>Papilledema; cranial nerve palsies; altered mental status; macrocephaly</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Posterior Fossa Stroke</strong></td>
<td>Sudden onset; may have cardiac disease, sickle cell disease, or coagulopathy; focal deficits</td>
<td>Sudden onset with focal signs; altered consciousness</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Cerebellar Hemorrhage</strong></td>
<td>Sudden severe headache; vomiting; rapid deterioration; may follow trauma or occur with vascular malformation</td>
<td>Rapid deterioration; signs of herniation</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Opsoclonus-Myoclonus-Ataxia Syndrome</strong></td>
<td>Opsoclonus (dancing eyes); myoclonus; irritability; median age 18 months; 50% have occult neuroblastoma</td>
<td>Requires urgent tumor screening; paraneoplastic emergency</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Metabolic Crisis</strong></td>
<td>Known metabolic disorder or consanguinity; triggered by illness or fasting; acidosis, hyperammonemia, or hypoglycemia</td>
<td>Altered mental status; vomiting; known metabolic disease</td>
</tr>
</tbody>
</table>
</div>
<h2>Episodic/Recurrent Ataxia</h2>
<p>Children who experience discrete episodes of ataxia with return to baseline between episodes represent a distinct diagnostic category.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Probability</th>
<th>Condition</th>
<th>Episode Duration</th>
<th>Key Features</th>
</tr>
</thead>
<tbody>
<tr class=”bg-common”>
<td rowspan=”2″><strong>COMMON</strong></td>
<td><strong>Migraine with Brainstem Aura (Basilar Migraine)</strong></td>
<td>Hours</td>
<td>Vertigo, visual symptoms, dysarthria followed by headache; family history of migraine; adolescents</td>
</tr>
<tr class=”bg-common”>
<td><strong>Benign Paroxysmal Vertigo of Childhood</strong></td>
<td>Minutes</td>
<td>Brief episodes of vertigo with ataxia; age 2-6 years; associated with pallor and nystagmus; migraine precursor</td>
</tr>
<tr class=”bg-less-common”>
<td rowspan=”3″><strong>LESS COMMON</strong></td>
<td><strong>Episodic Ataxia Type 2</strong></td>
<td>Hours to days</td>
<td>CACNA1A mutation; triggered by stress, exercise, caffeine; interictal nystagmus; responds to acetazolamide</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Episodic Ataxia Type 1</strong></td>
<td>Seconds to minutes</td>
<td>KCNA1 mutation; very brief attacks; associated myokymia (muscle rippling); triggered by startle</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Metabolic Disorders</strong></td>
<td>Variable</td>
<td>Maple syrup urine disease, pyruvate dehydrogenase deficiency, mitochondrial disorders; triggered by illness or dietary changes</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>UNCOMMON</strong></td>
<td><strong>Epileptic Ataxia</strong></td>
<td>Minutes to hours</td>
<td>Ataxia as ictal or post-ictal phenomenon; may have subtle seizures</td>
</tr>
</tbody>
</table>
</div>
<h2>Chronic Progressive Ataxia</h2>
<p>Progressive ataxia developing over weeks to months is concerning for serious underlying pathology and requires thorough investigation.</p>
<div class=”highlight-box”>
<p><strong>Step-by-Step Approach to Chronic Progressive Ataxia:</strong></p>
<ol>
<li><strong>Step 1:</strong> Urgent MRI brain and spine — Rule out posterior fossa tumor, hydrocephalus, structural malformation</li>
<li><strong>Step 2:</strong> If MRI normal, consider hereditary and metabolic causes based on associated features</li>
<li><strong>Step 3:</strong> Directed genetic and metabolic testing based on clinical phenotype</li>
<li><strong>Step 4:</strong> If diagnosis remains elusive, consider comprehensive genetic panel or whole exome sequencing</li>
</ol>
</div>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Probability</th>
<th>Condition</th>
<th>Typical Age of Onset</th>
<th>Key Distinguishing Features</th>
</tr>
</thead>
<tbody>
<tr class=”bg-common”>
<td rowspan=”2″><strong>COMMON<br>(among progressive ataxias)</strong></td>
<td><strong>Posterior Fossa Tumor</strong></td>
<td>Any; peak 5-9 years</td>
<td>Morning headache/vomiting; papilledema; cranial nerve palsies; medulloblastoma, pilocytic astrocytoma, ependymoma most common</td>
</tr>
<tr class=”bg-common”>
<td><strong>Friedreich Ataxia</strong></td>
<td>Before age 25; typical onset 10-15 years</td>
<td>Gait ataxia → limb ataxia → dysarthria; areflexia with extensor plantars; scoliosis; pes cavus; cardiomyopathy; diabetes</td>
</tr>
<tr class=”bg-less-common”>
<td rowspan=”4″><strong>LESS COMMON</strong></td>
<td><strong>Ataxia-Telangiectasia</strong></td>
<td>Infancy to early childhood</td>
<td>Progressive ataxia by age 2; oculomotor apraxia; telangiectasias (age 3-6); recurrent sinopulmonary infections; elevated alpha-fetoprotein; cancer risk</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Spinocerebellar Ataxias (various types)</strong></td>
<td>Variable; some childhood-onset</td>
<td>Autosomal dominant inheritance (usually affected parent); progressive cerebellar syndrome; variable associated features by type</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Ataxia with Oculomotor Apraxia Types 1 and 2</strong></td>
<td>Childhood</td>
<td>Progressive ataxia with oculomotor apraxia; peripheral neuropathy; elevated alpha-fetoprotein (type 2); autosomal recessive</td>
</tr>
<tr class=”bg-less-common”>
<td><strong>Multiple Sclerosis</strong></td>
<td>Adolescence (rare before puberty)</td>
<td>Relapsing-remitting course; optic neuritis; sensory symptoms; MRI shows periventricular white matter lesions</td>
</tr>
<tr class=”bg-uncommon”>
<td rowspan=”4″><strong>UNCOMMON</strong></td>
<td><strong>Neuronal Ceroid Lipofuscinosis</strong></td>
<td>Variable by subtype</td>
<td>Progressive visual loss; seizures; cognitive decline; ataxia; neurodegenerative</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Niemann-Pick Disease Type C</strong></td>
<td>Childhood to adolescence</td>
<td>Vertical supranuclear gaze palsy; hepatosplenomegaly; cognitive decline; ataxia; dystonia</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Wilson Disease</strong></td>
<td>School-age to adolescence</td>
<td>Hepatic dysfunction; Kayser-Fleischer rings; psychiatric symptoms; movement disorders including ataxia</td>
</tr>
<tr class=”bg-uncommon”>
<td><strong>Abetalipoproteinemia</strong></td>
<td>Early childhood</td>
<td>Steatorrhea; failure to thrive; retinitis pigmentosa; acanthocytes on blood smear; progressive ataxia and neuropathy</td>
</tr>
</tbody>
</table>
</div>
<h2>Chronic Non-Progressive (Static) Ataxia</h2>
<p>Ataxia present from early life without progression suggests a congenital or early-acquired structural abnormality.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Condition</th>
<th>Key Features</th>
<th>Diagnostic Approach</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Ataxic Cerebral Palsy</strong></td>
<td>Nonprogressive motor disorder from early brain injury; hypotonia in infancy evolving to ataxia; may have associated cognitive impairment</td>
<td>MRI may show cerebellar hypoplasia or periventricular leukomalacia; history of prematurity or perinatal insult</td>
</tr>
<tr>
<td><strong>Joubert Syndrome</strong></td>
<td>”Molar tooth sign” on MRI; hypotonia; developmental delay; abnormal breathing patterns in infancy; oculomotor apraxia</td>
<td>MRI shows characteristic molar tooth sign; genetic testing confirms diagnosis</td>
</tr>
<tr>
<td><strong>Dandy-Walker Malformation</strong></td>
<td>Cystic dilation of fourth ventricle; cerebellar hypoplasia; hydrocephalus common; variable cognitive impairment</td>
<td>MRI shows characteristic posterior fossa cyst and vermian hypoplasia</td>
</tr>
<tr>
<td><strong>Pontocerebellar Hypoplasia</strong></td>
<td>Severe microcephaly; profound developmental delay; seizures; early death in severe forms</td>
<td>MRI shows marked cerebellar and pontine hypoplasia; genetic testing</td>
</tr>
<tr>
<td><strong>Congenital Disorders of Glycosylation</strong></td>
<td>Multisystem involvement; inverted nipples; abnormal fat distribution; cerebellar hypoplasia; developmental delay</td>
<td>Transferrin isoelectric focusing; genetic testing</td>
</tr>
</tbody>
</table>
</div>
<h2>Anatomical Approach to Ataxia</h2>
<div class=”eisenhower-matrix”>
<div class=”quadrant q2″>
<h3>Cerebellar (Most Common)</h3>
<p><strong>Acute:</strong> Acute cerebellar ataxia, intoxication, stroke, hemorrhage, ADEM</p>
<p><strong>Chronic:</strong> Tumors, Friedreich ataxia, ataxia-telangiectasia, spinocerebellar ataxias</p>
<p><strong>Congenital:</strong> Joubert syndrome, Dandy-Walker, cerebellar hypoplasia</p>
</div>
<div class=”quadrant q1″>
<h3>Sensory (Proprioceptive)</h3>
<p><strong>Peripheral neuropathy:</strong> Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, hereditary neuropathies</p>
<p><strong>Dorsal column:</strong> Friedreich ataxia, vitamin B12 deficiency, subacute combined degeneration</p>
<p><strong>Key feature:</strong> Positive Romberg sign</p>
</div>
<div class=”quadrant q4″>
<h3>Vestibular</h3>
<p><strong>Peripheral:</strong> Labyrinthitis, vestibular neuritis, benign paroxysmal positional vertigo</p>
<p><strong>Central:</strong> Brainstem lesions, cerebellar lesions affecting vestibulocerebellum</p>
<p><strong>Key feature:</strong> Prominent vertigo and nystagmus</p>
</div>
<div class=”quadrant q3″>
<h3>Supratentorial/Mixed</h3>
<p><strong>Frontal lobe:</strong> Frontal gait disorder (gait apraxia)</p>
<p><strong>Basal ganglia:</strong> Movement disorders may mimic ataxia</p>
<p><strong>Functional:</strong> Conversion disorder — inconsistent findings</p>
</div>
</div>
<h2>Age-Based Differential Diagnosis</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Age Group</th>
<th>Most Likely Causes</th>
<th>Must Not Miss</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Infant (0-12 months)</strong></td>
<td>Congenital malformations (Joubert, Dandy-Walker); metabolic disorders; hypoxic-ischemic injury; genetic syndromes</td>
<td>Hydrocephalus; metabolic crisis; brain tumor (rare but possible)</td>
</tr>
<tr>
<td><strong>Toddler (1-3 years)</strong></td>
<td>Acute cerebellar ataxia (peak age); drug ingestion; opsoclonus-myoclonus-ataxia syndrome</td>
<td>Neuroblastoma; posterior fossa tumor; metabolic disorder</td>
</tr>
<tr>
<td><strong>Preschool (3-6 years)</strong></td>
<td>Acute cerebellar ataxia; drug ingestion; ataxia-telangiectasia (becoming apparent)</td>
<td>Posterior fossa tumor; ADEM; ataxia-telangiectasia</td>
</tr>
<tr>
<td><strong>School-age (6-12 years)</strong></td>
<td>Posterior fossa tumor (peak incidence); migraine-associated; Friedreich ataxia (late in range)</td>
<td>Brain tumor; demyelinating disease; hereditary ataxia</td>
</tr>
<tr>
<td><strong>Adolescent (12-18 years)</strong></td>
<td>Friedreich ataxia; spinocerebellar ataxias; migraine; conversion disorder; substance use</td>
<td>Multiple sclerosis; Wilson disease; brain tumor</td>
</tr>
</tbody>
</table>
</div>
<h2>Drug-Induced Ataxia in Children</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Drug or Drug Class</th>
<th>Mechanism</th>
<th>Characteristics</th>
<th>Resolution After Stopping</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Phenytoin</strong></td>
<td>Cerebellar Purkinje cell toxicity; dose-related and idiosyncratic</td>
<td>Nystagmus often first sign; ataxia with higher levels; chronic use may cause permanent damage</td>
<td>Acute toxicity: days; chronic damage may be irreversible</td>
</tr>
<tr>
<td><strong>Carbamazepine</strong></td>
<td>Cerebellar toxicity at supratherapeutic levels</td>
<td>Diplopia, dizziness, ataxia; usually with toxic levels</td>
<td>Days with dose reduction</td>
</tr>
<tr>
<td><strong>Benzodiazepines</strong></td>
<td>GABAergic suppression of cerebellar function</td>
<td>Sedation, ataxia, dysarthria; dose-dependent</td>
<td>Hours to days depending on half-life</td>
</tr>
<tr>
<td><strong>Antihistamines (diphenhydramine)</strong></td>
<td>Anticholinergic effects; CNS depression</td>
<td>Sedation, ataxia, mydriasis, dry mucous membranes; common in accidental ingestion</td>
<td>Hours to 1 day</td>
</tr>
<tr>
<td><strong>Valproic Acid</strong></td>
<td>Multiple mechanisms including cerebellar toxicity</td>
<td>Tremor, ataxia; may occur at therapeutic levels</td>
<td>Days to weeks</td>
</tr>
<tr>
<td><strong>Lithium</strong></td>
<td>Direct cerebellar toxicity</td>
<td>Tremor progressing to ataxia; may cause permanent damage</td>
<td>Variable; some damage irreversible</td>
</tr>
<tr>
<td><strong>Metronidazole</strong></td>
<td>Cerebellar white matter toxicity with prolonged use</td>
<td>Progressive ataxia, dysarthria; MRI shows cerebellar lesions</td>
<td>Weeks to months; usually reversible</td>
</tr>
<tr>
<td><strong>Alcohol</strong></td>
<td>Acute: GABAergic effect; Chronic: direct cerebellar toxicity</td>
<td>Acute intoxication features; consider in adolescents</td>
<td>Acute: hours; chronic damage irreversible</td>
</tr>
</tbody>
</table>
</div>
<h2>Quick Reference: “If You See This, Think This First”</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Clue</th>
<th>Think This First</th>
<th>Next Step</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Well child, age 2-4, recent viral illness, acute truncal ataxia</strong></td>
<td>Acute cerebellar ataxia (post-infectious)</td>
<td>MRI to exclude other causes; supportive care if imaging normal</td>
</tr>
<tr>
<td><strong>Altered mental status + ataxia, access to medications</strong></td>
<td>Drug intoxication</td>
<td>Toxicology screen; check anticonvulsant levels if applicable</td>
</tr>
<tr>
<td><strong>Morning headache, vomiting, progressive ataxia</strong></td>
<td>Posterior fossa tumor</td>
<td>Urgent MRI brain with contrast</td>
</tr>
<tr>
<td><strong>Dancing eyes (opsoclonus), myoclonus, irritability</strong></td>
<td>Opsoclonus-myoclonus-ataxia syndrome (neuroblastoma)</td>
<td>Urgent: urine catecholamines, CT/MRI chest-abdomen-pelvis, MIBG scan</td>
</tr>
<tr>
<td><strong>Progressive ataxia + areflexia + extensor plantars</strong></td>
<td>Friedreich ataxia</td>
<td>Genetic testing for FXN gene GAA repeat expansion</td>
</tr>
<tr>
<td><strong>Ataxia + oculomotor apraxia + telangiectasias</strong></td>
<td>Ataxia-telangiectasia</td>
<td>Alpha-fetoprotein level; immunoglobulin levels; ATM gene testing</td>
</tr>
<tr>
<td><strong>Recurrent episodes + family history + responds to acetazolamide</strong></td>
<td>Episodic ataxia type 2</td>
<td>Trial of acetazolamide; CACNA1A gene testing</td>
</tr>
<tr>
<td><strong>Infant with hypotonia, molar tooth sign on MRI</strong></td>
<td>Joubert syndrome</td>
<td>Genetic panel for Joubert-related genes; renal and ophthalmologic evaluation</td>
</tr>
<tr>
<td><strong>Fever + encephalopathy + multifocal deficits</strong></td>
<td>Acute disseminated encephalomyelitis</td>
<td>MRI brain and spine; CSF analysis; high-dose corticosteroids</td>
</tr>
<tr>
<td><strong>Adolescent + inconsistent exam + recent stressor</strong></td>
<td>Conversion disorder (functional ataxia)</td>
<td>Exclude organic causes; supportive approach; psychology/psychiatry referral</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Critical Diagnostic Principle</h4>
<p><strong>Acute cerebellar ataxia is a diagnosis of exclusion.</strong> Before attributing acute ataxia in a child to a benign post-infectious cause, you must:</p>
<ul>
<li>Exclude drug intoxication (history, toxicology screen)</li>
<li>Exclude posterior fossa pathology (MRI brain)</li>
<li>Exclude opsoclonus-myoclonus-ataxia syndrome (careful examination for opsoclonus)</li>
<li>Ensure no features of raised intracranial pressure</li>
</ul>
<p>Only when these serious causes have been ruled out can a diagnosis of acute cerebellar ataxia be made.</p>
</div>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 6: INVESTIGATIONS ==================== –>
<div class=”task-content” id=”task6-content”>
<div class=”task-header”>
<h1 class=”task-title”>6. Diagnostic Investigations</h1>
<p class=”task-subtitle”>A stepwise, clinically-guided approach to investigating pediatric ataxia</p>
</div>
<div class=”task-body”>
<p>The investigation of pediatric ataxia should be guided by the clinical presentation, particularly the temporal profile (acute versus chronic) and associated features. A stepwise approach avoids unnecessary testing while ensuring serious conditions are not missed.</p>
<h2>Urgent Investigations for Acute Ataxia</h2>
<p>All children presenting with acute ataxia require urgent evaluation to exclude life-threatening causes.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Investigation</th>
<th>Purpose</th>
<th>What to Look For</th>
<th>Practical Points</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>MRI Brain (with and without contrast)</strong></td>
<td>Exclude structural lesion, stroke, demyelination, cerebellar swelling</td>
<td>Mass lesion; hydrocephalus; hemorrhage; infarction; demyelinating lesions; cerebellar swelling</td>
<td>Gold standard for posterior fossa imaging; CT acceptable if MRI not immediately available but less sensitive</td>
</tr>
<tr>
<td><strong>CT Head (if MRI not immediately available)</strong></td>
<td>Rapid assessment for mass, hemorrhage, hydrocephalus</td>
<td>Large mass; blood; dilated ventricles; midline shift</td>
<td>Useful for emergencies; posterior fossa artifact limits cerebellar visualization; follow with MRI</td>
</tr>
<tr>
<td><strong>Toxicology Screen</strong></td>
<td>Detect drug intoxication</td>
<td>Benzodiazepines, barbiturates, anticonvulsants, antihistamines, alcohol</td>
<td>Include urine and serum; many anticonvulsants not on standard panels — request specifically</td>
</tr>
<tr>
<td><strong>Anticonvulsant Levels</strong></td>
<td>Assess for toxicity in children on these medications</td>
<td>Phenytoin, carbamazepine, valproate, phenobarbital levels</td>
<td>Phenytoin toxicity is a common cause; check levels even if “compliant”</td>
</tr>
<tr>
<td><strong>Blood Glucose</strong></td>
<td>Exclude hypoglycemia</td>
<td>Low glucose causing neurological symptoms</td>
<td>Point-of-care testing for rapid result</td>
</tr>
<tr>
<td><strong>Basic Metabolic Panel</strong></td>
<td>Assess electrolytes, renal function</td>
<td>Hyponatremia; hypoglycemia; metabolic acidosis</td>
<td>Acidosis may suggest metabolic disorder</td>
</tr>
<tr>
<td><strong>Complete Blood Count</strong></td>
<td>Assess for infection, anemia</td>
<td>Leukocytosis (infection); anemia (chronic disease)</td>
<td>Baseline for all patients</td>
</tr>
</tbody>
</table>
</div>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Imaging Considerations in Children</h4>
<ul>
<li><strong>MRI is preferred</strong> over CT for posterior fossa evaluation due to superior resolution and absence of radiation</li>
<li><strong>Sedation</strong> may be required for young children; discuss urgency with radiology to determine if sedation can be arranged emergently</li>
<li><strong>CT with contrast</strong> is acceptable for emergency evaluation if MRI is not immediately available, but should be followed by MRI</li>
<li><strong>Do not delay imaging</strong> in a child with signs of raised intracranial pressure or rapid deterioration</li>
</ul>
</div>
</div>
<h2>Second-Line Investigations Based on Clinical Suspicion</h2>
<h3>If Suspecting Opsoclonus-Myoclonus-Ataxia Syndrome</h3>
<div class=”columns”>
<div class=”column”>
<h4>Tumor Screening (Urgent)</h4>
<ul>
<li><strong>Urine catecholamines:</strong> Vanillylmandelic acid (VMA), homovanillic acid (HVA) — elevated in neuroblastoma</li>
<li><strong>CT or MRI chest, abdomen, pelvis:</strong> Look for primary tumor (adrenal, paraspinal, mediastinal)</li>
<li><strong>MIBG scan:</strong> Metaiodobenzylguanidine scan for neuroblastoma if initial imaging negative</li>
<li><strong>Bone marrow biopsy:</strong> If metastatic disease suspected</li>
</ul>
</div>
<div class=”column”>
<h4>Additional Workup</h4>
<ul>
<li><strong>CSF analysis:</strong> May show pleocytosis, oligoclonal bands</li>
<li><strong>Anti-neuronal antibodies:</strong> Anti-Hu, others (often negative in pediatric cases)</li>
<li><strong>Note:</strong> Tumor may be occult — repeat screening at intervals if initial workup negative</li>
</ul>
</div>
</div>
<h3>If Suspecting Infectious or Inflammatory Cause</h3>
<div class=”columns”>
<div class=”column”>
<h4>Lumbar Puncture (if safe)</h4>
<ul>
<li><strong>Opening pressure:</strong> Elevated in raised intracranial pressure</li>
<li><strong>Cell count and differential:</strong> Pleocytosis in infection/inflammation</li>
<li><strong>Protein and glucose:</strong> Elevated protein in inflammation; low glucose in bacterial infection</li>
<li><strong>Viral PCR panel:</strong> Enterovirus, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus</li>
<li><strong>Oligoclonal bands:</strong> Positive in multiple sclerosis, ADEM</li>
</ul>
</div>
<div class=”column”>
<h4>Serology</h4>
<ul>
<li><strong>Epstein-Barr virus serology:</strong> Associated with acute cerebellar ataxia</li>
<li><strong>Mycoplasma pneumoniae:</strong> Associated with ADEM and cerebellitis</li>
<li><strong>Varicella-zoster virus:</strong> Common trigger for acute cerebellar ataxia</li>
<li><strong>Anti-MOG antibodies:</strong> Associated with ADEM; helps distinguish from multiple sclerosis</li>
</ul>
</div>
</div>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>Lumbar Puncture Safety</h4>
<p>Perform lumbar puncture <strong>only after</strong> neuroimaging has excluded a mass lesion or significant raised intracranial pressure. In acute cerebellar ataxia without red flags and with normal MRI, lumbar puncture is often not necessary but may be performed to confirm the diagnosis or exclude encephalitis if there are atypical features.</p>
</div>
</div>
<h3>If Suspecting Hereditary Ataxia</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Suspected Condition</th>
<th>First-Line Tests</th>
<th>Second-Line Tests</th>
<th>Key Findings</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Friedreich Ataxia</strong></td>
<td>Genetic testing for FXN gene GAA repeat expansion</td>
<td>Echocardiogram; glucose tolerance test; nerve conduction studies</td>
<td>Homozygous GAA expansion (>66 repeats); cardiomyopathy in most; sensory axonal neuropathy</td>
</tr>
<tr>
<td><strong>Ataxia-Telangiectasia</strong></td>
<td>Serum alpha-fetoprotein (elevated); immunoglobulin levels (low IgA, IgG)</td>
<td>ATM gene sequencing; chromosomal radiosensitivity testing</td>
<td>Alpha-fetoprotein persistently elevated (95%); low IgA (70%); lymphopenia</td>
</tr>
<tr>
<td><strong>Ataxia with Oculomotor Apraxia Type 1</strong></td>
<td>Serum albumin (low); cholesterol (elevated)</td>
<td>APTX gene testing</td>
<td>Hypoalbuminemia; hypercholesterolemia; sensorimotor neuropathy</td>
</tr>
<tr>
<td><strong>Ataxia with Oculomotor Apraxia Type 2</strong></td>
<td>Serum alpha-fetoprotein (elevated)</td>
<td>SETX gene testing</td>
<td>Elevated alpha-fetoprotein (90%); sensorimotor neuropathy</td>
</tr>
<tr>
<td><strong>Spinocerebellar Ataxias</strong></td>
<td>Targeted genetic testing based on phenotype</td>
<td>SCA gene panel or whole exome sequencing</td>
<td>Variable; autosomal dominant inheritance pattern</td>
</tr>
<tr>
<td><strong>Episodic Ataxia Type 2</strong></td>
<td>CACNA1A gene testing; trial of acetazolamide</td>
<td>EEG (interictal abnormalities may be seen)</td>
<td>CACNA1A mutation; clinical response to acetazolamide is diagnostic clue</td>
</tr>
</tbody>
</table>
</div>
<h3>If Suspecting Metabolic Disorder</h3>
<div class=”columns”>
<div class=”column”>
<h4>Initial Metabolic Screen</h4>
<ul>
<li><strong>Blood gas:</strong> Metabolic acidosis</li>
<li><strong>Ammonia:</strong> Elevated in urea cycle disorders</li>
<li><strong>Lactate:</strong> Elevated in mitochondrial disorders, pyruvate metabolism defects</li>
<li><strong>Plasma amino acids:</strong> Maple syrup urine disease, other aminoacidopathies</li>
<li><strong>Urine organic acids:</strong> Organic acidemias</li>
<li><strong>Acylcarnitine profile:</strong> Fatty acid oxidation defects</li>
</ul>
</div>
<div class=”column”>
<h4>Specific Tests</h4>
<ul>
<li><strong>Very long chain fatty acids:</strong> Adrenoleukodystrophy, peroxisomal disorders</li>
<li><strong>Vitamin E level:</strong> Ataxia with vitamin E deficiency</li>
<li><strong>Ceruloplasmin and 24-hour urine copper:</strong> Wilson disease</li>
<li><strong>Lysosomal enzyme panel:</strong> Storage disorders</li>
<li><strong>Transferrin isoelectric focusing:</strong> Congenital disorders of glycosylation</li>
<li><strong>CSF lactate:</strong> Mitochondrial disorders (if serum lactate elevated)</li>
</ul>
</div>
</div>
<h2>Neuroimaging Findings in Pediatric Ataxia</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Condition</th>
<th>MRI Findings</th>
<th>Key Features</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Acute Cerebellar Ataxia</strong></td>
<td>Often normal; may show subtle cerebellar signal change</td>
<td>Normal MRI supports diagnosis if clinical picture fits</td>
</tr>
<tr>
<td><strong>Acute Cerebellitis</strong></td>
<td>Cerebellar swelling, increased T2 signal, possible hydrocephalus</td>
<td>More severe than acute cerebellar ataxia; may need neurosurgical involvement</td>
</tr>
<tr>
<td><strong>ADEM</strong></td>
<td>Multifocal T2/FLAIR hyperintense lesions in white matter; may enhance</td>
<td>Lesions typically larger and more diffuse than in multiple sclerosis</td>
</tr>
<tr>
<td><strong>Medulloblastoma</strong></td>
<td>Midline posterior fossa mass; typically hyperdense on CT; restricted diffusion on MRI</td>
<td>Arises from vermis; often causes hydrocephalus; contrast enhancement</td>
</tr>
<tr>
<td><strong>Pilocytic Astrocytoma</strong></td>
<td>Cystic mass with enhancing nodule; cerebellar hemisphere</td>
<td>Classic “cyst with mural nodule”; excellent prognosis</td>
</tr>
<tr>
<td><strong>Joubert Syndrome</strong></td>
<td>Molar tooth sign on axial imaging</td>
<td>Pathognomonic appearance due to vermian hypoplasia and elongated superior cerebellar peduncles</td>
</tr>
<tr>
<td><strong>Dandy-Walker Malformation</strong></td>
<td>Cystic dilation of fourth ventricle; vermian hypoplasia; elevated torcula</td>
<td>Associated with hydrocephalus in most cases</td>
</tr>
<tr>
<td><strong>Friedreich Ataxia</strong></td>
<td>Cervical spinal cord atrophy; cerebellar atrophy (late); normal initially</td>
<td>Spinal cord atrophy may precede cerebellar changes</td>
</tr>
<tr>
<td><strong>Ataxia-Telangiectasia</strong></td>
<td>Progressive cerebellar atrophy (vermis > hemispheres)</td>
<td>May be normal early in disease; atrophy develops over time</td>
</tr>
</tbody>
</table>
</div>
<h2>Additional Investigations</h2>
<h3>Electrodiagnostic Studies</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Test</th>
<th>When to Order</th>
<th>What It Shows</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Nerve Conduction Studies/EMG</strong></td>
<td>Suspected sensory ataxia; Friedreich ataxia; peripheral neuropathy</td>
<td>Sensory axonal neuropathy in Friedreich ataxia; demyelinating pattern in Guillain-Barré syndrome</td>
</tr>
<tr>
<td><strong>EEG</strong></td>
<td>Suspected seizures; episodic ataxia; encephalopathy</td>
<td>Epileptiform activity; encephalopathic pattern; may show interictal abnormalities in episodic ataxia</td>
</tr>
<tr>
<td><strong>Visual Evoked Potentials</strong></td>
<td>Suspected multiple sclerosis; optic pathway involvement</td>
<td>Delayed latency suggests demyelination</td>
</tr>
<tr>
<td><strong>Somatosensory Evoked Potentials</strong></td>
<td>Assessing dorsal column function; Friedreich ataxia</td>
<td>Abnormal in sensory ataxias; absent in Friedreich ataxia</td>
</tr>
</tbody>
</table>
</div>
<h3>Cardiac Evaluation</h3>
<div class=”callout-box info-box”>
<div class=”callout-icon”><i class=”fa fa-info-circle”></i></div>
<div class=”callout-content”>
<h4>When to Order Echocardiogram</h4>
<ul>
<li><strong>Suspected Friedreich ataxia:</strong> Hypertrophic cardiomyopathy present in majority of patients; may cause arrhythmias and heart failure</li>
<li><strong>Unexplained progressive ataxia:</strong> Cardiac involvement may suggest specific diagnoses</li>
<li><strong>Mitochondrial disorders:</strong> Often have cardiac involvement</li>
</ul>
<p>Also consider ECG for arrhythmia screening in hereditary ataxias.</p>
</div>
</div>
<div class=”section-divider”>
<div class=”section-divider-icon”><i class=”fa fa-flask”></i></div>
</div>
<h2>Empiric Treatment Trials as Diagnostic Tools</h2>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Therapeutic Trials in Episodic Ataxia</h4>
<p>In children with episodic ataxia and a clinical picture consistent with episodic ataxia type 2, a trial of <strong>acetazolamide</strong> can be both therapeutic and diagnostic:</p>
<ul>
<li><strong>Dose:</strong> Start at 5 mg/kg/day divided twice daily; may increase to 10-20 mg/kg/day</li>
<li><strong>Response:</strong> Dramatic reduction in episode frequency and severity suggests episodic ataxia type 2</li>
<li><strong>Side effects:</strong> Paresthesias, fatigue, nephrolithiasis; monitor electrolytes</li>
<li><strong>Confirmation:</strong> Positive response supports diagnosis; genetic testing can confirm</li>
</ul>
</div>
</div>
<h2>Investigation Algorithm Summary</h2>
<div class=”highlight-box”>
<p><strong>Acute Ataxia Investigation Pathway:</strong></p>
<ol>
<li><strong>All patients:</strong> Blood glucose, electrolytes, toxicology screen, anticonvulsant levels (if applicable)</li>
<li><strong>If any red flags:</strong> Urgent MRI brain (or CT if MRI not available)</li>
<li><strong>If opsoclonus present:</strong> Urine catecholamines, imaging for neuroblastoma</li>
<li><strong>If febrile with encephalopathy:</strong> Lumbar puncture (after imaging), viral studies</li>
<li><strong>If well-appearing, post-viral, MRI normal:</strong> Diagnosis of acute cerebellar ataxia; supportive care</li>
</ol>
</div>
<div class=”highlight-box”>
<p><strong>Chronic Progressive Ataxia Investigation Pathway:</strong></p>
<ol>
<li><strong>All patients:</strong> MRI brain and spine with contrast</li>
<li><strong>If MRI shows tumor:</strong> Refer to neurosurgery/oncology</li>
<li><strong>If MRI normal or shows atrophy:</strong> Alpha-fetoprotein, vitamin E, immunoglobulins</li>
<li><strong>Based on phenotype:</strong> Targeted genetic testing (Friedreich ataxia, ataxia-telangiectasia, and others)</li>
<li><strong>If diagnosis elusive:</strong> Comprehensive ataxia gene panel or whole exome sequencing</li>
<li><strong>Consider metabolic workup:</strong> If acute-on-chronic pattern or developmental regression</li>
</ol>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 7: CLINICAL DECISION-MAKING ==================== –>
<div class=”task-content” id=”task7-content”>
<div class=”task-header”>
<h1 class=”task-title”>7. Clinical Decision-Making</h1>
<p class=”task-subtitle”>Practical algorithms and decision pathways for pediatric ataxia</p>
</div>
<div class=”task-body”>
<p>Clinical decision-making in pediatric ataxia requires rapid triage to identify emergencies, followed by systematic evaluation guided by the temporal profile and associated features. This section provides practical algorithms for the bedside clinician.</p>
<h2>Step 1: Is This Urgent?</h2>
<p>The first priority is identifying children who need immediate intervention.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Scenario</th>
<th>Urgency Level</th>
<th>Immediate Action</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Altered mental status (GCS <15) with ataxia</strong></td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>ABCs; blood glucose; toxicology screen; urgent CT head; consider intubation if GCS ≤8</td>
</tr>
<tr>
<td><strong>Signs of raised intracranial pressure</strong> (headache, vomiting, papilledema, bulging fontanelle, bradycardia with hypertension)</td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>Elevate head of bed; urgent CT/MRI; neurosurgery consultation; do NOT perform lumbar puncture</td>
</tr>
<tr>
<td><strong>Rapidly progressive neurological deterioration</strong></td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>Urgent neuroimaging; consider stroke, hemorrhage, or herniation; neurology/neurosurgery consultation</td>
</tr>
<tr>
<td><strong>Suspected significant toxic ingestion</strong></td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>Poison control; supportive care; consider activated charcoal if within 1 hour; specific antidotes if available</td>
</tr>
<tr>
<td><strong>Fever with meningismus and ataxia</strong></td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>Blood cultures; empiric antibiotics; CT before lumbar puncture if focal signs; urgent infectious disease consultation</td>
</tr>
<tr>
<td><strong>Opsoclonus-myoclonus identified</strong></td>
<td style=”color: #ff9800;”><strong>URGENT</strong></td>
<td>Admit for tumor workup; urine catecholamines; chest/abdomen/pelvis imaging within 24-48 hours</td>
</tr>
<tr>
<td><strong>Progressive ataxia over days to weeks</strong></td>
<td style=”color: #ff9800;”><strong>URGENT</strong></td>
<td>MRI brain with contrast within 24-48 hours; neurology consultation</td>
</tr>
<tr>
<td><strong>New ataxia in child on anticonvulsants</strong></td>
<td style=”color: #ff9800;”><strong>URGENT</strong></td>
<td>Check drug levels immediately; hold medication if toxic level suspected; supportive care</td>
</tr>
<tr>
<td><strong>Well-appearing child, acute ataxia, clear viral prodrome, no red flags</strong></td>
<td style=”color: #2e7d32;”><strong>SEMI-URGENT</strong></td>
<td>MRI brain to exclude structural cause; if normal, likely acute cerebellar ataxia; outpatient follow-up acceptable if stable</td>
</tr>
<tr>
<td><strong>Chronic stable ataxia, developmental concern</strong></td>
<td style=”color: #2e7d32;”><strong>ROUTINE</strong></td>
<td>Outpatient neurology referral; elective MRI; developmental assessment</td>
</tr>
</tbody>
</table>
</div>
<h2>Step 2: Classify by Temporal Profile</h2>
<div class=”grid-3″>
<div class=”grid-item”>
<h3>Acute Onset (<72 hours)</h3>
<p>Proceed to <strong>Algorithm A</strong></p>
<p>Key question: Is this intoxication, infection, or structural lesion?</p>
</div>
<div class=”grid-item”>
<h3>Episodic/Recurrent</h3>
<p>Proceed to <strong>Algorithm B</strong></p>
<p>Key question: What is the pattern and what are the triggers?</p>
</div>
<div class=”grid-item”>
<h3>Chronic (Progressive or Static)</h3>
<p>Proceed to <strong>Algorithm C</strong></p>
<p>Key question: Is this progressive or has it been stable since early life?</p>
</div>
</div>
<h2>Step 3: Follow the Appropriate Algorithm</h2>
<h3>Algorithm A: Acute Ataxia</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Scenario</th>
<th>Most Likely Diagnosis</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td>Altered mental status + ataxia + access to medications</td>
<td>Drug intoxication</td>
<td>Toxicology screen; supportive care; antidote if applicable; observe until mental status normalizes</td>
</tr>
<tr>
<td>Child on anticonvulsants + nystagmus + ataxia</td>
<td>Anticonvulsant toxicity</td>
<td>Check drug levels; hold medication; supportive care; adjust dose once levels known</td>
</tr>
<tr>
<td>Viral prodrome 1-3 weeks ago + well-appearing + truncal ataxia + age 2-4 years</td>
<td>Acute cerebellar ataxia</td>
<td>MRI to exclude structural cause; if normal, supportive care; expect recovery in weeks to months</td>
</tr>
<tr>
<td>Fever + headache + ataxia + encephalopathy</td>
<td>Encephalitis or ADEM</td>
<td>MRI; lumbar puncture; empiric acyclovir; high-dose corticosteroids if ADEM suspected</td>
</tr>
<tr>
<td>Opsoclonus + myoclonus + ataxia + irritability</td>
<td>Opsoclonus-myoclonus-ataxia syndrome</td>
<td>Urgent neuroblastoma screening; immunotherapy (corticosteroids, IVIG); oncology consultation</td>
</tr>
<tr>
<td>Sudden onset + focal deficits + risk factors (cardiac disease, sickle cell)</td>
<td>Posterior fossa stroke</td>
<td>Urgent MRI/MRA; neurology consultation; consider thrombolysis if within window; treat underlying cause</td>
</tr>
<tr>
<td>Morning headache + vomiting + progressive ataxia + papilledema</td>
<td>Posterior fossa tumor with hydrocephalus</td>
<td>Urgent MRI; neurosurgery consultation; may need emergent ventricular drainage</td>
</tr>
</tbody>
</table>
</div>
<h3>Algorithm B: Episodic Ataxia</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Scenario</th>
<th>Most Likely Diagnosis</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brief episodes (seconds to minutes) + startle trigger + myokymia</td>
<td>Episodic ataxia type 1</td>
<td>KCNA1 gene testing; trial of carbamazepine or phenytoin; avoid triggers</td>
</tr>
<tr>
<td>Episodes lasting hours + stress/exercise trigger + interictal nystagmus</td>
<td>Episodic ataxia type 2</td>
<td>Trial of acetazolamide; CACNA1A gene testing; dramatic response supports diagnosis</td>
</tr>
<tr>
<td>Episodes with headache + visual aura + family history of migraine</td>
<td>Migraine with brainstem aura</td>
<td>MRI (first episode); migraine prophylaxis; acute treatment with triptans (if age appropriate) or NSAIDs</td>
</tr>
<tr>
<td>Brief vertigo episodes + age 2-6 years + nystagmus during episodes</td>
<td>Benign paroxysmal vertigo of childhood</td>
<td>Reassurance; usually self-limiting; may evolve into typical migraine; consider migraine prophylaxis if frequent</td>
</tr>
<tr>
<td>Episodes triggered by illness or fasting + metabolic derangement</td>
<td>Metabolic disorder</td>
<td>Metabolic workup during acute episode; specific dietary management; avoid fasting</td>
</tr>
</tbody>
</table>
</div>
<h3>Algorithm C: Chronic Ataxia</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Scenario</th>
<th>Most Likely Diagnosis</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td>Progressive ataxia + areflexia + extensor plantars + scoliosis + onset before 25 years</td>
<td>Friedreich ataxia</td>
<td>FXN gene testing; echocardiogram; glucose tolerance test; cardiology follow-up; physical therapy</td>
</tr>
<tr>
<td>Progressive ataxia from infancy + oculomotor apraxia + telangiectasias + recurrent infections</td>
<td>Ataxia-telangiectasia</td>
<td>Alpha-fetoprotein; immunoglobulin levels; ATM gene testing; cancer surveillance; avoid radiation</td>
</tr>
<tr>
<td>Progressive ataxia + affected parent + variable phenotype</td>
<td>Spinocerebellar ataxia</td>
<td>SCA gene panel; genetic counseling; supportive care; screen for specific complications based on SCA type</td>
</tr>
<tr>
<td>Static ataxia since infancy + hypotonia + developmental delay + molar tooth sign on MRI</td>
<td>Joubert syndrome</td>
<td>Joubert gene panel; renal ultrasound; ophthalmologic evaluation; developmental support</td>
</tr>
<tr>
<td>Static ataxia + history of prematurity or perinatal insult</td>
<td>Ataxic cerebral palsy</td>
<td>MRI (may show periventricular leukomalacia or cerebellar injury); physical/occupational therapy; developmental support</td>
</tr>
</tbody>
</table>
</div>
<h2>”What Do I Do If…” Decision Reference</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Situation</th>
<th>Immediate Action</th>
<th>Next Step</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>MRI shows posterior fossa mass</strong></td>
<td>Assess for hydrocephalus; neurosurgery consultation</td>
<td>Staging workup; surgical planning; multidisciplinary oncology discussion</td>
</tr>
<tr>
<td><strong>MRI normal in acute ataxia</strong></td>
<td>Reassess for toxic ingestion; confirm no red flags</td>
<td>If consistent with acute cerebellar ataxia, supportive care and follow-up; if atypical, consider lumbar puncture</td>
</tr>
<tr>
<td><strong>Phenytoin level is toxic</strong></td>
<td>Hold phenytoin; supportive care</td>
<td>Recheck level; restart at lower dose when level therapeutic; consider alternative anticonvulsant</td>
</tr>
<tr>
<td><strong>Child has opsoclonus but tumor workup is negative</strong></td>
<td>Repeat imaging in 3-6 months; start immunotherapy</td>
<td>Consider MIBG scan if not done; some tumors are occult; continue surveillance</td>
</tr>
<tr>
<td><strong>Alpha-fetoprotein is elevated</strong></td>
<td>Consider ataxia-telangiectasia or ataxia with oculomotor apraxia type 2</td>
<td>Immunoglobulin levels; genetic testing for ATM or SETX genes</td>
</tr>
<tr>
<td><strong>Child with acute cerebellar ataxia is not improving at 1 week</strong></td>
<td>Reassess for red flags; consider repeat imaging</td>
<td>Most improve by 2-4 weeks; if worsening, reconsider diagnosis; lumbar puncture if not done</td>
</tr>
<tr>
<td><strong>Adolescent has inconsistent examination findings</strong></td>
<td>Exclude organic causes thoroughly; explore psychosocial stressors</td>
<td>If functional/conversion disorder likely, supportive approach; psychology/psychiatry referral; avoid iatrogenic harm</td>
</tr>
<tr>
<td><strong>Family history suggests dominant inheritance</strong></td>
<td>Detailed three-generation pedigree; examine parents</td>
<td>Consider spinocerebellar ataxia gene panel; genetic counseling for family</td>
</tr>
<tr>
<td><strong>Progressive ataxia with cardiomyopathy</strong></td>
<td>Suspect Friedreich ataxia; urgent echocardiogram</td>
<td>FXN gene testing; cardiology follow-up for arrhythmia screening and heart failure management</td>
</tr>
<tr>
<td><strong>Episodic ataxia responds dramatically to acetazolamide</strong></td>
<td>Continue acetazolamide; monitor electrolytes</td>
<td>CACNA1A gene testing for confirmation; genetic counseling; continue prophylaxis</td>
</tr>
</tbody>
</table>
</div>
<h2>When to Involve Subspecialists</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h4>Pediatric Neurology</h4>
<ul>
<li>All cases of progressive ataxia</li>
<li>Acute ataxia not clearly explained by intoxication or post-infectious cause</li>
<li>Episodic ataxia requiring diagnosis and management</li>
<li>Suspected hereditary ataxia</li>
<li>Ataxia with seizures or other neurological features</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Pediatric Neurosurgery</h4>
<ul>
<li>Posterior fossa mass lesion</li>
<li>Hydrocephalus requiring intervention</li>
<li>Cerebellar hemorrhage or stroke with mass effect</li>
<li>Chiari malformation with symptoms</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Pediatric Oncology</h4>
<ul>
<li>Posterior fossa tumor</li>
<li>Opsoclonus-myoclonus-ataxia syndrome (even if tumor not yet found)</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Medical Genetics</h4>
<ul>
<li>Suspected hereditary ataxia</li>
<li>Consanguineous family</li>
<li>Multiple affected family members</li>
<li>Congenital malformations with ataxia</li>
</ul>
</div>
</div>
<h2>Troubleshooting: Ataxia Not Resolving as Expected</h2>
<div class=”callout-box takeaway-box”>
<div class=”callout-icon”><i class=”fa fa-check-square-o”></i></div>
<div class=”callout-content”>
<h4>Ask These Questions</h4>
<ul>
<li><strong>Is the diagnosis correct?</strong> Reconsider differential; repeat imaging if not recently done</li>
<li><strong>Was something missed on initial workup?</strong> Review MRI carefully; consider additional sequences or spinal imaging</li>
<li><strong>Is there ongoing toxic exposure?</strong> Recheck medication compliance and levels; consider occult ingestion</li>
<li><strong>Are there new symptoms?</strong> Progression suggests incorrect initial diagnosis or evolving condition</li>
<li><strong>Is the timeline appropriate?</strong> Acute cerebellar ataxia may take 1-3 months to resolve; reassure if improving</li>
<li><strong>Should additional testing be done?</strong> Consider lumbar puncture, metabolic workup, or genetic testing if not done</li>
<li><strong>Is this functional/conversion disorder?</strong> Consider if examination inconsistent and organic workup negative</li>
</ul>
</div>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 8: PEARLS AND PITFALLS ==================== –>
<div class=”task-content” id=”task8-content”>
<div class=”task-header”>
<h1 class=”task-title”>8. Clinical Pearls and Pitfalls</h1>
<p class=”task-subtitle”>Practical wisdom for approaching pediatric ataxia</p>
</div>
<div class=”task-body”>
<!– Pearls –>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Must-Know Clinical Pearls</h4>
<div class=”points-list”>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>The “Big Three” of acute pediatric ataxia:</strong> Acute cerebellar ataxia (post-infectious), drug intoxication, and posterior fossa lesions account for the vast majority of cases. Always exclude intoxication and structural lesions before diagnosing acute cerebellar ataxia.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Acute cerebellar ataxia is a diagnosis of exclusion:</strong> It should only be diagnosed after MRI has excluded structural pathology and toxicology has excluded ingestion. A well-appearing child with clear viral prodrome and normal MRI has an excellent prognosis.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Always check the medicine cabinet:</strong> Toddlers are curious and medications are accessible. Anticonvulsants, benzodiazepines, and antihistamines are common culprits. Check drug levels for any child on anticonvulsants presenting with ataxia.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Opsoclonus demands a tumor search:</strong> The combination of opsoclonus (chaotic eye movements), myoclonus, and ataxia with irritability requires urgent neuroblastoma screening, even if the child appears well. Up to 50% have an occult tumor.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Romberg helps localize:</strong> A positive Romberg test (falls only with eyes closed) indicates sensory ataxia, not cerebellar ataxia. Cerebellar ataxia is present with eyes both open and closed.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Areflexia with extensor plantars equals Friedreich:</strong> This combination (absent reflexes plus Babinski sign) is highly characteristic of Friedreich ataxia and should prompt genetic testing. Don’t forget the echocardiogram—cardiomyopathy is common and treatable.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Alpha-fetoprotein is a useful screening test:</strong> Elevated alpha-fetoprotein in a child with progressive ataxia suggests ataxia-telangiectasia or ataxia with oculomotor apraxia type 2. It’s inexpensive and widely available.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Acetazolamide response is diagnostic:</strong> Dramatic improvement with acetazolamide strongly supports episodic ataxia type 2. A therapeutic trial can be both diagnostic and therapeutic while awaiting genetic confirmation.</span>
</div>
</div>
</div>
</div>
<!– Pitfalls –>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Critical Pitfalls to Avoid</h4>
<div class=”points-list”>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Diagnosing acute cerebellar ataxia without imaging:</strong> Never assume benign post-infectious ataxia without first excluding a posterior fossa tumor or other structural lesion with MRI. A “normal examination” does not exclude serious pathology.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Performing lumbar puncture before imaging:</strong> In a child with ataxia and any signs of raised intracranial pressure, lumbar puncture can precipitate herniation. Always image first if there is any concern for mass lesion or hydrocephalus.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Missing opsoclonus:</strong> Opsoclonus can be subtle and intermittent. Specifically look for chaotic, multidirectional eye movements in any young child with ataxia. Missing this finding delays neuroblastoma diagnosis.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Attributing ataxia to “viral syndrome” in an older child:</strong> Acute cerebellar ataxia is most common in children aged 2-4 years. In older children and adolescents, be more suspicious of other causes including tumors, hereditary ataxias, and demyelinating disease.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Forgetting to ask about medications and ingestions:</strong> Drug toxicity is one of the most common and most treatable causes of acute ataxia. Always obtain a detailed medication history and ask about access to household medications.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Missing chronic phenytoin toxicity:</strong> Chronic phenytoin exposure can cause permanent cerebellar damage even at “therapeutic” levels. A child on phenytoin with progressive ataxia may have irreversible Purkinje cell loss.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Overlooking telangiectasias:</strong> Conjunctival and auricular telangiectasias in ataxia-telangiectasia may not appear until age 3-6 years. A young child with progressive ataxia and recurrent infections should be tested for ataxia-telangiectasia even without visible telangiectasias.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Dismissing functional ataxia without thorough workup:</strong> While conversion disorder is a real diagnosis, it should only be made after organic causes have been excluded. An adolescent with “inconsistent” findings may still have organic disease.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Forgetting cardiac screening in hereditary ataxias:</strong> Cardiomyopathy in Friedreich ataxia is a major cause of morbidity and mortality. Every child diagnosed with Friedreich ataxia needs an echocardiogram and ongoing cardiac surveillance.</span>
</div>
</div>
</div>
</div>
<!– Key Takeaways –>
<div class=”callout-box takeaway-box”>
<div class=”callout-icon”><i class=”fa fa-check-square-o”></i></div>
<div class=”callout-content”>
<h4>Key Takeaways</h4>
<ul>
<li><strong>Temporal classification is the foundation:</strong> Determine whether ataxia is acute, episodic, or chronic progressive/static before proceeding with workup.</li>
<li><strong>Acute ataxia requires urgent imaging:</strong> MRI brain (or CT if MRI unavailable) should be performed to exclude posterior fossa tumor, stroke, or hemorrhage before diagnosing benign causes.</li>
<li><strong>Always exclude drug intoxication:</strong> Obtain toxicology screen and anticonvulsant levels in all children with acute ataxia. This is treatable and common.</li>
<li><strong>Opsoclonus-myoclonus-ataxia syndrome is a paraneoplastic emergency:</strong> Requires urgent tumor screening for neuroblastoma; treatment with immunotherapy should not await tumor identification.</li>
<li><strong>Acute cerebellar ataxia has an excellent prognosis:</strong> When properly diagnosed (after excluding other causes), most children recover completely within weeks to months.</li>
<li><strong>Progressive ataxia always warrants thorough investigation:</strong> Consider posterior fossa tumor, Friedreich ataxia, ataxia-telangiectasia, and other hereditary causes.</li>
<li><strong>Hereditary ataxias have systemic manifestations:</strong> Screen for cardiomyopathy (Friedreich), immunodeficiency (ataxia-telangiectasia), and other organ involvement based on the suspected diagnosis.</li>
<li><strong>Family history and genetic testing are essential:</strong> Many ataxias are hereditary; a three-generation pedigree and appropriate genetic testing guide diagnosis and genetic counseling.</li>
<li><strong>Alpha-fetoprotein is a useful and inexpensive screening test:</strong> Elevated in ataxia-telangiectasia and ataxia with oculomotor apraxia type 2.</li>
<li><strong>Episodic ataxias often respond to treatment:</strong> Acetazolamide for episodic ataxia type 2 and migraine prophylaxis for migraine-associated ataxia can dramatically improve quality of life.</li>
</ul>
</div>
</div>
<!– Quick Reference Algorithm –>
<h2>Quick Reference Algorithm</h2>
<div class=”highlight-box”>
<p><strong>Systematic Approach to Pediatric Ataxia:</strong></p>
<ol>
<li><strong>Assess urgency:</strong> Check for altered mental status, signs of raised intracranial pressure, and vital sign instability. Stabilize if emergent.</li>
<li><strong>Classify by time course:</strong> Acute (<72 hours), episodic/recurrent, or chronic (progressive vs static).</li>
<li><strong>For acute ataxia:</strong> Obtain toxicology screen and drug levels; perform MRI brain to exclude structural lesion.</li>
<li><strong>Look for specific patterns:</strong> Opsoclonus (tumor search), areflexia with Babinski (Friedreich), telangiectasias (ataxia-telangiectasia), episodic pattern (channelopathy or migraine).</li>
<li><strong>Targeted investigations:</strong> Based on clinical suspicion—genetic testing for hereditary causes, metabolic workup if triggered by illness/fasting, tumor screening if paraneoplastic suspected.</li>
<li><strong>Involve subspecialists early:</strong> Neurology for all progressive ataxia; neurosurgery if mass lesion; genetics for hereditary ataxia; oncology if tumor suspected.</li>
<li><strong>Provide supportive care and follow-up:</strong> Physical therapy, developmental support, and regular monitoring for complications (cardiac, orthopedic, developmental).</li>
</ol>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
</div>
</div>
</div>
</body>
</html>
<div class=”task-content” id=”task7-content”>
<div class=”task-header”>
<h1 class=”task-title”>7. Clinical Decision-Making</h1>
<p class=”task-subtitle”>Practical algorithms and decision pathways for pediatric ataxia</p>
</div>
<div class=”task-body”>
<p>Clinical decision-making in pediatric ataxia requires rapid triage to identify emergencies, followed by systematic evaluation guided by the temporal profile and associated features. This section provides practical algorithms for the bedside clinician.</p>
<h2>Step 1: Is This Urgent?</h2>
<p>The first priority is identifying children who need immediate intervention.</p>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Scenario</th>
<th>Urgency Level</th>
<th>Immediate Action</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Altered mental status (GCS <15) with ataxia</strong></td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>ABCs; blood glucose; toxicology screen; urgent CT head; consider intubation if GCS ≤8</td>
</tr>
<tr>
<td><strong>Signs of raised intracranial pressure</strong> (headache, vomiting, papilledema, bulging fontanelle, bradycardia with hypertension)</td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>Elevate head of bed; urgent CT/MRI; neurosurgery consultation; do NOT perform lumbar puncture</td>
</tr>
<tr>
<td><strong>Rapidly progressive neurological deterioration</strong></td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>Urgent neuroimaging; consider stroke, hemorrhage, or herniation; neurology/neurosurgery consultation</td>
</tr>
<tr>
<td><strong>Suspected significant toxic ingestion</strong></td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>Poison control; supportive care; consider activated charcoal if within 1 hour; specific antidotes if available</td>
</tr>
<tr>
<td><strong>Fever with meningismus and ataxia</strong></td>
<td style=”color: #d32f2f;”><strong>EMERGENT</strong></td>
<td>Blood cultures; empiric antibiotics; CT before lumbar puncture if focal signs; urgent infectious disease consultation</td>
</tr>
<tr>
<td><strong>Opsoclonus-myoclonus identified</strong></td>
<td style=”color: #ff9800;”><strong>URGENT</strong></td>
<td>Admit for tumor workup; urine catecholamines; chest/abdomen/pelvis imaging within 24-48 hours</td>
</tr>
<tr>
<td><strong>Progressive ataxia over days to weeks</strong></td>
<td style=”color: #ff9800;”><strong>URGENT</strong></td>
<td>MRI brain with contrast within 24-48 hours; neurology consultation</td>
</tr>
<tr>
<td><strong>New ataxia in child on anticonvulsants</strong></td>
<td style=”color: #ff9800;”><strong>URGENT</strong></td>
<td>Check drug levels immediately; hold medication if toxic level suspected; supportive care</td>
</tr>
<tr>
<td><strong>Well-appearing child, acute ataxia, clear viral prodrome, no red flags</strong></td>
<td style=”color: #2e7d32;”><strong>SEMI-URGENT</strong></td>
<td>MRI brain to exclude structural cause; if normal, likely acute cerebellar ataxia; outpatient follow-up acceptable if stable</td>
</tr>
<tr>
<td><strong>Chronic stable ataxia, developmental concern</strong></td>
<td style=”color: #2e7d32;”><strong>ROUTINE</strong></td>
<td>Outpatient neurology referral; elective MRI; developmental assessment</td>
</tr>
</tbody>
</table>
</div>
<h2>Step 2: Classify by Temporal Profile</h2>
<div class=”grid-3″>
<div class=”grid-item”>
<h3>Acute Onset (<72 hours)</h3>
<p>Proceed to <strong>Algorithm A</strong></p>
<p>Key question: Is this intoxication, infection, or structural lesion?</p>
</div>
<div class=”grid-item”>
<h3>Episodic/Recurrent</h3>
<p>Proceed to <strong>Algorithm B</strong></p>
<p>Key question: What is the pattern and what are the triggers?</p>
</div>
<div class=”grid-item”>
<h3>Chronic (Progressive or Static)</h3>
<p>Proceed to <strong>Algorithm C</strong></p>
<p>Key question: Is this progressive or has it been stable since early life?</p>
</div>
</div>
<h2>Step 3: Follow the Appropriate Algorithm</h2>
<h3>Algorithm A: Acute Ataxia</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Scenario</th>
<th>Most Likely Diagnosis</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td>Altered mental status + ataxia + access to medications</td>
<td>Drug intoxication</td>
<td>Toxicology screen; supportive care; antidote if applicable; observe until mental status normalizes</td>
</tr>
<tr>
<td>Child on anticonvulsants + nystagmus + ataxia</td>
<td>Anticonvulsant toxicity</td>
<td>Check drug levels; hold medication; supportive care; adjust dose once levels known</td>
</tr>
<tr>
<td>Viral prodrome 1-3 weeks ago + well-appearing + truncal ataxia + age 2-4 years</td>
<td>Acute cerebellar ataxia</td>
<td>MRI to exclude structural cause; if normal, supportive care; expect recovery in weeks to months</td>
</tr>
<tr>
<td>Fever + headache + ataxia + encephalopathy</td>
<td>Encephalitis or ADEM</td>
<td>MRI; lumbar puncture; empiric acyclovir; high-dose corticosteroids if ADEM suspected</td>
</tr>
<tr>
<td>Opsoclonus + myoclonus + ataxia + irritability</td>
<td>Opsoclonus-myoclonus-ataxia syndrome</td>
<td>Urgent neuroblastoma screening; immunotherapy (corticosteroids, IVIG); oncology consultation</td>
</tr>
<tr>
<td>Sudden onset + focal deficits + risk factors (cardiac disease, sickle cell)</td>
<td>Posterior fossa stroke</td>
<td>Urgent MRI/MRA; neurology consultation; consider thrombolysis if within window; treat underlying cause</td>
</tr>
<tr>
<td>Morning headache + vomiting + progressive ataxia + papilledema</td>
<td>Posterior fossa tumor with hydrocephalus</td>
<td>Urgent MRI; neurosurgery consultation; may need emergent ventricular drainage</td>
</tr>
</tbody>
</table>
</div>
<h3>Algorithm B: Episodic Ataxia</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Scenario</th>
<th>Most Likely Diagnosis</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brief episodes (seconds to minutes) + startle trigger + myokymia</td>
<td>Episodic ataxia type 1</td>
<td>KCNA1 gene testing; trial of carbamazepine or phenytoin; avoid triggers</td>
</tr>
<tr>
<td>Episodes lasting hours + stress/exercise trigger + interictal nystagmus</td>
<td>Episodic ataxia type 2</td>
<td>Trial of acetazolamide; CACNA1A gene testing; dramatic response supports diagnosis</td>
</tr>
<tr>
<td>Episodes with headache + visual aura + family history of migraine</td>
<td>Migraine with brainstem aura</td>
<td>MRI (first episode); migraine prophylaxis; acute treatment with triptans (if age appropriate) or NSAIDs</td>
</tr>
<tr>
<td>Brief vertigo episodes + age 2-6 years + nystagmus during episodes</td>
<td>Benign paroxysmal vertigo of childhood</td>
<td>Reassurance; usually self-limiting; may evolve into typical migraine; consider migraine prophylaxis if frequent</td>
</tr>
<tr>
<td>Episodes triggered by illness or fasting + metabolic derangement</td>
<td>Metabolic disorder</td>
<td>Metabolic workup during acute episode; specific dietary management; avoid fasting</td>
</tr>
</tbody>
</table>
</div>
<h3>Algorithm C: Chronic Ataxia</h3>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Scenario</th>
<th>Most Likely Diagnosis</th>
<th>Action</th>
</tr>
</thead>
<tbody>
<tr>
<td>Progressive ataxia + areflexia + extensor plantars + scoliosis + onset before 25 years</td>
<td>Friedreich ataxia</td>
<td>FXN gene testing; echocardiogram; glucose tolerance test; cardiology follow-up; physical therapy</td>
</tr>
<tr>
<td>Progressive ataxia from infancy + oculomotor apraxia + telangiectasias + recurrent infections</td>
<td>Ataxia-telangiectasia</td>
<td>Alpha-fetoprotein; immunoglobulin levels; ATM gene testing; cancer surveillance; avoid radiation</td>
</tr>
<tr>
<td>Progressive ataxia + affected parent + variable phenotype</td>
<td>Spinocerebellar ataxia</td>
<td>SCA gene panel; genetic counseling; supportive care; screen for specific complications based on SCA type</td>
</tr>
<tr>
<td>Static ataxia since infancy + hypotonia + developmental delay + molar tooth sign on MRI</td>
<td>Joubert syndrome</td>
<td>Joubert gene panel; renal ultrasound; ophthalmologic evaluation; developmental support</td>
</tr>
<tr>
<td>Static ataxia + history of prematurity or perinatal insult</td>
<td>Ataxic cerebral palsy</td>
<td>MRI (may show periventricular leukomalacia or cerebellar injury); physical/occupational therapy; developmental support</td>
</tr>
</tbody>
</table>
</div>
<h2>”What Do I Do If…” Decision Reference</h2>
<div class=”table-rounded”>
<table>
<thead>
<tr>
<th>Clinical Situation</th>
<th>Immediate Action</th>
<th>Next Step</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>MRI shows posterior fossa mass</strong></td>
<td>Assess for hydrocephalus; neurosurgery consultation</td>
<td>Staging workup; surgical planning; multidisciplinary oncology discussion</td>
</tr>
<tr>
<td><strong>MRI normal in acute ataxia</strong></td>
<td>Reassess for toxic ingestion; confirm no red flags</td>
<td>If consistent with acute cerebellar ataxia, supportive care and follow-up; if atypical, consider lumbar puncture</td>
</tr>
<tr>
<td><strong>Phenytoin level is toxic</strong></td>
<td>Hold phenytoin; supportive care</td>
<td>Recheck level; restart at lower dose when level therapeutic; consider alternative anticonvulsant</td>
</tr>
<tr>
<td><strong>Child has opsoclonus but tumor workup is negative</strong></td>
<td>Repeat imaging in 3-6 months; start immunotherapy</td>
<td>Consider MIBG scan if not done; some tumors are occult; continue surveillance</td>
</tr>
<tr>
<td><strong>Alpha-fetoprotein is elevated</strong></td>
<td>Consider ataxia-telangiectasia or ataxia with oculomotor apraxia type 2</td>
<td>Immunoglobulin levels; genetic testing for ATM or SETX genes</td>
</tr>
<tr>
<td><strong>Child with acute cerebellar ataxia is not improving at 1 week</strong></td>
<td>Reassess for red flags; consider repeat imaging</td>
<td>Most improve by 2-4 weeks; if worsening, reconsider diagnosis; lumbar puncture if not done</td>
</tr>
<tr>
<td><strong>Adolescent has inconsistent examination findings</strong></td>
<td>Exclude organic causes thoroughly; explore psychosocial stressors</td>
<td>If functional/conversion disorder likely, supportive approach; psychology/psychiatry referral; avoid iatrogenic harm</td>
</tr>
<tr>
<td><strong>Family history suggests dominant inheritance</strong></td>
<td>Detailed three-generation pedigree; examine parents</td>
<td>Consider spinocerebellar ataxia gene panel; genetic counseling for family</td>
</tr>
<tr>
<td><strong>Progressive ataxia with cardiomyopathy</strong></td>
<td>Suspect Friedreich ataxia; urgent echocardiogram</td>
<td>FXN gene testing; cardiology follow-up for arrhythmia screening and heart failure management</td>
</tr>
<tr>
<td><strong>Episodic ataxia responds dramatically to acetazolamide</strong></td>
<td>Continue acetazolamide; monitor electrolytes</td>
<td>CACNA1A gene testing for confirmation; genetic counseling; continue prophylaxis</td>
</tr>
</tbody>
</table>
</div>
<h2>When to Involve Subspecialists</h2>
<div class=”grid-2″>
<div class=”grid-item”>
<h4>Pediatric Neurology</h4>
<ul>
<li>All cases of progressive ataxia</li>
<li>Acute ataxia not clearly explained by intoxication or post-infectious cause</li>
<li>Episodic ataxia requiring diagnosis and management</li>
<li>Suspected hereditary ataxia</li>
<li>Ataxia with seizures or other neurological features</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Pediatric Neurosurgery</h4>
<ul>
<li>Posterior fossa mass lesion</li>
<li>Hydrocephalus requiring intervention</li>
<li>Cerebellar hemorrhage or stroke with mass effect</li>
<li>Chiari malformation with symptoms</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Pediatric Oncology</h4>
<ul>
<li>Posterior fossa tumor</li>
<li>Opsoclonus-myoclonus-ataxia syndrome (even if tumor not yet found)</li>
</ul>
</div>
<div class=”grid-item”>
<h4>Medical Genetics</h4>
<ul>
<li>Suspected hereditary ataxia</li>
<li>Consanguineous family</li>
<li>Multiple affected family members</li>
<li>Congenital malformations with ataxia</li>
</ul>
</div>
</div>
<h2>Troubleshooting: Ataxia Not Resolving as Expected</h2>
<div class=”callout-box takeaway-box”>
<div class=”callout-icon”><i class=”fa fa-check-square-o”></i></div>
<div class=”callout-content”>
<h4>Ask These Questions</h4>
<ul>
<li><strong>Is the diagnosis correct?</strong> Reconsider differential; repeat imaging if not recently done</li>
<li><strong>Was something missed on initial workup?</strong> Review MRI carefully; consider additional sequences or spinal imaging</li>
<li><strong>Is there ongoing toxic exposure?</strong> Recheck medication compliance and levels; consider occult ingestion</li>
<li><strong>Are there new symptoms?</strong> Progression suggests incorrect initial diagnosis or evolving condition</li>
<li><strong>Is the timeline appropriate?</strong> Acute cerebellar ataxia may take 1-3 months to resolve; reassure if improving</li>
<li><strong>Should additional testing be done?</strong> Consider lumbar puncture, metabolic workup, or genetic testing if not done</li>
<li><strong>Is this functional/conversion disorder?</strong> Consider if examination inconsistent and organic workup negative</li>
</ul>
</div>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
<!– ==================== TASK 8: PEARLS AND PITFALLS ==================== –>
<div class=”task-content” id=”task8-content”>
<div class=”task-header”>
<h1 class=”task-title”>8. Clinical Pearls and Pitfalls</h1>
<p class=”task-subtitle”>Practical wisdom for approaching pediatric ataxia</p>
</div>
<div class=”task-body”>
<!– Pearls –>
<div class=”callout-box tip-box”>
<div class=”callout-icon”><i class=”fa fa-lightbulb-o”></i></div>
<div class=”callout-content”>
<h4>Must-Know Clinical Pearls</h4>
<div class=”points-list”>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>The “Big Three” of acute pediatric ataxia:</strong> Acute cerebellar ataxia (post-infectious), drug intoxication, and posterior fossa lesions account for the vast majority of cases. Always exclude intoxication and structural lesions before diagnosing acute cerebellar ataxia.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Acute cerebellar ataxia is a diagnosis of exclusion:</strong> It should only be diagnosed after MRI has excluded structural pathology and toxicology has excluded ingestion. A well-appearing child with clear viral prodrome and normal MRI has an excellent prognosis.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Always check the medicine cabinet:</strong> Toddlers are curious and medications are accessible. Anticonvulsants, benzodiazepines, and antihistamines are common culprits. Check drug levels for any child on anticonvulsants presenting with ataxia.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Opsoclonus demands a tumor search:</strong> The combination of opsoclonus (chaotic eye movements), myoclonus, and ataxia with irritability requires urgent neuroblastoma screening, even if the child appears well. Up to 50% have an occult tumor.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Romberg helps localize:</strong> A positive Romberg test (falls only with eyes closed) indicates sensory ataxia, not cerebellar ataxia. Cerebellar ataxia is present with eyes both open and closed.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Areflexia with extensor plantars equals Friedreich:</strong> This combination (absent reflexes plus Babinski sign) is highly characteristic of Friedreich ataxia and should prompt genetic testing. Don’t forget the echocardiogram—cardiomyopathy is common and treatable.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Alpha-fetoprotein is a useful screening test:</strong> Elevated alpha-fetoprotein in a child with progressive ataxia suggests ataxia-telangiectasia or ataxia with oculomotor apraxia type 2. It’s inexpensive and widely available.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-check-circle” style=”color: #2e7d32;”></i>
<span class=”point-text”><strong>Acetazolamide response is diagnostic:</strong> Dramatic improvement with acetazolamide strongly supports episodic ataxia type 2. A therapeutic trial can be both diagnostic and therapeutic while awaiting genetic confirmation.</span>
</div>
</div>
</div>
</div>
<!– Pitfalls –>
<div class=”callout-box warning-box”>
<div class=”callout-icon”><i class=”fa fa-exclamation-triangle”></i></div>
<div class=”callout-content”>
<h4>Critical Pitfalls to Avoid</h4>
<div class=”points-list”>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Diagnosing acute cerebellar ataxia without imaging:</strong> Never assume benign post-infectious ataxia without first excluding a posterior fossa tumor or other structural lesion with MRI. A “normal examination” does not exclude serious pathology.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Performing lumbar puncture before imaging:</strong> In a child with ataxia and any signs of raised intracranial pressure, lumbar puncture can precipitate herniation. Always image first if there is any concern for mass lesion or hydrocephalus.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Missing opsoclonus:</strong> Opsoclonus can be subtle and intermittent. Specifically look for chaotic, multidirectional eye movements in any young child with ataxia. Missing this finding delays neuroblastoma diagnosis.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Attributing ataxia to “viral syndrome” in an older child:</strong> Acute cerebellar ataxia is most common in children aged 2-4 years. In older children and adolescents, be more suspicious of other causes including tumors, hereditary ataxias, and demyelinating disease.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Forgetting to ask about medications and ingestions:</strong> Drug toxicity is one of the most common and most treatable causes of acute ataxia. Always obtain a detailed medication history and ask about access to household medications.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Missing chronic phenytoin toxicity:</strong> Chronic phenytoin exposure can cause permanent cerebellar damage even at “therapeutic” levels. A child on phenytoin with progressive ataxia may have irreversible Purkinje cell loss.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Overlooking telangiectasias:</strong> Conjunctival and auricular telangiectasias in ataxia-telangiectasia may not appear until age 3-6 years. A young child with progressive ataxia and recurrent infections should be tested for ataxia-telangiectasia even without visible telangiectasias.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Dismissing functional ataxia without thorough workup:</strong> While conversion disorder is a real diagnosis, it should only be made after organic causes have been excluded. An adolescent with “inconsistent” findings may still have organic disease.</span>
</div>
<div class=”point-item”>
<i class=”fa fa-times-circle” style=”color: #d32f2f;”></i>
<span class=”point-text”><strong>Forgetting cardiac screening in hereditary ataxias:</strong> Cardiomyopathy in Friedreich ataxia is a major cause of morbidity and mortality. Every child diagnosed with Friedreich ataxia needs an echocardiogram and ongoing cardiac surveillance.</span>
</div>
</div>
</div>
</div>
<!– Key Takeaways –>
<div class=”callout-box takeaway-box”>
<div class=”callout-icon”><i class=”fa fa-check-square-o”></i></div>
<div class=”callout-content”>
<h4>Key Takeaways</h4>
<ul>
<li><strong>Temporal classification is the foundation:</strong> Determine whether ataxia is acute, episodic, or chronic progressive/static before proceeding with workup.</li>
<li><strong>Acute ataxia requires urgent imaging:</strong> MRI brain (or CT if MRI unavailable) should be performed to exclude posterior fossa tumor, stroke, or hemorrhage before diagnosing benign causes.</li>
<li><strong>Always exclude drug intoxication:</strong> Obtain toxicology screen and anticonvulsant levels in all children with acute ataxia. This is treatable and common.</li>
<li><strong>Opsoclonus-myoclonus-ataxia syndrome is a paraneoplastic emergency:</strong> Requires urgent tumor screening for neuroblastoma; treatment with immunotherapy should not await tumor identification.</li>
<li><strong>Acute cerebellar ataxia has an excellent prognosis:</strong> When properly diagnosed (after excluding other causes), most children recover completely within weeks to months.</li>
<li><strong>Progressive ataxia always warrants thorough investigation:</strong> Consider posterior fossa tumor, Friedreich ataxia, ataxia-telangiectasia, and other hereditary causes.</li>
<li><strong>Hereditary ataxias have systemic manifestations:</strong> Screen for cardiomyopathy (Friedreich), immunodeficiency (ataxia-telangiectasia), and other organ involvement based on the suspected diagnosis.</li>
<li><strong>Family history and genetic testing are essential:</strong> Many ataxias are hereditary; a three-generation pedigree and appropriate genetic testing guide diagnosis and genetic counseling.</li>
<li><strong>Alpha-fetoprotein is a useful and inexpensive screening test:</strong> Elevated in ataxia-telangiectasia and ataxia with oculomotor apraxia type 2.</li>
<li><strong>Episodic ataxias often respond to treatment:</strong> Acetazolamide for episodic ataxia type 2 and migraine prophylaxis for migraine-associated ataxia can dramatically improve quality of life.</li>
</ul>
</div>
</div>
<!– Quick Reference Algorithm –>
<h2>Quick Reference Algorithm</h2>
<div class=”highlight-box”>
<p><strong>Systematic Approach to Pediatric Ataxia:</strong></p>
<ol>
<li><strong>Assess urgency:</strong> Check for altered mental status, signs of raised intracranial pressure, and vital sign instability. Stabilize if emergent.</li>
<li><strong>Classify by time course:</strong> Acute (<72 hours), episodic/recurrent, or chronic (progressive vs static).</li>
<li><strong>For acute ataxia:</strong> Obtain toxicology screen and drug levels; perform MRI brain to exclude structural lesion.</li>
<li><strong>Look for specific patterns:</strong> Opsoclonus (tumor search), areflexia with Babinski (Friedreich), telangiectasias (ataxia-telangiectasia), episodic pattern (channelopathy or migraine).</li>
<li><strong>Targeted investigations:</strong> Based on clinical suspicion—genetic testing for hereditary causes, metabolic workup if triggered by illness/fasting, tumor screening if paraneoplastic suspected.</li>
<li><strong>Involve subspecialists early:</strong> Neurology for all progressive ataxia; neurosurgery if mass lesion; genetics for hereditary ataxia; oncology if tumor suspected.</li>
<li><strong>Provide supportive care and follow-up:</strong> Physical therapy, developmental support, and regular monitoring for complications (cardiac, orthopedic, developmental).</li>
</ol>
</div>
<div class=”content-footer”>
<div class=”copyright”>© Medaptly. All rights reserved.</div>
<div class=”logo”><img src=”https://medaptlytemplates.doo.ee/Medaptly_Logo-removebg-preview.png” alt=”Medaptly Logo”></div>
</div>
</div>
</div>
</div>
</div>
</div>
</body>
</html>